id	sid	tid	token	lemma	pos
ajlm-2104	1	1	abstract	abstract	ADJ
ajlm-2104	1	2	introduction	introduction	NOUN
ajlm-2104	1	3	methods	method	NOUN
ajlm-2104	1	4	results	result	VERB
ajlm-2104	1	5	discussion	discussion	NOUN
ajlm-2104	1	6	acknowledgements	acknowledgement	NOUN
ajlm-2104	1	7	references	reference	NOUN
ajlm-2104	1	8	about	about	ADP
ajlm-2104	1	9	the	the	DET
ajlm-2104	1	10	author(s	author(s	NOUN
ajlm-2104	1	11	)	)	PUNCT
ajlm-2104	1	12	jason	jason	PROPN
ajlm-2104	1	13	van	van	PROPN
ajlm-2104	1	14	rensburg	rensburg	PROPN
ajlm-2104	1	15	department	department	PROPN
ajlm-2104	1	16	of	of	ADP
ajlm-2104	1	17	biomedical	biomedical	ADJ
ajlm-2104	1	18	sciences	science	NOUN
ajlm-2104	1	19	,	,	PUNCT
ajlm-2104	1	20	faculty	faculty	NOUN
ajlm-2104	1	21	of	of	ADP
ajlm-2104	1	22	health	health	NOUN
ajlm-2104	1	23	and	and	CCONJ
ajlm-2104	1	24	wellness	wellness	NOUN
ajlm-2104	1	25	,	,	PUNCT
ajlm-2104	1	26	cape	cape	NOUN
ajlm-2104	1	27	peninsula	peninsula	PROPN
ajlm-2104	1	28	university	university	PROPN
ajlm-2104	1	29	of	of	ADP
ajlm-2104	1	30	technology	technology	NOUN
ajlm-2104	1	31	,	,	PUNCT
ajlm-2104	1	32	cape	cape	NOUN
ajlm-2104	1	33	town	town	NOUN
ajlm-2104	1	34	,	,	PUNCT
ajlm-2104	1	35	south	south	PROPN
ajlm-2104	1	36	africa	africa	PROPN
ajlm-2104	1	37	saarah	saarah	PROPN
ajlm-2104	1	38	davids	davids	PROPN
ajlm-2104	1	39	south	south	PROPN
ajlm-2104	1	40	african	african	PROPN
ajlm-2104	1	41	medical	medical	PROPN
ajlm-2104	1	42	research	research	PROPN
ajlm-2104	1	43	council	council	PROPN
ajlm-2104	1	44	/	/	SYM
ajlm-2104	1	45	cape	cape	PROPN
ajlm-2104	1	46	peninsula	peninsula	PROPN
ajlm-2104	1	47	university	university	PROPN
ajlm-2104	1	48	of	of	ADP
ajlm-2104	1	49	technology	technology	PROPN
ajlm-2104	1	50	cardiometabolic	cardiometabolic	PROPN
ajlm-2104	1	51	health	health	PROPN
ajlm-2104	1	52	research	research	NOUN
ajlm-2104	1	53	unit	unit	NOUN
ajlm-2104	1	54	and	and	CCONJ
ajlm-2104	1	55	biomedical	biomedical	ADJ
ajlm-2104	1	56	sciences	science	NOUN
ajlm-2104	1	57	,	,	PUNCT
ajlm-2104	1	58	faculty	faculty	NOUN
ajlm-2104	1	59	of	of	ADP
ajlm-2104	1	60	health	health	NOUN
ajlm-2104	1	61	and	and	CCONJ
ajlm-2104	1	62	wellness	wellness	NOUN
ajlm-2104	1	63	,	,	PUNCT
ajlm-2104	1	64	cape	cape	NOUN
ajlm-2104	1	65	peninsula	peninsula	PROPN
ajlm-2104	1	66	university	university	PROPN
ajlm-2104	1	67	of	of	ADP
ajlm-2104	1	68	technology	technology	NOUN
ajlm-2104	1	69	,	,	PUNCT
ajlm-2104	1	70	cape	cape	NOUN
ajlm-2104	1	71	town	town	NOUN
ajlm-2104	1	72	,	,	PUNCT
ajlm-2104	1	73	south	south	PROPN
ajlm-2104	1	74	africa	africa	PROPN
ajlm-2104	1	75	carine	carine	PROPN
ajlm-2104	1	76	smuts	smuts	PROPN
ajlm-2104	1	77	department	department	PROPN
ajlm-2104	1	78	of	of	ADP
ajlm-2104	1	79	biomedical	biomedical	ADJ
ajlm-2104	1	80	sciences	science	NOUN
ajlm-2104	1	81	,	,	PUNCT
ajlm-2104	1	82	faculty	faculty	NOUN
ajlm-2104	1	83	of	of	ADP
ajlm-2104	1	84	health	health	NOUN
ajlm-2104	1	85	and	and	CCONJ
ajlm-2104	1	86	wellness	wellness	NOUN
ajlm-2104	1	87	,	,	PUNCT
ajlm-2104	1	88	cape	cape	NOUN
ajlm-2104	1	89	peninsula	peninsula	PROPN
ajlm-2104	1	90	university	university	PROPN
ajlm-2104	1	91	of	of	ADP
ajlm-2104	1	92	technology	technology	NOUN
ajlm-2104	1	93	,	,	PUNCT
ajlm-2104	1	94	cape	cape	NOUN
ajlm-2104	1	95	town	town	NOUN
ajlm-2104	1	96	,	,	PUNCT
ajlm-2104	1	97	south	south	PROPN
ajlm-2104	1	98	africa	africa	PROPN
ajlm-2104	1	99	glenda	glenda	PROPN
ajlm-2104	1	100	m.	m.	PROPN
ajlm-2104	1	101	davison	davison	PROPN
ajlm-2104	1	102	south	south	PROPN
ajlm-2104	1	103	african	african	PROPN
ajlm-2104	1	104	medical	medical	PROPN
ajlm-2104	1	105	research	research	PROPN
ajlm-2104	1	106	council	council	PROPN
ajlm-2104	1	107	/	/	SYM
ajlm-2104	1	108	cape	cape	PROPN
ajlm-2104	1	109	peninsula	peninsula	PROPN
ajlm-2104	1	110	university	university	PROPN
ajlm-2104	1	111	of	of	ADP
ajlm-2104	1	112	technology	technology	PROPN
ajlm-2104	1	113	cardiometabolic	cardiometabolic	PROPN
ajlm-2104	1	114	health	health	PROPN
ajlm-2104	1	115	research	research	NOUN
ajlm-2104	1	116	unit	unit	NOUN
ajlm-2104	1	117	and	and	CCONJ
ajlm-2104	1	118	biomedical	biomedical	ADJ
ajlm-2104	1	119	sciences	science	NOUN
ajlm-2104	1	120	,	,	PUNCT
ajlm-2104	1	121	faculty	faculty	NOUN
ajlm-2104	1	122	of	of	ADP
ajlm-2104	1	123	health	health	NOUN
ajlm-2104	1	124	and	and	CCONJ
ajlm-2104	1	125	wellness	wellness	NOUN
ajlm-2104	1	126	,	,	PUNCT
ajlm-2104	1	127	cape	cape	NOUN
ajlm-2104	1	128	peninsula	peninsula	PROPN
ajlm-2104	1	129	university	university	PROPN
ajlm-2104	1	130	of	of	ADP
ajlm-2104	1	131	technology	technology	NOUN
ajlm-2104	1	132	,	,	PUNCT
ajlm-2104	1	133	cape	cape	NOUN
ajlm-2104	1	134	town	town	NOUN
ajlm-2104	1	135	,	,	PUNCT
ajlm-2104	1	136	south	south	PROPN
ajlm-2104	1	137	africa	africa	PROPN
ajlm-2104	1	138	division	division	NOUN
ajlm-2104	1	139	of	of	ADP
ajlm-2104	1	140	haematology	haematology	NOUN
ajlm-2104	1	141	,	,	PUNCT
ajlm-2104	1	142	faculty	faculty	NOUN
ajlm-2104	1	143	of	of	ADP
ajlm-2104	1	144	health	health	NOUN
ajlm-2104	1	145	sciences	sciences	PROPN
ajlm-2104	1	146	,	,	PUNCT
ajlm-2104	1	147	university	university	NOUN
ajlm-2104	1	148	of	of	ADP
ajlm-2104	1	149	cape	cape	PROPN
ajlm-2104	1	150	town	town	NOUN
ajlm-2104	1	151	,	,	PUNCT
ajlm-2104	1	152	cape	cape	NOUN
ajlm-2104	1	153	town	town	NOUN
ajlm-2104	1	154	,	,	PUNCT
ajlm-2104	1	155	south	south	PROPN
ajlm-2104	1	156	africa	africa	PROPN
ajlm-2104	1	157	citation	citation	PROPN
ajlm-2104	1	158	van	van	PROPN
ajlm-2104	1	159	rensburg	rensburg	PROPN
ajlm-2104	1	160	j	j	PROPN
ajlm-2104	1	161	,	,	PUNCT
ajlm-2104	1	162	davids	davids	PROPN
ajlm-2104	1	163	s	s	PROPN
ajlm-2104	1	164	,	,	PUNCT
ajlm-2104	1	165	smuts	smut	NOUN
ajlm-2104	1	166	c	c	NOUN
ajlm-2104	1	167	,	,	PUNCT
ajlm-2104	1	168	davison	davison	PROPN
ajlm-2104	1	169	gm	gm	PROPN
ajlm-2104	1	170	.	.	PUNCT
ajlm-2104	2	1	use	use	NOUN
ajlm-2104	2	2	of	of	ADP
ajlm-2104	2	3	full	full	ADJ
ajlm-2104	2	4	blood	blood	NOUN
ajlm-2104	2	5	count	count	NOUN
ajlm-2104	2	6	parameters	parameter	NOUN
ajlm-2104	2	7	and	and	CCONJ
ajlm-2104	2	8	haematology	haematology	NOUN
ajlm-2104	2	9	cell	cell	NOUN
ajlm-2104	2	10	ratios	ratio	NOUN
ajlm-2104	2	11	in	in	ADP
ajlm-2104	2	12	screening	screen	VERB
ajlm-2104	2	13	for	for	ADP
ajlm-2104	2	14	sepsis	sepsis	NOUN
ajlm-2104	2	15	in	in	ADP
ajlm-2104	2	16	south	south	PROPN
ajlm-2104	2	17	africa	africa	PROPN
ajlm-2104	2	18	.	.	PUNCT
ajlm-2104	3	1	afr	afr	PROPN
ajlm-2104	3	2	j	j	PROPN
ajlm-2104	3	3	lab	lab	PROPN
ajlm-2104	3	4	med	med	PROPN
ajlm-2104	3	5	.	.	PUNCT
ajlm-2104	4	1	2023;12(1	2023;12(1	NUM
ajlm-2104	4	2	)	)	PUNCT
ajlm-2104	4	3	,	,	PUNCT
ajlm-2104	4	4	a2104	a2104	PROPN
ajlm-2104	4	5	.	.	PUNCT
ajlm-2104	4	6	https://doi.org/10.4102/ajlm.v12i1.2104	https://doi.org/10.4102/ajlm.v12i1.2104	X
ajlm-2104	5	1	original	original	ADJ
ajlm-2104	5	2	research	research	NOUN
ajlm-2104	5	3	use	use	NOUN
ajlm-2104	5	4	of	of	ADP
ajlm-2104	5	5	full	full	ADJ
ajlm-2104	5	6	blood	blood	NOUN
ajlm-2104	5	7	count	count	NOUN
ajlm-2104	5	8	parameters	parameter	NOUN
ajlm-2104	5	9	and	and	CCONJ
ajlm-2104	5	10	haematology	haematology	NOUN
ajlm-2104	5	11	cell	cell	NOUN
ajlm-2104	5	12	ratios	ratio	NOUN
ajlm-2104	5	13	in	in	ADP
ajlm-2104	5	14	screening	screen	VERB
ajlm-2104	5	15	for	for	ADP
ajlm-2104	5	16	sepsis	sepsis	NOUN
ajlm-2104	5	17	in	in	ADP
ajlm-2104	5	18	south	south	PROPN
ajlm-2104	5	19	africa	africa	PROPN
ajlm-2104	5	20	jason	jason	PROPN
ajlm-2104	5	21	van	van	PROPN
ajlm-2104	5	22	rensburg	rensburg	PROPN
ajlm-2104	5	23	,	,	PUNCT
ajlm-2104	5	24	saarah	saarah	PROPN
ajlm-2104	5	25	davids	davids	PROPN
ajlm-2104	5	26	,	,	PUNCT
ajlm-2104	5	27	carine	carine	NOUN
ajlm-2104	5	28	smuts	smut	NOUN
ajlm-2104	5	29	,	,	PUNCT
ajlm-2104	5	30	glenda	glenda	PROPN
ajlm-2104	5	31	m.	m.	PROPN
ajlm-2104	5	32	davison	davison	PROPN
ajlm-2104	5	33	received	receive	VERB
ajlm-2104	5	34	:	:	PUNCT
ajlm-2104	5	35	21	21	NUM
ajlm-2104	5	36	oct	oct	PROPN
ajlm-2104	5	37	.	.	PROPN
ajlm-2104	5	38	2022	2022	NUM
ajlm-2104	5	39	;	;	PUNCT
ajlm-2104	5	40	accepted	accept	VERB
ajlm-2104	5	41	:	:	PUNCT
ajlm-2104	5	42	31	31	NUM
ajlm-2104	5	43	jan	jan	PROPN
ajlm-2104	5	44	.	.	PROPN
ajlm-2104	5	45	2023	2023	NUM
ajlm-2104	5	46	;	;	PUNCT
ajlm-2104	5	47	published	publish	VERB
ajlm-2104	5	48	:	:	PUNCT
ajlm-2104	5	49	11	11	NUM
ajlm-2104	5	50	apr	apr	NOUN
ajlm-2104	5	51	.	.	PUNCT
ajlm-2104	6	1	2023	2023	NUM
ajlm-2104	6	2	copyright	copyright	NOUN
ajlm-2104	6	3	:	:	PUNCT
ajlm-2104	6	4	©	©	PROPN
ajlm-2104	6	5	2023	2023	NUM
ajlm-2104	6	6	.	.	PUNCT
ajlm-2104	7	1	the	the	DET
ajlm-2104	7	2	author(s	author(s	NOUN
ajlm-2104	7	3	)	)	PUNCT
ajlm-2104	7	4	.	.	PUNCT
ajlm-2104	8	1	licensee	licensee	NOUN
ajlm-2104	8	2	:	:	PUNCT
ajlm-2104	8	3	aosis	aosis	NOUN
ajlm-2104	8	4	.	.	PUNCT
ajlm-2104	9	1	this	this	PRON
ajlm-2104	9	2	is	be	AUX
ajlm-2104	9	3	an	an	DET
ajlm-2104	9	4	open	open	ADJ
ajlm-2104	9	5	access	access	NOUN
ajlm-2104	9	6	article	article	NOUN
ajlm-2104	9	7	distributed	distribute	VERB
ajlm-2104	9	8	under	under	ADP
ajlm-2104	9	9	the	the	DET
ajlm-2104	9	10	terms	term	NOUN
ajlm-2104	9	11	of	of	ADP
ajlm-2104	9	12	the	the	DET
ajlm-2104	9	13	creative	creative	ADJ
ajlm-2104	9	14	commons	common	NOUN
ajlm-2104	9	15	attribution	attribution	NOUN
ajlm-2104	9	16	license	license	NOUN
ajlm-2104	9	17	,	,	PUNCT
ajlm-2104	9	18	which	which	PRON
ajlm-2104	9	19	permits	permit	VERB
ajlm-2104	9	20	unrestricted	unrestricted	ADJ
ajlm-2104	9	21	use	use	NOUN
ajlm-2104	9	22	,	,	PUNCT
ajlm-2104	9	23	distribution	distribution	NOUN
ajlm-2104	9	24	,	,	PUNCT
ajlm-2104	9	25	and	and	CCONJ
ajlm-2104	9	26	reproduction	reproduction	NOUN
ajlm-2104	9	27	in	in	ADP
ajlm-2104	9	28	any	any	DET
ajlm-2104	9	29	medium	medium	NOUN
ajlm-2104	9	30	,	,	PUNCT
ajlm-2104	9	31	provided	provide	VERB
ajlm-2104	9	32	the	the	DET
ajlm-2104	9	33	original	original	ADJ
ajlm-2104	9	34	work	work	NOUN
ajlm-2104	9	35	is	be	AUX
ajlm-2104	9	36	properly	properly	ADV
ajlm-2104	9	37	cited	cite	VERB
ajlm-2104	9	38	.	.	PUNCT
ajlm-2104	10	1	abstract	abstract	ADJ
ajlm-2104	10	2	background	background	NOUN
ajlm-2104	10	3	:	:	PUNCT
ajlm-2104	10	4	sepsis	sepsis	NOUN
ajlm-2104	10	5	is	be	AUX
ajlm-2104	10	6	characterised	characterise	VERB
ajlm-2104	10	7	by	by	ADP
ajlm-2104	10	8	multi	multi	ADJ
ajlm-2104	10	9	-	-	ADJ
ajlm-2104	10	10	organ	organ	ADJ
ajlm-2104	10	11	failure	failure	NOUN
ajlm-2104	10	12	due	due	ADP
ajlm-2104	10	13	to	to	ADP
ajlm-2104	10	14	an	an	DET
ajlm-2104	10	15	uncontrolled	uncontrolled	ADJ
ajlm-2104	10	16	immune	immune	ADJ
ajlm-2104	10	17	response	response	NOUN
ajlm-2104	10	18	to	to	ADP
ajlm-2104	10	19	infection	infection	NOUN
ajlm-2104	10	20	.	.	PUNCT
ajlm-2104	11	1	sepsis	sepsis	NOUN
ajlm-2104	11	2	prevalence	prevalence	NOUN
ajlm-2104	11	3	is	be	AUX
ajlm-2104	11	4	increased	increase	VERB
ajlm-2104	11	5	in	in	ADP
ajlm-2104	11	6	developing	develop	VERB
ajlm-2104	11	7	countries	country	NOUN
ajlm-2104	11	8	and	and	CCONJ
ajlm-2104	11	9	requires	require	VERB
ajlm-2104	11	10	prompt	prompt	ADJ
ajlm-2104	11	11	diagnosis	diagnosis	NOUN
ajlm-2104	11	12	and	and	CCONJ
ajlm-2104	11	13	treatment	treatment	NOUN
ajlm-2104	11	14	.	.	PUNCT
ajlm-2104	12	1	reports	report	NOUN
ajlm-2104	12	2	,	,	PUNCT
ajlm-2104	12	3	although	although	SCONJ
ajlm-2104	12	4	controversial	controversial	ADJ
ajlm-2104	12	5	,	,	PUNCT
ajlm-2104	12	6	suggest	suggest	VERB
ajlm-2104	12	7	that	that	SCONJ
ajlm-2104	12	8	full	full	ADJ
ajlm-2104	12	9	blood	blood	NOUN
ajlm-2104	12	10	count	count	NOUN
ajlm-2104	12	11	parameters	parameter	NOUN
ajlm-2104	12	12	and	and	CCONJ
ajlm-2104	12	13	cell	cell	NOUN
ajlm-2104	12	14	ratios	ratio	NOUN
ajlm-2104	12	15	could	could	AUX
ajlm-2104	12	16	assist	assist	VERB
ajlm-2104	12	17	in	in	ADP
ajlm-2104	12	18	the	the	DET
ajlm-2104	12	19	early	early	ADJ
ajlm-2104	12	20	screening	screening	NOUN
ajlm-2104	12	21	for	for	ADP
ajlm-2104	12	22	sepsis	sepsis	NOUN
ajlm-2104	12	23	.	.	PUNCT
ajlm-2104	13	1	objective	objective	NOUN
ajlm-2104	13	2	:	:	PUNCT
ajlm-2104	13	3	the	the	DET
ajlm-2104	13	4	study	study	NOUN
ajlm-2104	13	5	evaluated	evaluate	VERB
ajlm-2104	13	6	the	the	DET
ajlm-2104	13	7	use	use	NOUN
ajlm-2104	13	8	of	of	ADP
ajlm-2104	13	9	haematological	haematological	ADJ
ajlm-2104	13	10	cell	cell	NOUN
ajlm-2104	13	11	ratios	ratio	NOUN
ajlm-2104	13	12	in	in	ADP
ajlm-2104	13	13	screening	screen	VERB
ajlm-2104	13	14	for	for	ADP
ajlm-2104	13	15	sepsis	sepsis	NOUN
ajlm-2104	13	16	in	in	ADP
ajlm-2104	13	17	a	a	DET
ajlm-2104	13	18	south	south	ADJ
ajlm-2104	13	19	african	african	ADJ
ajlm-2104	13	20	population	population	NOUN
ajlm-2104	13	21	.	.	PUNCT
ajlm-2104	14	1	methods	method	NOUN
ajlm-2104	14	2	:	:	PUNCT
ajlm-2104	14	3	the	the	DET
ajlm-2104	14	4	study	study	NOUN
ajlm-2104	14	5	retrospectively	retrospectively	ADV
ajlm-2104	14	6	analysed	analyse	VERB
ajlm-2104	14	7	the	the	DET
ajlm-2104	14	8	complete	complete	ADJ
ajlm-2104	14	9	blood	blood	NOUN
ajlm-2104	14	10	counts	count	NOUN
ajlm-2104	14	11	,	,	PUNCT
ajlm-2104	14	12	blood	blood	NOUN
ajlm-2104	14	13	cultures	culture	NOUN
ajlm-2104	14	14	(	(	PUNCT
ajlm-2104	14	15	bc	bc	PROPN
ajlm-2104	14	16	)	)	PUNCT
ajlm-2104	14	17	and	and	CCONJ
ajlm-2104	14	18	biochemical	biochemical	ADJ
ajlm-2104	14	19	test	test	NOUN
ajlm-2104	14	20	results	result	NOUN
ajlm-2104	14	21	of	of	ADP
ajlm-2104	14	22	125	125	NUM
ajlm-2104	14	23	adult	adult	NOUN
ajlm-2104	14	24	patients	patient	NOUN
ajlm-2104	14	25	who	who	PRON
ajlm-2104	14	26	presented	present	VERB
ajlm-2104	14	27	between	between	ADP
ajlm-2104	14	28	january	january	PROPN
ajlm-2104	14	29	2021	2021	NUM
ajlm-2104	14	30	and	and	CCONJ
ajlm-2104	14	31	july	july	PROPN
ajlm-2104	14	32	2021	2021	NUM
ajlm-2104	14	33	at	at	ADP
ajlm-2104	14	34	a	a	DET
ajlm-2104	14	35	hospital	hospital	NOUN
ajlm-2104	14	36	in	in	ADP
ajlm-2104	14	37	cape	cape	NOUN
ajlm-2104	14	38	town	town	NOUN
ajlm-2104	14	39	.	.	PUNCT
ajlm-2104	15	1	an	an	DET
ajlm-2104	15	2	iso15189	iso15189	ADV
ajlm-2104	15	3	-	-	PUNCT
ajlm-2104	15	4	accredited	accredit	VERB
ajlm-2104	15	5	laboratory	laboratory	NOUN
ajlm-2104	15	6	performed	perform	VERB
ajlm-2104	15	7	all	all	PRON
ajlm-2104	15	8	of	of	ADP
ajlm-2104	15	9	the	the	DET
ajlm-2104	15	10	tests	test	NOUN
ajlm-2104	15	11	.	.	PUNCT
ajlm-2104	16	1	we	we	PRON
ajlm-2104	16	2	compared	compare	VERB
ajlm-2104	16	3	and	and	CCONJ
ajlm-2104	16	4	correlated	correlate	VERB
ajlm-2104	16	5	the	the	DET
ajlm-2104	16	6	automated	automate	VERB
ajlm-2104	16	7	differential	differential	NOUN
ajlm-2104	16	8	counts	count	NOUN
ajlm-2104	16	9	,	,	PUNCT
ajlm-2104	16	10	neutrophil	neutrophil	ADJ
ajlm-2104	16	11	,	,	PUNCT
ajlm-2104	16	12	monocyte	monocyte	NOUN
ajlm-2104	16	13	and	and	CCONJ
ajlm-2104	16	14	platelet	platelet	NOUN
ajlm-2104	16	15	-	-	PUNCT
ajlm-2104	16	16	to	to	ADP
ajlm-2104	16	17	-	-	PUNCT
ajlm-2104	16	18	lymphocyte	lymphocyte	ADJ
ajlm-2104	16	19	ratios	ratio	NOUN
ajlm-2104	16	20	with	with	ADP
ajlm-2104	16	21	procalcitonin	procalcitonin	ADJ
ajlm-2104	16	22	levels	level	NOUN
ajlm-2104	16	23	.	.	PUNCT
ajlm-2104	17	1	a	a	DET
ajlm-2104	17	2	p	p	NOUN
ajlm-2104	17	3	-	-	PUNCT
ajlm-2104	17	4	value	value	NOUN
ajlm-2104	17	5	of	of	ADP
ajlm-2104	17	6	<	<	X
ajlm-2104	17	7	0.05	0.05	NUM
ajlm-2104	17	8	was	be	AUX
ajlm-2104	17	9	considered	consider	VERB
ajlm-2104	17	10	significant	significant	ADJ
ajlm-2104	17	11	.	.	PUNCT
ajlm-2104	18	1	results	result	NOUN
ajlm-2104	18	2	:	:	PUNCT
ajlm-2104	18	3	sixty	sixty	NUM
ajlm-2104	18	4	-	-	PUNCT
ajlm-2104	18	5	two	two	NUM
ajlm-2104	18	6	sepsis	sepsis	NOUN
ajlm-2104	18	7	patients	patient	NOUN
ajlm-2104	18	8	(	(	PUNCT
ajlm-2104	18	9	procalcitonin	procalcitonin	VERB
ajlm-2104	18	10	>	>	X
ajlm-2104	18	11	2	2	NUM
ajlm-2104	18	12	ng	ng	PROPN
ajlm-2104	18	13	/	/	SYM
ajlm-2104	18	14	l	l	PROPN
ajlm-2104	18	15	and	and	CCONJ
ajlm-2104	18	16	positive	positive	ADJ
ajlm-2104	18	17	bc	bc	PROPN
ajlm-2104	18	18	)	)	PUNCT
ajlm-2104	18	19	were	be	AUX
ajlm-2104	18	20	identified	identify	VERB
ajlm-2104	18	21	and	and	CCONJ
ajlm-2104	18	22	compared	compare	VERB
ajlm-2104	18	23	to	to	ADP
ajlm-2104	18	24	63	63	NUM
ajlm-2104	18	25	non	non	ADJ
ajlm-2104	18	26	-	-	ADJ
ajlm-2104	18	27	sepsis	sepsis	NOUN
ajlm-2104	18	28	controls	control	NOUN
ajlm-2104	18	29	.	.	PUNCT
ajlm-2104	19	1	all	all	DET
ajlm-2104	19	2	cell	cell	NOUN
ajlm-2104	19	3	ratios	ratio	NOUN
ajlm-2104	19	4	were	be	AUX
ajlm-2104	19	5	significantly	significantly	ADV
ajlm-2104	19	6	elevated	elevate	VERB
ajlm-2104	19	7	in	in	ADP
ajlm-2104	19	8	sepsis	sepsis	NOUN
ajlm-2104	19	9	patients	patient	NOUN
ajlm-2104	19	10	(	(	PUNCT
ajlm-2104	19	11	p	p	X
ajlm-2104	19	12	<	<	X
ajlm-2104	19	13	0.001	0.001	NUM
ajlm-2104	19	14	)	)	PUNCT
ajlm-2104	19	15	.	.	PUNCT
ajlm-2104	20	1	however	however	ADV
ajlm-2104	20	2	,	,	PUNCT
ajlm-2104	20	3	the	the	DET
ajlm-2104	20	4	two	two	NUM
ajlm-2104	20	5	groups	group	NOUN
ajlm-2104	20	6	had	have	VERB
ajlm-2104	20	7	no	no	DET
ajlm-2104	20	8	significant	significant	ADJ
ajlm-2104	20	9	difference	difference	NOUN
ajlm-2104	20	10	in	in	ADP
ajlm-2104	20	11	absolute	absolute	ADJ
ajlm-2104	20	12	monocyte	monocyte	NOUN
ajlm-2104	20	13	counts	count	NOUN
ajlm-2104	20	14	(	(	PUNCT
ajlm-2104	20	15	p	p	X
ajlm-2104	20	16	=	=	NOUN
ajlm-2104	20	17	0.377	0.377	NUM
ajlm-2104	20	18	)	)	PUNCT
ajlm-2104	20	19	.	.	PUNCT
ajlm-2104	21	1	in	in	ADP
ajlm-2104	21	2	addition	addition	NOUN
ajlm-2104	21	3	,	,	PUNCT
ajlm-2104	21	4	no	no	DET
ajlm-2104	21	5	correlation	correlation	NOUN
ajlm-2104	21	6	was	be	AUX
ajlm-2104	21	7	detected	detect	VERB
ajlm-2104	21	8	between	between	ADP
ajlm-2104	21	9	any	any	DET
ajlm-2104	21	10	cell	cell	NOUN
ajlm-2104	21	11	ratios	ratio	NOUN
ajlm-2104	21	12	and	and	CCONJ
ajlm-2104	21	13	procalcitonin	procalcitonin	NOUN
ajlm-2104	21	14	.	.	PUNCT
ajlm-2104	22	1	conclusion	conclusion	NOUN
ajlm-2104	22	2	:	:	PUNCT
ajlm-2104	22	3	in	in	ADP
ajlm-2104	22	4	combination	combination	NOUN
ajlm-2104	22	5	with	with	ADP
ajlm-2104	22	6	complete	complete	ADJ
ajlm-2104	22	7	blood	blood	NOUN
ajlm-2104	22	8	count	count	NOUN
ajlm-2104	22	9	parameters	parameter	NOUN
ajlm-2104	22	10	,	,	PUNCT
ajlm-2104	22	11	haematology	haematology	NOUN
ajlm-2104	22	12	cell	cell	NOUN
ajlm-2104	22	13	ratios	ratio	NOUN
ajlm-2104	22	14	can	can	AUX
ajlm-2104	22	15	be	be	AUX
ajlm-2104	22	16	used	use	VERB
ajlm-2104	22	17	for	for	ADP
ajlm-2104	22	18	early	early	ADJ
ajlm-2104	22	19	sepsis	sepsis	NOUN
ajlm-2104	22	20	detection	detection	NOUN
ajlm-2104	22	21	.	.	PUNCT
ajlm-2104	23	1	the	the	DET
ajlm-2104	23	2	full	full	ADJ
ajlm-2104	23	3	blood	blood	NOUN
ajlm-2104	23	4	count	count	NOUN
ajlm-2104	23	5	is	be	AUX
ajlm-2104	23	6	widely	widely	ADV
ajlm-2104	23	7	available	available	ADJ
ajlm-2104	23	8	,	,	PUNCT
ajlm-2104	23	9	inexpensive	inexpensive	ADJ
ajlm-2104	23	10	,	,	PUNCT
ajlm-2104	23	11	and	and	CCONJ
ajlm-2104	23	12	routinely	routinely	ADV
ajlm-2104	23	13	requested	request	VERB
ajlm-2104	23	14	by	by	ADP
ajlm-2104	23	15	emergency	emergency	NOUN
ajlm-2104	23	16	care	care	NOUN
ajlm-2104	23	17	clinicians	clinician	NOUN
ajlm-2104	23	18	.	.	PUNCT
ajlm-2104	24	1	although	although	SCONJ
ajlm-2104	24	2	procalcitonin	procalcitonin	ADJ
ajlm-2104	24	3	and	and	CCONJ
ajlm-2104	24	4	bc	bc	PROPN
ajlm-2104	24	5	remain	remain	VERB
ajlm-2104	24	6	the	the	DET
ajlm-2104	24	7	gold	gold	NOUN
ajlm-2104	24	8	standard	standard	NOUN
ajlm-2104	24	9	,	,	PUNCT
ajlm-2104	24	10	the	the	DET
ajlm-2104	24	11	calculation	calculation	NOUN
ajlm-2104	24	12	of	of	ADP
ajlm-2104	24	13	cell	cell	NOUN
ajlm-2104	24	14	ratios	ratio	NOUN
ajlm-2104	24	15	could	could	AUX
ajlm-2104	24	16	provide	provide	VERB
ajlm-2104	24	17	a	a	DET
ajlm-2104	24	18	simple	simple	ADJ
ajlm-2104	24	19	screening	screening	NOUN
ajlm-2104	24	20	tool	tool	NOUN
ajlm-2104	24	21	for	for	ADP
ajlm-2104	24	22	the	the	DET
ajlm-2104	24	23	early	early	ADJ
ajlm-2104	24	24	detection	detection	NOUN
ajlm-2104	24	25	of	of	ADP
ajlm-2104	24	26	sepsis	sepsis	NOUN
ajlm-2104	24	27	.	.	PUNCT
ajlm-2104	25	1	what	what	PRON
ajlm-2104	25	2	this	this	DET
ajlm-2104	25	3	study	study	NOUN
ajlm-2104	25	4	adds	add	VERB
ajlm-2104	25	5	:	:	PUNCT
ajlm-2104	25	6	this	this	DET
ajlm-2104	25	7	study	study	NOUN
ajlm-2104	25	8	adds	add	VERB
ajlm-2104	25	9	evidence	evidence	NOUN
ajlm-2104	25	10	to	to	ADP
ajlm-2104	25	11	the	the	DET
ajlm-2104	25	12	proposal	proposal	NOUN
ajlm-2104	25	13	that	that	SCONJ
ajlm-2104	25	14	calculating	calculate	VERB
ajlm-2104	25	15	haematological	haematological	ADJ
ajlm-2104	25	16	cell	cell	NOUN
ajlm-2104	25	17	ratios	ratio	NOUN
ajlm-2104	25	18	assists	assist	VERB
ajlm-2104	25	19	in	in	ADP
ajlm-2104	25	20	the	the	DET
ajlm-2104	25	21	early	early	ADJ
ajlm-2104	25	22	screening	screening	NOUN
ajlm-2104	25	23	of	of	ADP
ajlm-2104	25	24	sepsis	sepsis	NOUN
ajlm-2104	25	25	in	in	ADP
ajlm-2104	25	26	a	a	DET
ajlm-2104	25	27	south	south	ADJ
ajlm-2104	25	28	african	african	ADJ
ajlm-2104	25	29	setting	setting	NOUN
ajlm-2104	25	30	.	.	PUNCT
ajlm-2104	26	1	keywords	keyword	NOUN
ajlm-2104	26	2	:	:	PUNCT
ajlm-2104	26	3	sepsis	sepsis	NOUN
ajlm-2104	26	4	;	;	PUNCT
ajlm-2104	26	5	full	full	ADJ
ajlm-2104	26	6	blood	blood	NOUN
ajlm-2104	26	7	count	count	NOUN
ajlm-2104	26	8	;	;	PUNCT
ajlm-2104	26	9	neutrophil	neutrophil	ADJ
ajlm-2104	26	10	-	-	PUNCT
ajlm-2104	26	11	to	to	ADP
ajlm-2104	26	12	-	-	PUNCT
ajlm-2104	26	13	lymphocyte	lymphocyte	NOUN
ajlm-2104	26	14	ratio	ratio	NOUN
ajlm-2104	26	15	;	;	PUNCT
ajlm-2104	26	16	monocyte	monocyte	NOUN
ajlm-2104	26	17	to	to	ADP
ajlm-2104	26	18	lymphocyte	lymphocyte	ADJ
ajlm-2104	26	19	ratio	ratio	NOUN
ajlm-2104	26	20	;	;	PUNCT
ajlm-2104	26	21	platelet	platelet	NOUN
ajlm-2104	26	22	-	-	PUNCT
ajlm-2104	26	23	to	to	ADP
ajlm-2104	26	24	-	-	PUNCT
ajlm-2104	26	25	lymphocyte	lymphocyte	ADJ
ajlm-2104	26	26	ratio	ratio	NOUN
ajlm-2104	26	27	.	.	PUNCT
ajlm-2104	27	1	introduction	introduction	NOUN
ajlm-2104	27	2	sepsis	sepsis	NOUN
ajlm-2104	27	3	is	be	AUX
ajlm-2104	27	4	a	a	DET
ajlm-2104	27	5	life	life	NOUN
ajlm-2104	27	6	-	-	PUNCT
ajlm-2104	27	7	threatening	threaten	VERB
ajlm-2104	27	8	condition	condition	NOUN
ajlm-2104	27	9	characterised	characterise	VERB
ajlm-2104	27	10	by	by	ADP
ajlm-2104	27	11	multiple	multiple	ADJ
ajlm-2104	27	12	organ	organ	NOUN
ajlm-2104	27	13	system	system	NOUN
ajlm-2104	27	14	failures	failure	NOUN
ajlm-2104	27	15	due	due	ADJ
ajlm-2104	27	16	to	to	ADP
ajlm-2104	27	17	a	a	DET
ajlm-2104	27	18	dysregulated	dysregulated	ADJ
ajlm-2104	27	19	immune	immune	ADJ
ajlm-2104	27	20	response	response	NOUN
ajlm-2104	27	21	manifesting	manifest	VERB
ajlm-2104	27	22	secondary	secondary	ADJ
ajlm-2104	27	23	to	to	ADP
ajlm-2104	27	24	a	a	DET
ajlm-2104	27	25	bacterial	bacterial	ADJ
ajlm-2104	27	26	or	or	CCONJ
ajlm-2104	27	27	fungal	fungal	ADJ
ajlm-2104	27	28	infection.1	infection.1	NOUN
ajlm-2104	27	29	due	due	ADP
ajlm-2104	27	30	to	to	ADP
ajlm-2104	27	31	differing	differ	VERB
ajlm-2104	27	32	definitions	definition	NOUN
ajlm-2104	27	33	of	of	ADP
ajlm-2104	27	34	sepsis	sepsis	NOUN
ajlm-2104	27	35	,	,	PUNCT
ajlm-2104	27	36	global	global	ADJ
ajlm-2104	27	37	prevalence	prevalence	NOUN
ajlm-2104	27	38	figures	figure	NOUN
ajlm-2104	27	39	remain	remain	VERB
ajlm-2104	27	40	unclear	unclear	ADJ
ajlm-2104	27	41	;	;	PUNCT
ajlm-2104	27	42	however	however	ADV
ajlm-2104	27	43	,	,	PUNCT
ajlm-2104	27	44	a	a	DET
ajlm-2104	27	45	minimum	minimum	NOUN
ajlm-2104	27	46	of	of	ADP
ajlm-2104	27	47	49	49	NUM
ajlm-2104	27	48	million	million	NUM
ajlm-2104	27	49	sepsis	sepsis	NOUN
ajlm-2104	27	50	cases	case	NOUN
ajlm-2104	27	51	are	be	AUX
ajlm-2104	27	52	estimated	estimate	VERB
ajlm-2104	27	53	to	to	PART
ajlm-2104	27	54	occur	occur	VERB
ajlm-2104	27	55	annually	annually	ADV
ajlm-2104	27	56	,	,	PUNCT
ajlm-2104	27	57	with	with	SCONJ
ajlm-2104	27	58	up	up	ADP
ajlm-2104	27	59	to	to	PART
ajlm-2104	27	60	11	11	NUM
ajlm-2104	27	61	million	million	NUM
ajlm-2104	27	62	mortality.2	mortality.2	NOUN
ajlm-2104	27	63	sepsis	sepsis	NOUN
ajlm-2104	27	64	prevalence	prevalence	NOUN
ajlm-2104	27	65	is	be	AUX
ajlm-2104	27	66	high	high	ADJ
ajlm-2104	27	67	in	in	ADP
ajlm-2104	27	68	lowand	lowand	ADJ
ajlm-2104	27	69	middle	middle	ADJ
ajlm-2104	27	70	-	-	PUNCT
ajlm-2104	27	71	income	income	NOUN
ajlm-2104	27	72	countries	country	NOUN
ajlm-2104	27	73	due	due	ADP
ajlm-2104	27	74	to	to	ADP
ajlm-2104	27	75	high	high	ADJ
ajlm-2104	27	76	poverty	poverty	NOUN
ajlm-2104	27	77	levels	level	NOUN
ajlm-2104	27	78	and	and	CCONJ
ajlm-2104	27	79	lack	lack	NOUN
ajlm-2104	27	80	of	of	ADP
ajlm-2104	27	81	healthcare	healthcare	NOUN
ajlm-2104	27	82	resources	resource	NOUN
ajlm-2104	27	83	.	.	PUNCT
ajlm-2104	28	1	immunocompromised	immunocompromise	VERB
ajlm-2104	28	2	individuals	individual	NOUN
ajlm-2104	28	3	,	,	PUNCT
ajlm-2104	28	4	the	the	DET
ajlm-2104	28	5	elderly	elderly	ADJ
ajlm-2104	28	6	and	and	CCONJ
ajlm-2104	28	7	neonates	neonate	NOUN
ajlm-2104	28	8	are	be	AUX
ajlm-2104	28	9	most	most	ADV
ajlm-2104	28	10	at	at	ADP
ajlm-2104	28	11	risk.3	risk.3	NOUN
ajlm-2104	28	12	sepsis	sepsis	NOUN
ajlm-2104	28	13	is	be	AUX
ajlm-2104	28	14	a	a	DET
ajlm-2104	28	15	medical	medical	ADJ
ajlm-2104	28	16	emergency	emergency	NOUN
ajlm-2104	28	17	that	that	PRON
ajlm-2104	28	18	requires	require	VERB
ajlm-2104	28	19	prompt	prompt	ADJ
ajlm-2104	28	20	treatment	treatment	NOUN
ajlm-2104	28	21	to	to	PART
ajlm-2104	28	22	achieve	achieve	VERB
ajlm-2104	28	23	a	a	DET
ajlm-2104	28	24	favourable	favourable	ADJ
ajlm-2104	28	25	clinical	clinical	ADJ
ajlm-2104	28	26	outcome	outcome	NOUN
ajlm-2104	28	27	.	.	PUNCT
ajlm-2104	29	1	clinical	clinical	ADJ
ajlm-2104	29	2	symptoms	symptom	NOUN
ajlm-2104	29	3	are	be	AUX
ajlm-2104	29	4	often	often	ADV
ajlm-2104	29	5	non	non	ADJ
ajlm-2104	29	6	-	-	ADJ
ajlm-2104	29	7	specific	specific	ADJ
ajlm-2104	29	8	making	making	NOUN
ajlm-2104	29	9	diagnosis	diagnosis	NOUN
ajlm-2104	29	10	difficult	difficult	ADJ
ajlm-2104	29	11	,	,	PUNCT
ajlm-2104	29	12	variable	variable	ADJ
ajlm-2104	29	13	and	and	CCONJ
ajlm-2104	29	14	unclear	unclear	ADJ
ajlm-2104	29	15	.	.	PUNCT
ajlm-2104	30	1	the	the	DET
ajlm-2104	30	2	diagnosis	diagnosis	NOUN
ajlm-2104	30	3	is	be	AUX
ajlm-2104	30	4	predominantly	predominantly	ADV
ajlm-2104	30	5	based	base	VERB
ajlm-2104	30	6	on	on	ADP
ajlm-2104	30	7	the	the	DET
ajlm-2104	30	8	sequential	sequential	ADJ
ajlm-2104	30	9	organ	organ	NOUN
ajlm-2104	30	10	failure	failure	NOUN
ajlm-2104	30	11	assessment	assessment	NOUN
ajlm-2104	30	12	score	score	NOUN
ajlm-2104	30	13	,	,	PUNCT
ajlm-2104	30	14	which	which	PRON
ajlm-2104	30	15	measures	measure	VERB
ajlm-2104	30	16	the	the	DET
ajlm-2104	30	17	functional	functional	ADJ
ajlm-2104	30	18	status	status	NOUN
ajlm-2104	30	19	of	of	ADP
ajlm-2104	30	20	the	the	DET
ajlm-2104	30	21	respiratory	respiratory	ADJ
ajlm-2104	30	22	,	,	PUNCT
ajlm-2104	30	23	haemostatic	haemostatic	ADJ
ajlm-2104	30	24	,	,	PUNCT
ajlm-2104	30	25	hepatic	hepatic	ADJ
ajlm-2104	30	26	,	,	PUNCT
ajlm-2104	30	27	renal	renal	ADJ
ajlm-2104	30	28	,	,	PUNCT
ajlm-2104	30	29	cardiovascular	cardiovascular	ADJ
ajlm-2104	30	30	and	and	CCONJ
ajlm-2104	30	31	nervous	nervous	ADJ
ajlm-2104	30	32	systems.4,5	systems.4,5	PROPN
ajlm-2104	30	33	the	the	DET
ajlm-2104	30	34	sequential	sequential	ADJ
ajlm-2104	30	35	organ	organ	NOUN
ajlm-2104	30	36	failure	failure	NOUN
ajlm-2104	30	37	assessment	assessment	NOUN
ajlm-2104	30	38	score	score	NOUN
ajlm-2104	30	39	is	be	AUX
ajlm-2104	30	40	not	not	PART
ajlm-2104	30	41	specific	specific	ADJ
ajlm-2104	30	42	to	to	ADP
ajlm-2104	30	43	sepsis	sepsis	NOUN
ajlm-2104	30	44	;	;	PUNCT
ajlm-2104	30	45	thus	thus	ADV
ajlm-2104	30	46	,	,	PUNCT
ajlm-2104	30	47	biological	biological	ADJ
ajlm-2104	30	48	markers	marker	NOUN
ajlm-2104	30	49	such	such	ADJ
ajlm-2104	30	50	as	as	ADP
ajlm-2104	30	51	blood	blood	NOUN
ajlm-2104	30	52	cultures	culture	NOUN
ajlm-2104	30	53	(	(	PUNCT
ajlm-2104	30	54	bc	bc	PROPN
ajlm-2104	30	55	)	)	PUNCT
ajlm-2104	30	56	,	,	PUNCT
ajlm-2104	30	57	procalcitonin	procalcitonin	NOUN
ajlm-2104	30	58	,	,	PUNCT
ajlm-2104	30	59	and	and	CCONJ
ajlm-2104	30	60	c	c	X
ajlm-2104	30	61	-	-	PUNCT
ajlm-2104	30	62	reactive	reactive	ADJ
ajlm-2104	30	63	protein	protein	NOUN
ajlm-2104	30	64	have	have	AUX
ajlm-2104	30	65	been	be	AUX
ajlm-2104	30	66	adopted	adopt	VERB
ajlm-2104	30	67	in	in	ADP
ajlm-2104	30	68	clinical	clinical	ADJ
ajlm-2104	30	69	practice.6	practice.6	ADP
ajlm-2104	30	70	these	these	DET
ajlm-2104	30	71	biomarkers	biomarker	NOUN
ajlm-2104	30	72	,	,	PUNCT
ajlm-2104	30	73	although	although	SCONJ
ajlm-2104	30	74	important	important	ADJ
ajlm-2104	30	75	,	,	PUNCT
ajlm-2104	30	76	have	have	VERB
ajlm-2104	30	77	limitations	limitation	NOUN
ajlm-2104	30	78	.	.	PUNCT
ajlm-2104	31	1	procalcitonin	procalcitonin	ADJ
ajlm-2104	31	2	is	be	AUX
ajlm-2104	31	3	a	a	DET
ajlm-2104	31	4	precursor	precursor	NOUN
ajlm-2104	31	5	molecule	molecule	NOUN
ajlm-2104	31	6	to	to	ADP
ajlm-2104	31	7	the	the	DET
ajlm-2104	31	8	thyroid	thyroid	NOUN
ajlm-2104	31	9	hormone	hormone	NOUN
ajlm-2104	31	10	calcitonin	calcitonin	NOUN
ajlm-2104	31	11	and	and	CCONJ
ajlm-2104	31	12	is	be	AUX
ajlm-2104	31	13	undetectable	undetectable	ADJ
ajlm-2104	31	14	in	in	ADP
ajlm-2104	31	15	the	the	DET
ajlm-2104	31	16	serum	serum	NOUN
ajlm-2104	31	17	of	of	ADP
ajlm-2104	31	18	healthy	healthy	ADJ
ajlm-2104	31	19	individuals	individual	NOUN
ajlm-2104	31	20	.	.	PUNCT
ajlm-2104	32	1	procalcitonin	procalcitonin	ADJ
ajlm-2104	32	2	levels	level	NOUN
ajlm-2104	32	3	correlate	correlate	VERB
ajlm-2104	32	4	with	with	ADP
ajlm-2104	32	5	sepsis	sepsis	NOUN
ajlm-2104	32	6	severity	severity	NOUN
ajlm-2104	32	7	,	,	PUNCT
ajlm-2104	32	8	with	with	ADP
ajlm-2104	32	9	serum	serum	NOUN
ajlm-2104	32	10	concentrations	concentration	NOUN
ajlm-2104	32	11	between	between	ADP
ajlm-2104	32	12	0.5	0.5	NUM
ajlm-2104	32	13	ng	ng	PROPN
ajlm-2104	32	14	/	/	SYM
ajlm-2104	32	15	l	l	PROPN
ajlm-2104	32	16	and	and	CCONJ
ajlm-2104	32	17	2.0	2.0	NUM
ajlm-2104	32	18	ng	ng	PROPN
ajlm-2104	32	19	/	/	SYM
ajlm-2104	32	20	l	l	NOUN
ajlm-2104	32	21	indicative	indicative	ADJ
ajlm-2104	32	22	of	of	ADP
ajlm-2104	32	23	bacterial	bacterial	ADJ
ajlm-2104	32	24	infection	infection	NOUN
ajlm-2104	32	25	and	and	CCONJ
ajlm-2104	32	26	those	those	PRON
ajlm-2104	32	27	>	>	X
ajlm-2104	32	28	2.0	2.0	NUM
ajlm-2104	32	29	ng	ng	PROPN
ajlm-2104	32	30	/	/	SYM
ajlm-2104	32	31	l	l	PROPN
ajlm-2104	32	32	indicative	indicative	ADJ
ajlm-2104	32	33	of	of	ADP
ajlm-2104	32	34	sepsis.7,8	sepsis.7,8	PRON
ajlm-2104	32	35	although	although	SCONJ
ajlm-2104	32	36	highly	highly	ADV
ajlm-2104	32	37	specific	specific	ADJ
ajlm-2104	32	38	,	,	PUNCT
ajlm-2104	32	39	procalcitonin	procalcitonin	ADJ
ajlm-2104	32	40	assays	assay	NOUN
ajlm-2104	32	41	may	may	AUX
ajlm-2104	32	42	not	not	PART
ajlm-2104	32	43	be	be	AUX
ajlm-2104	32	44	widely	widely	ADV
ajlm-2104	32	45	available	available	ADJ
ajlm-2104	32	46	,	,	PUNCT
ajlm-2104	32	47	have	have	VERB
ajlm-2104	32	48	a	a	DET
ajlm-2104	32	49	longer	long	ADJ
ajlm-2104	32	50	turnaround	turnaround	NOUN
ajlm-2104	32	51	time	time	NOUN
ajlm-2104	32	52	than	than	ADP
ajlm-2104	32	53	a	a	DET
ajlm-2104	32	54	complete	complete	ADJ
ajlm-2104	32	55	blood	blood	NOUN
ajlm-2104	32	56	count	count	NOUN
ajlm-2104	32	57	and	and	CCONJ
ajlm-2104	32	58	require	require	VERB
ajlm-2104	32	59	specialised	specialised	ADJ
ajlm-2104	32	60	instrumentation	instrumentation	NOUN
ajlm-2104	32	61	and	and	CCONJ
ajlm-2104	32	62	costly	costly	ADJ
ajlm-2104	32	63	reagents	reagent	NOUN
ajlm-2104	32	64	.	.	PUNCT
ajlm-2104	33	1	additionally	additionally	ADV
ajlm-2104	33	2	,	,	PUNCT
ajlm-2104	33	3	procalcitonin	procalcitonin	PROPN
ajlm-2104	33	4	may	may	AUX
ajlm-2104	33	5	be	be	AUX
ajlm-2104	33	6	falsely	falsely	ADV
ajlm-2104	33	7	elevated	elevate	VERB
ajlm-2104	33	8	in	in	ADP
ajlm-2104	33	9	conditions	condition	NOUN
ajlm-2104	33	10	such	such	ADJ
ajlm-2104	33	11	as	as	ADP
ajlm-2104	33	12	renal	renal	ADJ
ajlm-2104	33	13	impairment	impairment	NOUN
ajlm-2104	33	14	,	,	PUNCT
ajlm-2104	33	15	congestive	congestive	ADJ
ajlm-2104	33	16	heart	heart	NOUN
ajlm-2104	33	17	disease	disease	NOUN
ajlm-2104	33	18	,	,	PUNCT
ajlm-2104	33	19	burn	burn	VERB
ajlm-2104	33	20	wounds	wound	NOUN
ajlm-2104	33	21	,	,	PUNCT
ajlm-2104	33	22	malignancies	malignancy	NOUN
ajlm-2104	33	23	and	and	CCONJ
ajlm-2104	33	24	acute	acute	PROPN
ajlm-2104	33	25	pancreatitis	pancreatitis	PROPN
ajlm-2104	33	26	,	,	PUNCT
ajlm-2104	33	27	and	and	CCONJ
ajlm-2104	33	28	all	all	DET
ajlm-2104	33	29	common	common	ADJ
ajlm-2104	33	30	sepsis	sepsis	NOUN
ajlm-2104	33	31	complications.9	complications.9	NOUN
ajlm-2104	33	32	c	c	NOUN
ajlm-2104	33	33	-	-	PUNCT
ajlm-2104	33	34	reactive	reactive	ADJ
ajlm-2104	33	35	protein	protein	NOUN
ajlm-2104	33	36	is	be	AUX
ajlm-2104	33	37	an	an	DET
ajlm-2104	33	38	acute	acute	ADJ
ajlm-2104	33	39	-	-	PUNCT
ajlm-2104	33	40	phase	phase	NOUN
ajlm-2104	33	41	protein	protein	NOUN
ajlm-2104	33	42	synthesised	synthesise	VERB
ajlm-2104	33	43	by	by	ADP
ajlm-2104	33	44	the	the	DET
ajlm-2104	33	45	liver	liver	NOUN
ajlm-2104	33	46	in	in	ADP
ajlm-2104	33	47	response	response	NOUN
ajlm-2104	33	48	to	to	ADP
ajlm-2104	33	49	inflammation	inflammation	NOUN
ajlm-2104	33	50	,	,	PUNCT
ajlm-2104	33	51	making	make	VERB
ajlm-2104	33	52	it	it	PRON
ajlm-2104	33	53	an	an	DET
ajlm-2104	33	54	early	early	ADJ
ajlm-2104	33	55	and	and	CCONJ
ajlm-2104	33	56	sensitive	sensitive	ADJ
ajlm-2104	33	57	marker	marker	NOUN
ajlm-2104	33	58	of	of	ADP
ajlm-2104	33	59	sepsis.10	sepsis.10	ADJ
ajlm-2104	33	60	c	c	NOUN
ajlm-2104	33	61	-	-	PUNCT
ajlm-2104	33	62	reactive	reactive	ADJ
ajlm-2104	33	63	protein	protein	NOUN
ajlm-2104	33	64	is	be	AUX
ajlm-2104	33	65	elevated	elevate	VERB
ajlm-2104	33	66	in	in	ADP
ajlm-2104	33	67	infection	infection	NOUN
ajlm-2104	33	68	,	,	PUNCT
ajlm-2104	33	69	injury	injury	NOUN
ajlm-2104	33	70	or	or	CCONJ
ajlm-2104	33	71	chronic	chronic	ADJ
ajlm-2104	33	72	disease	disease	NOUN
ajlm-2104	33	73	inflammations	inflammation	NOUN
ajlm-2104	33	74	.	.	PUNCT
ajlm-2104	34	1	thus	thus	ADV
ajlm-2104	34	2	,	,	PUNCT
ajlm-2104	34	3	it	it	PRON
ajlm-2104	34	4	is	be	AUX
ajlm-2104	34	5	not	not	PART
ajlm-2104	34	6	specific	specific	ADJ
ajlm-2104	34	7	,	,	PUNCT
ajlm-2104	34	8	limiting	limit	VERB
ajlm-2104	34	9	its	its	PRON
ajlm-2104	34	10	use	use	NOUN
ajlm-2104	34	11	as	as	ADP
ajlm-2104	34	12	a	a	DET
ajlm-2104	34	13	marker	marker	NOUN
ajlm-2104	34	14	of	of	ADP
ajlm-2104	34	15	sepsis.11	sepsis.11	NOUN
ajlm-2104	34	16	on	on	ADP
ajlm-2104	34	17	the	the	DET
ajlm-2104	34	18	other	other	ADJ
ajlm-2104	34	19	hand	hand	NOUN
ajlm-2104	34	20	,	,	PUNCT
ajlm-2104	34	21	bc	bc	PROPN
ajlm-2104	34	22	is	be	AUX
ajlm-2104	34	23	a	a	DET
ajlm-2104	34	24	specialised	specialised	ADJ
ajlm-2104	34	25	investigation	investigation	NOUN
ajlm-2104	34	26	that	that	PRON
ajlm-2104	34	27	can	can	AUX
ajlm-2104	34	28	detect	detect	VERB
ajlm-2104	34	29	microorganism	microorganism	NOUN
ajlm-2104	34	30	growth	growth	NOUN
ajlm-2104	34	31	in	in	ADP
ajlm-2104	34	32	a	a	DET
ajlm-2104	34	33	patient	patient	NOUN
ajlm-2104	34	34	’s	’s	PART
ajlm-2104	34	35	blood	blood	NOUN
ajlm-2104	34	36	.	.	PUNCT
ajlm-2104	35	1	it	it	PRON
ajlm-2104	35	2	uses	use	VERB
ajlm-2104	35	3	an	an	DET
ajlm-2104	35	4	enriched	enriched	ADJ
ajlm-2104	35	5	growth	growth	NOUN
ajlm-2104	35	6	medium	medium	NOUN
ajlm-2104	35	7	to	to	PART
ajlm-2104	35	8	support	support	VERB
ajlm-2104	35	9	microbial	microbial	ADJ
ajlm-2104	35	10	growth	growth	NOUN
ajlm-2104	35	11	and	and	CCONJ
ajlm-2104	35	12	a	a	DET
ajlm-2104	35	13	colourimetric	colourimetric	ADJ
ajlm-2104	35	14	detection	detection	NOUN
ajlm-2104	35	15	system	system	NOUN
ajlm-2104	35	16	to	to	PART
ajlm-2104	35	17	detect	detect	VERB
ajlm-2104	35	18	carbon	carbon	NOUN
ajlm-2104	35	19	dioxide	dioxide	NOUN
ajlm-2104	35	20	produced	produce	VERB
ajlm-2104	35	21	by	by	ADP
ajlm-2104	35	22	the	the	DET
ajlm-2104	35	23	growing	grow	VERB
ajlm-2104	35	24	blood	blood	NOUN
ajlm-2104	35	25	pathogens.12	pathogens.12	VERB
ajlm-2104	35	26	any	any	DET
ajlm-2104	35	27	growth	growth	NOUN
ajlm-2104	35	28	within	within	ADP
ajlm-2104	35	29	the	the	DET
ajlm-2104	35	30	media	medium	NOUN
ajlm-2104	35	31	indicates	indicate	VERB
ajlm-2104	35	32	sepsis	sepsis	NOUN
ajlm-2104	35	33	;	;	PUNCT
ajlm-2104	35	34	thus	thus	ADV
ajlm-2104	35	35	,	,	PUNCT
ajlm-2104	35	36	bcs	bc	NOUN
ajlm-2104	35	37	are	be	AUX
ajlm-2104	35	38	considered	consider	VERB
ajlm-2104	35	39	the	the	DET
ajlm-2104	35	40	gold	gold	ADJ
ajlm-2104	35	41	standard	standard	NOUN
ajlm-2104	35	42	of	of	ADP
ajlm-2104	35	43	sepsis	sepsis	NOUN
ajlm-2104	35	44	diagnosis	diagnosis	NOUN
ajlm-2104	35	45	.	.	PUNCT
ajlm-2104	36	1	however	however	ADV
ajlm-2104	36	2	,	,	PUNCT
ajlm-2104	36	3	this	this	DET
ajlm-2104	36	4	test	test	NOUN
ajlm-2104	36	5	has	have	VERB
ajlm-2104	36	6	limitations	limitation	NOUN
ajlm-2104	36	7	,	,	PUNCT
ajlm-2104	36	8	including	include	VERB
ajlm-2104	36	9	sample	sample	NOUN
ajlm-2104	36	10	contamination	contamination	NOUN
ajlm-2104	36	11	due	due	ADP
ajlm-2104	36	12	to	to	ADP
ajlm-2104	36	13	non	non	ADJ
ajlm-2104	36	14	-	-	ADJ
ajlm-2104	36	15	sterile	sterile	ADJ
ajlm-2104	36	16	collection	collection	NOUN
ajlm-2104	36	17	.	.	PUNCT
ajlm-2104	37	1	also	also	ADV
ajlm-2104	37	2	,	,	PUNCT
ajlm-2104	37	3	antibiotics	antibiotic	NOUN
ajlm-2104	37	4	use	use	NOUN
ajlm-2104	37	5	before	before	ADP
ajlm-2104	37	6	sampling	sample	VERB
ajlm-2104	37	7	may	may	AUX
ajlm-2104	37	8	cause	cause	VERB
ajlm-2104	37	9	false	false	ADJ
ajlm-2104	37	10	results	result	NOUN
ajlm-2104	37	11	.	.	PUNCT
ajlm-2104	38	1	in	in	ADP
ajlm-2104	38	2	addition	addition	NOUN
ajlm-2104	38	3	,	,	PUNCT
ajlm-2104	38	4	although	although	SCONJ
ajlm-2104	38	5	clinicians	clinician	NOUN
ajlm-2104	38	6	get	get	VERB
ajlm-2104	38	7	results	result	NOUN
ajlm-2104	38	8	within	within	ADP
ajlm-2104	38	9	24	24	NUM
ajlm-2104	38	10	h	h	NOUN
ajlm-2104	38	11	,	,	PUNCT
ajlm-2104	38	12	slow	slow	ADV
ajlm-2104	38	13	-	-	PUNCT
ajlm-2104	38	14	growing	grow	VERB
ajlm-2104	38	15	organisms	organism	NOUN
ajlm-2104	38	16	can	can	AUX
ajlm-2104	38	17	take	take	VERB
ajlm-2104	38	18	5	5	NUM
ajlm-2104	38	19	days	day	NOUN
ajlm-2104	38	20	or	or	CCONJ
ajlm-2104	38	21	longer	long	ADV
ajlm-2104	38	22	to	to	PART
ajlm-2104	38	23	grow	grow	VERB
ajlm-2104	38	24	,	,	PUNCT
ajlm-2104	38	25	which	which	PRON
ajlm-2104	38	26	is	be	AUX
ajlm-2104	38	27	unsuitable	unsuitable	ADJ
ajlm-2104	38	28	for	for	ADP
ajlm-2104	38	29	early	early	ADJ
ajlm-2104	38	30	diagnosis.13	diagnosis.13	NOUN
ajlm-2104	38	31	therefore	therefore	ADV
ajlm-2104	38	32	,	,	PUNCT
ajlm-2104	38	33	although	although	SCONJ
ajlm-2104	38	34	these	these	DET
ajlm-2104	38	35	biomarkers	biomarker	NOUN
ajlm-2104	38	36	and	and	CCONJ
ajlm-2104	38	37	culture	culture	NOUN
ajlm-2104	38	38	techniques	technique	NOUN
ajlm-2104	38	39	are	be	AUX
ajlm-2104	38	40	helpful	helpful	ADJ
ajlm-2104	38	41	,	,	PUNCT
ajlm-2104	38	42	the	the	DET
ajlm-2104	38	43	need	need	NOUN
ajlm-2104	38	44	for	for	ADP
ajlm-2104	38	45	a	a	DET
ajlm-2104	38	46	quick	quick	ADJ
ajlm-2104	38	47	,	,	PUNCT
ajlm-2104	38	48	efficient	efficient	ADJ
ajlm-2104	38	49	and	and	CCONJ
ajlm-2104	38	50	cost	cost	NOUN
ajlm-2104	38	51	-	-	PUNCT
ajlm-2104	38	52	effective	effective	ADJ
ajlm-2104	38	53	method	method	NOUN
ajlm-2104	38	54	to	to	PART
ajlm-2104	38	55	screen	screen	VERB
ajlm-2104	38	56	for	for	ADP
ajlm-2104	38	57	early	early	ADJ
ajlm-2104	38	58	sepsis	sepsis	NOUN
ajlm-2104	38	59	is	be	AUX
ajlm-2104	38	60	still	still	ADV
ajlm-2104	38	61	relevant	relevant	ADJ
ajlm-2104	38	62	.	.	PUNCT
ajlm-2104	39	1	recent	recent	ADJ
ajlm-2104	39	2	studies	study	NOUN
ajlm-2104	39	3	have	have	AUX
ajlm-2104	39	4	reported	report	VERB
ajlm-2104	39	5	using	use	VERB
ajlm-2104	39	6	full	full	ADJ
ajlm-2104	39	7	blood	blood	NOUN
ajlm-2104	39	8	count	count	NOUN
ajlm-2104	39	9	parameters	parameter	NOUN
ajlm-2104	39	10	and	and	CCONJ
ajlm-2104	39	11	cell	cell	NOUN
ajlm-2104	39	12	ratios	ratio	NOUN
ajlm-2104	39	13	to	to	PART
ajlm-2104	39	14	screen	screen	VERB
ajlm-2104	39	15	for	for	ADP
ajlm-2104	39	16	sepsis.14,15	sepsis.14,15	NOUN
ajlm-2104	39	17	it	it	PRON
ajlm-2104	39	18	is	be	AUX
ajlm-2104	39	19	generally	generally	ADV
ajlm-2104	39	20	accepted	accept	VERB
ajlm-2104	39	21	that	that	SCONJ
ajlm-2104	39	22	an	an	DET
ajlm-2104	39	23	abnormal	abnormal	ADJ
ajlm-2104	39	24	white	white	ADJ
ajlm-2104	39	25	cell	cell	NOUN
ajlm-2104	39	26	count	count	NOUN
ajlm-2104	39	27	with	with	ADP
ajlm-2104	39	28	an	an	DET
ajlm-2104	39	29	increase	increase	NOUN
ajlm-2104	39	30	in	in	ADP
ajlm-2104	39	31	immature	immature	ADJ
ajlm-2104	39	32	granulocytes	granulocyte	NOUN
ajlm-2104	39	33	indicates	indicate	VERB
ajlm-2104	39	34	sepsis	sepsis	NOUN
ajlm-2104	39	35	and	and	CCONJ
ajlm-2104	39	36	has	have	AUX
ajlm-2104	39	37	been	be	AUX
ajlm-2104	39	38	included	include	VERB
ajlm-2104	39	39	as	as	ADP
ajlm-2104	39	40	one	one	NUM
ajlm-2104	39	41	of	of	ADP
ajlm-2104	39	42	the	the	DET
ajlm-2104	39	43	four	four	NUM
ajlm-2104	39	44	systemic	systemic	ADJ
ajlm-2104	39	45	inflammatory	inflammatory	ADJ
ajlm-2104	39	46	response	response	NOUN
ajlm-2104	39	47	syndrome	syndrome	PROPN
ajlm-2104	39	48	criteria.16	criteria.16	PROPN
ajlm-2104	39	49	automated	automate	VERB
ajlm-2104	39	50	full	full	ADJ
ajlm-2104	39	51	blood	blood	NOUN
ajlm-2104	39	52	and	and	CCONJ
ajlm-2104	39	53	differential	differential	ADJ
ajlm-2104	39	54	counts	count	NOUN
ajlm-2104	39	55	are	be	AUX
ajlm-2104	39	56	essential	essential	ADJ
ajlm-2104	39	57	in	in	ADP
ajlm-2104	39	58	diagnosing	diagnosing	NOUN
ajlm-2104	39	59	sepsis	sepsis	NOUN
ajlm-2104	39	60	and	and	CCONJ
ajlm-2104	39	61	are	be	AUX
ajlm-2104	39	62	often	often	ADV
ajlm-2104	39	63	the	the	DET
ajlm-2104	39	64	first	first	ADJ
ajlm-2104	39	65	laboratory	laboratory	NOUN
ajlm-2104	39	66	test	test	NOUN
ajlm-2104	39	67	to	to	PART
ajlm-2104	39	68	be	be	AUX
ajlm-2104	39	69	requested	request	VERB
ajlm-2104	39	70	.	.	PUNCT
ajlm-2104	40	1	it	it	PRON
ajlm-2104	40	2	has	have	VERB
ajlm-2104	40	3	a	a	DET
ajlm-2104	40	4	fast	fast	ADJ
ajlm-2104	40	5	turnaround	turnaround	NOUN
ajlm-2104	40	6	time	time	NOUN
ajlm-2104	40	7	,	,	PUNCT
ajlm-2104	40	8	is	be	AUX
ajlm-2104	40	9	cost	cost	NOUN
ajlm-2104	40	10	-	-	PUNCT
ajlm-2104	40	11	effective	effective	ADJ
ajlm-2104	40	12	and	and	CCONJ
ajlm-2104	40	13	can	can	AUX
ajlm-2104	40	14	potentially	potentially	ADV
ajlm-2104	40	15	provide	provide	VERB
ajlm-2104	40	16	crucial	crucial	ADJ
ajlm-2104	40	17	information	information	NOUN
ajlm-2104	40	18	on	on	ADP
ajlm-2104	40	19	peripheral	peripheral	ADJ
ajlm-2104	40	20	blood	blood	NOUN
ajlm-2104	40	21	cell	cell	NOUN
ajlm-2104	40	22	populations	population	NOUN
ajlm-2104	40	23	if	if	SCONJ
ajlm-2104	40	24	interpreted	interpret	VERB
ajlm-2104	40	25	correctly	correctly	ADV
ajlm-2104	40	26	.	.	PUNCT
ajlm-2104	41	1	bacterial	bacterial	ADJ
ajlm-2104	41	2	sepsis	sepsis	NOUN
ajlm-2104	41	3	is	be	AUX
ajlm-2104	41	4	complex	complex	ADJ
ajlm-2104	41	5	and	and	CCONJ
ajlm-2104	41	6	results	result	NOUN
ajlm-2104	41	7	in	in	ADP
ajlm-2104	41	8	the	the	DET
ajlm-2104	41	9	initiation	initiation	NOUN
ajlm-2104	41	10	of	of	ADP
ajlm-2104	41	11	an	an	DET
ajlm-2104	41	12	acute	acute	ADJ
ajlm-2104	41	13	inflammatory	inflammatory	ADJ
ajlm-2104	41	14	response	response	NOUN
ajlm-2104	41	15	with	with	ADP
ajlm-2104	41	16	the	the	DET
ajlm-2104	41	17	release	release	NOUN
ajlm-2104	41	18	of	of	ADP
ajlm-2104	41	19	cytokines	cytokine	NOUN
ajlm-2104	41	20	,	,	PUNCT
ajlm-2104	41	21	chemokines	chemokine	NOUN
ajlm-2104	41	22	and	and	CCONJ
ajlm-2104	41	23	alterations	alteration	NOUN
ajlm-2104	41	24	in	in	ADP
ajlm-2104	41	25	the	the	DET
ajlm-2104	41	26	proportions	proportion	NOUN
ajlm-2104	41	27	and	and	CCONJ
ajlm-2104	41	28	numbers	number	NOUN
ajlm-2104	41	29	of	of	ADP
ajlm-2104	41	30	innate	innate	ADJ
ajlm-2104	41	31	and	and	CCONJ
ajlm-2104	41	32	adaptive	adaptive	ADJ
ajlm-2104	41	33	immune	immune	ADJ
ajlm-2104	41	34	cells	cell	NOUN
ajlm-2104	41	35	.	.	PUNCT
ajlm-2104	42	1	these	these	DET
ajlm-2104	42	2	changes	change	NOUN
ajlm-2104	42	3	can	can	AUX
ajlm-2104	42	4	be	be	AUX
ajlm-2104	42	5	detected	detect	VERB
ajlm-2104	42	6	by	by	ADP
ajlm-2104	42	7	analysing	analyse	VERB
ajlm-2104	42	8	the	the	DET
ajlm-2104	42	9	automated	automate	VERB
ajlm-2104	42	10	full	full	ADJ
ajlm-2104	42	11	blood	blood	NOUN
ajlm-2104	42	12	count	count	NOUN
ajlm-2104	42	13	and	and	CCONJ
ajlm-2104	42	14	differential	differential	ADJ
ajlm-2104	42	15	results.17	results.17	NOUN
ajlm-2104	42	16	neutrophils	neutrophil	NOUN
ajlm-2104	42	17	,	,	PUNCT
ajlm-2104	42	18	the	the	DET
ajlm-2104	42	19	most	most	ADV
ajlm-2104	42	20	common	common	ADJ
ajlm-2104	42	21	peripheral	peripheral	ADJ
ajlm-2104	42	22	leucocytes	leucocyte	NOUN
ajlm-2104	42	23	,	,	PUNCT
ajlm-2104	42	24	form	form	VERB
ajlm-2104	42	25	part	part	NOUN
ajlm-2104	42	26	of	of	ADP
ajlm-2104	42	27	the	the	DET
ajlm-2104	42	28	innate	innate	ADJ
ajlm-2104	42	29	immune	immune	ADJ
ajlm-2104	42	30	response	response	NOUN
ajlm-2104	42	31	and	and	CCONJ
ajlm-2104	42	32	are	be	AUX
ajlm-2104	42	33	released	release	VERB
ajlm-2104	42	34	by	by	ADP
ajlm-2104	42	35	the	the	DET
ajlm-2104	42	36	bone	bone	NOUN
ajlm-2104	42	37	marrow	marrow	NOUN
ajlm-2104	42	38	in	in	ADP
ajlm-2104	42	39	response	response	NOUN
ajlm-2104	42	40	to	to	ADP
ajlm-2104	42	41	several	several	ADJ
ajlm-2104	42	42	stimuli	stimulus	NOUN
ajlm-2104	42	43	,	,	PUNCT
ajlm-2104	42	44	including	include	VERB
ajlm-2104	42	45	stress	stress	NOUN
ajlm-2104	42	46	,	,	PUNCT
ajlm-2104	42	47	smoking	smoking	NOUN
ajlm-2104	42	48	and	and	CCONJ
ajlm-2104	42	49	inflammation.18	inflammation.18	VERB
ajlm-2104	42	50	during	during	ADP
ajlm-2104	42	51	sepsis	sepsis	NOUN
ajlm-2104	42	52	or	or	CCONJ
ajlm-2104	42	53	infection	infection	NOUN
ajlm-2104	42	54	,	,	PUNCT
ajlm-2104	42	55	they	they	PRON
ajlm-2104	42	56	increase	increase	VERB
ajlm-2104	42	57	rapidly	rapidly	ADV
ajlm-2104	42	58	and	and	CCONJ
ajlm-2104	42	59	can	can	AUX
ajlm-2104	42	60	eliminate	eliminate	VERB
ajlm-2104	42	61	pathogens	pathogen	NOUN
ajlm-2104	42	62	by	by	ADP
ajlm-2104	42	63	phagocytosis	phagocytosis	NOUN
ajlm-2104	42	64	and	and	CCONJ
ajlm-2104	42	65	oxidative	oxidative	ADJ
ajlm-2104	42	66	bursts	burst	NOUN
ajlm-2104	42	67	.	.	PUNCT
ajlm-2104	43	1	in	in	ADP
ajlm-2104	43	2	severe	severe	ADJ
ajlm-2104	43	3	cases	case	NOUN
ajlm-2104	43	4	,	,	PUNCT
ajlm-2104	43	5	the	the	DET
ajlm-2104	43	6	neutrophil	neutrophil	ADJ
ajlm-2104	43	7	function	function	NOUN
ajlm-2104	43	8	can	can	AUX
ajlm-2104	43	9	become	become	VERB
ajlm-2104	43	10	dysregulated	dysregulated	ADJ
ajlm-2104	43	11	,	,	PUNCT
ajlm-2104	43	12	leading	lead	VERB
ajlm-2104	43	13	to	to	ADP
ajlm-2104	43	14	chronic	chronic	ADJ
ajlm-2104	43	15	inflammation.18	inflammation.18	NOUN
ajlm-2104	43	16	it	it	PRON
ajlm-2104	43	17	is	be	AUX
ajlm-2104	43	18	believed	believe	VERB
ajlm-2104	43	19	that	that	SCONJ
ajlm-2104	43	20	after	after	SCONJ
ajlm-2104	43	21	exposure	exposure	NOUN
ajlm-2104	43	22	to	to	ADP
ajlm-2104	43	23	lipopolysaccharides	lipopolysaccharide	NOUN
ajlm-2104	43	24	,	,	PUNCT
ajlm-2104	43	25	anti	anti	ADJ
ajlm-2104	43	26	-	-	ADJ
ajlm-2104	43	27	apoptotic	apoptotic	ADJ
ajlm-2104	43	28	signals	signal	NOUN
ajlm-2104	43	29	of	of	ADP
ajlm-2104	43	30	the	the	DET
ajlm-2104	43	31	b	b	NOUN
ajlm-2104	43	32	-	-	PUNCT
ajlm-2104	43	33	cell	cell	NOUN
ajlm-2104	43	34	lymphoma	lymphoma	NOUN
ajlm-2104	43	35	2	2	NUM
ajlm-2104	43	36	(	(	PUNCT
ajlm-2104	43	37	bcl-2	bcl-2	NOUN
ajlm-2104	43	38	)	)	PUNCT
ajlm-2104	43	39	family	family	NOUN
ajlm-2104	43	40	are	be	AUX
ajlm-2104	43	41	upregulated	upregulate	VERB
ajlm-2104	43	42	,	,	PUNCT
ajlm-2104	43	43	leading	lead	VERB
ajlm-2104	43	44	to	to	ADP
ajlm-2104	43	45	neutrophils	neutrophil	NOUN
ajlm-2104	43	46	resisting	resist	VERB
ajlm-2104	43	47	apoptosis	apoptosis	NOUN
ajlm-2104	43	48	and	and	CCONJ
ajlm-2104	43	49	increasing	increase	VERB
ajlm-2104	43	50	their	their	PRON
ajlm-2104	43	51	lifespan.18	lifespan.18	NOUN
ajlm-2104	43	52	although	although	SCONJ
ajlm-2104	43	53	a	a	DET
ajlm-2104	43	54	disruption	disruption	NOUN
ajlm-2104	43	55	in	in	ADP
ajlm-2104	43	56	neutrophil	neutrophil	ADJ
ajlm-2104	43	57	numbers	number	NOUN
ajlm-2104	43	58	can	can	AUX
ajlm-2104	43	59	indicate	indicate	VERB
ajlm-2104	43	60	infection	infection	NOUN
ajlm-2104	43	61	,	,	PUNCT
ajlm-2104	43	62	on	on	ADP
ajlm-2104	43	63	their	their	PRON
ajlm-2104	43	64	own	own	ADJ
ajlm-2104	43	65	they	they	PRON
ajlm-2104	43	66	are	be	AUX
ajlm-2104	43	67	not	not	PART
ajlm-2104	43	68	a	a	DET
ajlm-2104	43	69	reliable	reliable	ADJ
ajlm-2104	43	70	indicator	indicator	NOUN
ajlm-2104	43	71	of	of	ADP
ajlm-2104	43	72	sepsis	sepsis	NOUN
ajlm-2104	43	73	.	.	PUNCT
ajlm-2104	44	1	in	in	ADP
ajlm-2104	44	2	africa	africa	PROPN
ajlm-2104	44	3	,	,	PUNCT
ajlm-2104	44	4	benign	benign	ADJ
ajlm-2104	44	5	ethnic	ethnic	ADJ
ajlm-2104	44	6	neutropenia	neutropenia	NOUN
ajlm-2104	44	7	,	,	PUNCT
ajlm-2104	44	8	defined	define	VERB
ajlm-2104	44	9	as	as	ADP
ajlm-2104	44	10	a	a	DET
ajlm-2104	44	11	neutrophil	neutrophil	ADJ
ajlm-2104	44	12	count	count	NOUN
ajlm-2104	44	13	of	of	ADP
ajlm-2104	44	14	<	<	X
ajlm-2104	44	15	1.5	1.5	NUM
ajlm-2104	44	16	×	×	NOUN
ajlm-2104	44	17	109	109	NUM
ajlm-2104	44	18	/	/	SYM
ajlm-2104	44	19	l	l	NOUN
ajlm-2104	44	20	in	in	ADP
ajlm-2104	44	21	normal	normal	ADJ
ajlm-2104	44	22	healthy	healthy	ADJ
ajlm-2104	44	23	individuals	individual	NOUN
ajlm-2104	44	24	,	,	PUNCT
ajlm-2104	44	25	is	be	AUX
ajlm-2104	44	26	common	common	ADJ
ajlm-2104	44	27	,	,	PUNCT
ajlm-2104	44	28	and	and	CCONJ
ajlm-2104	44	29	researchers	researcher	NOUN
ajlm-2104	44	30	have	have	AUX
ajlm-2104	44	31	proposed	propose	VERB
ajlm-2104	44	32	that	that	SCONJ
ajlm-2104	44	33	the	the	DET
ajlm-2104	44	34	reference	reference	NOUN
ajlm-2104	44	35	interval	interval	NOUN
ajlm-2104	44	36	for	for	ADP
ajlm-2104	44	37	neutrophils	neutrophil	NOUN
ajlm-2104	44	38	in	in	ADP
ajlm-2104	44	39	african	african	ADJ
ajlm-2104	44	40	populations	population	NOUN
ajlm-2104	44	41	is	be	AUX
ajlm-2104	44	42	lower	low	ADJ
ajlm-2104	44	43	than	than	ADP
ajlm-2104	44	44	in	in	ADP
ajlm-2104	44	45	other	other	ADJ
ajlm-2104	44	46	population	population	NOUN
ajlm-2104	44	47	groups.19,20	groups.19,20	NOUN
ajlm-2104	44	48	this	this	DET
ajlm-2104	44	49	african	african	ADJ
ajlm-2104	44	50	neutrophil	neutrophil	ADJ
ajlm-2104	44	51	reference	reference	NOUN
ajlm-2104	44	52	interval	interval	NOUN
ajlm-2104	44	53	is	be	AUX
ajlm-2104	44	54	essential	essential	ADJ
ajlm-2104	44	55	for	for	ADP
ajlm-2104	44	56	benchmarking	benchmarke	VERB
ajlm-2104	44	57	limits	limit	NOUN
ajlm-2104	44	58	at	at	ADP
ajlm-2104	44	59	which	which	PRON
ajlm-2104	44	60	the	the	DET
ajlm-2104	44	61	white	white	ADJ
ajlm-2104	44	62	cell	cell	NOUN
ajlm-2104	44	63	count	count	NOUN
ajlm-2104	44	64	and	and	CCONJ
ajlm-2104	44	65	neutrophil	neutrophil	ADJ
ajlm-2104	44	66	count	count	NOUN
ajlm-2104	44	67	can	can	AUX
ajlm-2104	44	68	screen	screen	VERB
ajlm-2104	44	69	sepsis	sepsis	NOUN
ajlm-2104	44	70	in	in	ADP
ajlm-2104	44	71	african	african	ADJ
ajlm-2104	44	72	populations	population	NOUN
ajlm-2104	44	73	.	.	PUNCT
ajlm-2104	45	1	on	on	ADP
ajlm-2104	45	2	the	the	DET
ajlm-2104	45	3	other	other	ADJ
ajlm-2104	45	4	hand	hand	NOUN
ajlm-2104	45	5	,	,	PUNCT
ajlm-2104	45	6	lymphocytes	lymphocyte	VERB
ajlm-2104	45	7	make	make	VERB
ajlm-2104	45	8	up	up	ADP
ajlm-2104	45	9	20	20	NUM
ajlm-2104	45	10	%	%	NOUN
ajlm-2104	45	11	–	–	PUNCT
ajlm-2104	45	12	40	40	NUM
ajlm-2104	45	13	%	%	NOUN
ajlm-2104	45	14	of	of	ADP
ajlm-2104	45	15	circulating	circulate	VERB
ajlm-2104	45	16	blood	blood	NOUN
ajlm-2104	45	17	cells	cell	NOUN
ajlm-2104	45	18	and	and	CCONJ
ajlm-2104	45	19	form	form	VERB
ajlm-2104	45	20	part	part	NOUN
ajlm-2104	45	21	of	of	ADP
ajlm-2104	45	22	the	the	DET
ajlm-2104	45	23	adaptive	adaptive	ADJ
ajlm-2104	45	24	immune	immune	ADJ
ajlm-2104	45	25	system	system	NOUN
ajlm-2104	45	26	.	.	PUNCT
ajlm-2104	46	1	during	during	ADP
ajlm-2104	46	2	sepsis	sepsis	NOUN
ajlm-2104	46	3	,	,	PUNCT
ajlm-2104	46	4	this	this	DET
ajlm-2104	46	5	cell	cell	NOUN
ajlm-2104	46	6	population	population	NOUN
ajlm-2104	46	7	,	,	PUNCT
ajlm-2104	46	8	unlike	unlike	ADP
ajlm-2104	46	9	neutrophils	neutrophil	NOUN
ajlm-2104	46	10	,	,	PUNCT
ajlm-2104	46	11	undergoes	undergoe	NOUN
ajlm-2104	46	12	apoptosis	apoptosis	NOUN
ajlm-2104	46	13	leading	lead	VERB
ajlm-2104	46	14	to	to	ADP
ajlm-2104	46	15	severe	severe	ADJ
ajlm-2104	46	16	lymphopenia	lymphopenia	NOUN
ajlm-2104	46	17	.	.	PUNCT
ajlm-2104	47	1	therefore	therefore	ADV
ajlm-2104	47	2	,	,	PUNCT
ajlm-2104	47	3	calculating	calculate	VERB
ajlm-2104	47	4	the	the	DET
ajlm-2104	47	5	neutrophil	neutrophil	NOUN
ajlm-2104	47	6	-	-	PUNCT
ajlm-2104	47	7	to	to	ADP
ajlm-2104	47	8	-	-	PUNCT
ajlm-2104	47	9	lymphocyte	lymphocyte	NOUN
ajlm-2104	47	10	ratio	ratio	NOUN
ajlm-2104	47	11	(	(	PUNCT
ajlm-2104	47	12	nlr	nlr	PROPN
ajlm-2104	47	13	)	)	PUNCT
ajlm-2104	47	14	can	can	AUX
ajlm-2104	47	15	be	be	AUX
ajlm-2104	47	16	a	a	DET
ajlm-2104	47	17	far	far	ADV
ajlm-2104	47	18	more	more	ADV
ajlm-2104	47	19	valuable	valuable	ADJ
ajlm-2104	47	20	and	and	CCONJ
ajlm-2104	47	21	reliable	reliable	ADJ
ajlm-2104	47	22	sepsis	sepsis	NOUN
ajlm-2104	47	23	biomarker	biomarker	NOUN
ajlm-2104	47	24	than	than	ADP
ajlm-2104	47	25	the	the	DET
ajlm-2104	47	26	neutrophil	neutrophil	ADJ
ajlm-2104	47	27	count	count	NOUN
ajlm-2104	47	28	alone.21,22,23,24,25	alone.21,22,23,24,25	PROPN
ajlm-2104	47	29	monocytes	monocyte	NOUN
ajlm-2104	47	30	,	,	PUNCT
ajlm-2104	47	31	also	also	ADV
ajlm-2104	47	32	measured	measure	VERB
ajlm-2104	47	33	by	by	ADP
ajlm-2104	47	34	an	an	DET
ajlm-2104	47	35	automated	automate	VERB
ajlm-2104	47	36	cell	cell	NOUN
ajlm-2104	47	37	counter	counter	NOUN
ajlm-2104	47	38	,	,	PUNCT
ajlm-2104	47	39	are	be	AUX
ajlm-2104	47	40	innate	innate	ADJ
ajlm-2104	47	41	immune	immune	ADJ
ajlm-2104	47	42	cells	cell	NOUN
ajlm-2104	47	43	that	that	PRON
ajlm-2104	47	44	function	function	VERB
ajlm-2104	47	45	as	as	ADP
ajlm-2104	47	46	phagocytes	phagocyte	NOUN
ajlm-2104	47	47	and	and	CCONJ
ajlm-2104	47	48	initiate	initiate	VERB
ajlm-2104	47	49	the	the	DET
ajlm-2104	47	50	adaptive	adaptive	ADJ
ajlm-2104	47	51	immune	immune	ADJ
ajlm-2104	47	52	response	response	NOUN
ajlm-2104	47	53	by	by	ADP
ajlm-2104	47	54	presenting	present	VERB
ajlm-2104	47	55	bacterial	bacterial	ADJ
ajlm-2104	47	56	antigens	antigen	NOUN
ajlm-2104	47	57	to	to	ADP
ajlm-2104	47	58	t	t	NOUN
ajlm-2104	47	59	-	-	PUNCT
ajlm-2104	47	60	cells	cell	NOUN
ajlm-2104	47	61	and	and	CCONJ
ajlm-2104	47	62	secreting	secrete	VERB
ajlm-2104	47	63	proinflammatory	proinflammatory	ADJ
ajlm-2104	47	64	cytokines	cytokine	NOUN
ajlm-2104	47	65	.	.	PUNCT
ajlm-2104	48	1	monocyte	monocyte	NOUN
ajlm-2104	48	2	counts	count	NOUN
ajlm-2104	48	3	are	be	AUX
ajlm-2104	48	4	known	know	VERB
ajlm-2104	48	5	to	to	PART
ajlm-2104	48	6	climb	climb	VERB
ajlm-2104	48	7	rapidly	rapidly	ADV
ajlm-2104	48	8	during	during	ADP
ajlm-2104	48	9	the	the	DET
ajlm-2104	48	10	early	early	ADJ
ajlm-2104	48	11	stages	stage	NOUN
ajlm-2104	48	12	of	of	ADP
ajlm-2104	48	13	infection	infection	NOUN
ajlm-2104	48	14	;	;	PUNCT
ajlm-2104	48	15	however	however	ADV
ajlm-2104	48	16	,	,	PUNCT
ajlm-2104	48	17	much	much	ADJ
ajlm-2104	48	18	like	like	ADP
ajlm-2104	48	19	neutrophils	neutrophil	NOUN
ajlm-2104	48	20	they	they	PRON
ajlm-2104	48	21	can	can	AUX
ajlm-2104	48	22	become	become	VERB
ajlm-2104	48	23	defective	defective	ADJ
ajlm-2104	48	24	and	and	CCONJ
ajlm-2104	48	25	undergo	undergo	VERB
ajlm-2104	48	26	rapid	rapid	ADJ
ajlm-2104	48	27	apoptosis.26,27	apoptosis.26,27	NOUN
ajlm-2104	48	28	it	it	PRON
ajlm-2104	48	29	has	have	AUX
ajlm-2104	48	30	been	be	AUX
ajlm-2104	48	31	suggested	suggest	VERB
ajlm-2104	48	32	that	that	SCONJ
ajlm-2104	48	33	the	the	DET
ajlm-2104	48	34	monocyte	monocyte	NOUN
ajlm-2104	48	35	-	-	PUNCT
ajlm-2104	48	36	to	to	ADP
ajlm-2104	48	37	-	-	PUNCT
ajlm-2104	48	38	lymphocyte	lymphocyte	ADJ
ajlm-2104	48	39	ratio	ratio	NOUN
ajlm-2104	48	40	(	(	PUNCT
ajlm-2104	48	41	mlr	mlr	NOUN
ajlm-2104	48	42	)	)	PUNCT
ajlm-2104	48	43	could	could	AUX
ajlm-2104	48	44	add	add	VERB
ajlm-2104	48	45	valuable	valuable	ADJ
ajlm-2104	48	46	information	information	NOUN
ajlm-2104	48	47	to	to	ADP
ajlm-2104	48	48	early	early	ADJ
ajlm-2104	48	49	sepsis	sepsis	NOUN
ajlm-2104	48	50	screening.28	screening.28	NOUN
ajlm-2104	48	51	however	however	ADV
ajlm-2104	48	52	,	,	PUNCT
ajlm-2104	48	53	studies	study	NOUN
ajlm-2104	48	54	examining	examine	VERB
ajlm-2104	48	55	this	this	DET
ajlm-2104	48	56	parameter	parameter	NOUN
ajlm-2104	48	57	are	be	AUX
ajlm-2104	48	58	scarce	scarce	ADJ
ajlm-2104	48	59	and	and	CCONJ
ajlm-2104	48	60	conflicting.29,30	conflicting.29,30	NOUN
ajlm-2104	48	61	platelets	platelet	NOUN
ajlm-2104	48	62	,	,	PUNCT
ajlm-2104	48	63	the	the	DET
ajlm-2104	48	64	smallest	small	ADJ
ajlm-2104	48	65	circulating	circulate	VERB
ajlm-2104	48	66	blood	blood	NOUN
ajlm-2104	48	67	cells	cell	NOUN
ajlm-2104	48	68	,	,	PUNCT
ajlm-2104	48	69	lack	lack	VERB
ajlm-2104	48	70	a	a	DET
ajlm-2104	48	71	nucleus	nucleus	NOUN
ajlm-2104	48	72	and	and	CCONJ
ajlm-2104	48	73	are	be	AUX
ajlm-2104	48	74	usually	usually	ADV
ajlm-2104	48	75	released	release	VERB
ajlm-2104	48	76	by	by	ADP
ajlm-2104	48	77	the	the	DET
ajlm-2104	48	78	bone	bone	NOUN
ajlm-2104	48	79	marrow	marrow	NOUN
ajlm-2104	48	80	in	in	ADP
ajlm-2104	48	81	response	response	NOUN
ajlm-2104	48	82	to	to	ADP
ajlm-2104	48	83	bleeding	bleeding	NOUN
ajlm-2104	48	84	and	and	CCONJ
ajlm-2104	48	85	endothelial	endothelial	ADJ
ajlm-2104	48	86	injury	injury	NOUN
ajlm-2104	48	87	.	.	PUNCT
ajlm-2104	49	1	platelets	platelet	NOUN
ajlm-2104	49	2	participate	participate	VERB
ajlm-2104	49	3	in	in	ADP
ajlm-2104	49	4	haemostasis	haemostasis	NOUN
ajlm-2104	49	5	and	and	CCONJ
ajlm-2104	49	6	the	the	DET
ajlm-2104	49	7	inflammatory	inflammatory	ADJ
ajlm-2104	49	8	response	response	NOUN
ajlm-2104	49	9	by	by	ADP
ajlm-2104	49	10	secreting	secrete	VERB
ajlm-2104	49	11	cytokines	cytokine	NOUN
ajlm-2104	49	12	,	,	PUNCT
ajlm-2104	49	13	recognising	recognise	VERB
ajlm-2104	49	14	pathogen	pathogen	NOUN
ajlm-2104	49	15	-	-	PUNCT
ajlm-2104	49	16	associated	associate	VERB
ajlm-2104	49	17	molecular	molecular	ADJ
ajlm-2104	49	18	patterns	pattern	NOUN
ajlm-2104	49	19	and	and	CCONJ
ajlm-2104	49	20	activating	activate	VERB
ajlm-2104	49	21	innate	innate	ADJ
ajlm-2104	49	22	immune	immune	ADJ
ajlm-2104	49	23	cells.31	cells.31	NOUN
ajlm-2104	49	24	thus	thus	ADV
ajlm-2104	49	25	,	,	PUNCT
ajlm-2104	49	26	their	their	PRON
ajlm-2104	49	27	involvement	involvement	NOUN
ajlm-2104	49	28	in	in	ADP
ajlm-2104	49	29	both	both	DET
ajlm-2104	49	30	processes	process	NOUN
ajlm-2104	49	31	makes	make	VERB
ajlm-2104	49	32	them	they	PRON
ajlm-2104	49	33	critical	critical	ADJ
ajlm-2104	49	34	in	in	ADP
ajlm-2104	49	35	sepsis	sepsis	NOUN
ajlm-2104	49	36	.	.	PUNCT
ajlm-2104	50	1	thrombocytopaenia	thrombocytopaenia	NOUN
ajlm-2104	50	2	,	,	PUNCT
ajlm-2104	50	3	defined	define	VERB
ajlm-2104	50	4	by	by	ADP
ajlm-2104	50	5	a	a	DET
ajlm-2104	50	6	platelet	platelet	NOUN
ajlm-2104	50	7	count	count	NOUN
ajlm-2104	50	8	of	of	ADP
ajlm-2104	50	9	<	<	X
ajlm-2104	50	10	150	150	NUM
ajlm-2104	50	11	×	×	NOUN
ajlm-2104	50	12	109	109	NUM
ajlm-2104	50	13	/	/	SYM
ajlm-2104	50	14	l	l	NOUN
ajlm-2104	50	15	,	,	PUNCT
ajlm-2104	50	16	is	be	AUX
ajlm-2104	50	17	common	common	ADJ
ajlm-2104	50	18	in	in	ADP
ajlm-2104	50	19	sepsis	sepsis	NOUN
ajlm-2104	50	20	and	and	CCONJ
ajlm-2104	50	21	forms	form	VERB
ajlm-2104	50	22	part	part	NOUN
ajlm-2104	50	23	of	of	ADP
ajlm-2104	50	24	the	the	DET
ajlm-2104	50	25	sequential	sequential	ADJ
ajlm-2104	50	26	organ	organ	NOUN
ajlm-2104	50	27	failure	failure	NOUN
ajlm-2104	50	28	assessment	assessment	NOUN
ajlm-2104	50	29	score,4	score,4	NOUN
ajlm-2104	50	30	which	which	PRON
ajlm-2104	50	31	measures	measure	VERB
ajlm-2104	50	32	organ	organ	NOUN
ajlm-2104	50	33	failure	failure	NOUN
ajlm-2104	50	34	and	and	CCONJ
ajlm-2104	50	35	forms	form	VERB
ajlm-2104	50	36	part	part	NOUN
ajlm-2104	50	37	of	of	ADP
ajlm-2104	50	38	the	the	DET
ajlm-2104	50	39	diagnostic	diagnostic	ADJ
ajlm-2104	50	40	criteria	criterion	NOUN
ajlm-2104	50	41	for	for	ADP
ajlm-2104	50	42	sepsis	sepsis	NOUN
ajlm-2104	50	43	.	.	PUNCT
ajlm-2104	51	1	furthermore	furthermore	ADV
ajlm-2104	51	2	,	,	PUNCT
ajlm-2104	51	3	the	the	DET
ajlm-2104	51	4	prognostic	prognostic	ADJ
ajlm-2104	51	5	value	value	NOUN
ajlm-2104	51	6	of	of	ADP
ajlm-2104	51	7	a	a	DET
ajlm-2104	51	8	severely	severely	ADV
ajlm-2104	51	9	decreased	decrease	VERB
ajlm-2104	51	10	platelet	platelet	NOUN
ajlm-2104	51	11	count	count	NOUN
ajlm-2104	51	12	(	(	PUNCT
ajlm-2104	51	13	<	<	X
ajlm-2104	51	14	50	50	NUM
ajlm-2104	51	15	×	×	NOUN
ajlm-2104	51	16	109	109	NUM
ajlm-2104	51	17	/	/	SYM
ajlm-2104	51	18	l	l	NOUN
ajlm-2104	51	19	)	)	PUNCT
ajlm-2104	51	20	in	in	ADP
ajlm-2104	51	21	septic	septic	ADJ
ajlm-2104	51	22	patients	patient	NOUN
ajlm-2104	51	23	has	have	AUX
ajlm-2104	51	24	been	be	AUX
ajlm-2104	51	25	demonstrated,32	demonstrated,32	VERB
ajlm-2104	51	26	while	while	SCONJ
ajlm-2104	51	27	a	a	DET
ajlm-2104	51	28	study	study	NOUN
ajlm-2104	51	29	of	of	ADP
ajlm-2104	51	30	5537	5537	NUM
ajlm-2104	51	31	patients	patient	NOUN
ajlm-2104	51	32	with	with	ADP
ajlm-2104	51	33	sepsis	sepsis	NOUN
ajlm-2104	51	34	reported	report	VERB
ajlm-2104	51	35	that	that	SCONJ
ajlm-2104	51	36	patients	patient	NOUN
ajlm-2104	51	37	with	with	ADP
ajlm-2104	51	38	an	an	DET
ajlm-2104	51	39	elevated	elevated	ADJ
ajlm-2104	51	40	platelet	platelet	NOUN
ajlm-2104	51	41	-	-	PUNCT
ajlm-2104	51	42	to	to	ADP
ajlm-2104	51	43	-	-	PUNCT
ajlm-2104	51	44	lymphocyte	lymphocyte	ADJ
ajlm-2104	51	45	ratio	ratio	NOUN
ajlm-2104	51	46	(	(	PUNCT
ajlm-2104	51	47	plr	plr	NOUN
ajlm-2104	51	48	)	)	PUNCT
ajlm-2104	51	49	at	at	ADP
ajlm-2104	51	50	diagnosis	diagnosis	NOUN
ajlm-2104	51	51	(	(	PUNCT
ajlm-2104	51	52	>	>	NOUN
ajlm-2104	51	53	200	200	NUM
ajlm-2104	51	54	)	)	PUNCT
ajlm-2104	51	55	were	be	AUX
ajlm-2104	51	56	associated	associate	VERB
ajlm-2104	51	57	with	with	ADP
ajlm-2104	51	58	increased	increase	VERB
ajlm-2104	51	59	mortality.33	mortality.33	NOUN
ajlm-2104	51	60	the	the	DET
ajlm-2104	51	61	calculation	calculation	NOUN
ajlm-2104	51	62	of	of	ADP
ajlm-2104	51	63	the	the	DET
ajlm-2104	51	64	nlr	nlr	PROPN
ajlm-2104	51	65	,	,	PUNCT
ajlm-2104	51	66	mlr	mlr	NOUN
ajlm-2104	51	67	and	and	CCONJ
ajlm-2104	51	68	plr	plr	NOUN
ajlm-2104	51	69	are	be	AUX
ajlm-2104	51	70	potential	potential	ADJ
ajlm-2104	51	71	rapid	rapid	ADJ
ajlm-2104	51	72	screening	screening	NOUN
ajlm-2104	51	73	tools	tool	NOUN
ajlm-2104	51	74	to	to	PART
ajlm-2104	51	75	detect	detect	VERB
ajlm-2104	51	76	sepsis	sepsis	NOUN
ajlm-2104	51	77	.	.	PUNCT
ajlm-2104	52	1	although	although	SCONJ
ajlm-2104	52	2	studies	study	NOUN
ajlm-2104	52	3	have	have	AUX
ajlm-2104	52	4	demonstrated	demonstrate	VERB
ajlm-2104	52	5	the	the	DET
ajlm-2104	52	6	value	value	NOUN
ajlm-2104	52	7	of	of	ADP
ajlm-2104	52	8	these	these	DET
ajlm-2104	52	9	ratios	ratio	NOUN
ajlm-2104	52	10	,	,	PUNCT
ajlm-2104	52	11	reports	report	NOUN
ajlm-2104	52	12	have	have	AUX
ajlm-2104	52	13	been	be	AUX
ajlm-2104	52	14	variable	variable	ADJ
ajlm-2104	52	15	and	and	CCONJ
ajlm-2104	52	16	often	often	ADV
ajlm-2104	52	17	unclear	unclear	ADJ
ajlm-2104	52	18	.	.	PUNCT
ajlm-2104	53	1	therefore	therefore	ADV
ajlm-2104	53	2	,	,	PUNCT
ajlm-2104	53	3	this	this	DET
ajlm-2104	53	4	study	study	NOUN
ajlm-2104	53	5	aimed	aim	VERB
ajlm-2104	53	6	to	to	PART
ajlm-2104	53	7	evaluate	evaluate	VERB
ajlm-2104	53	8	the	the	DET
ajlm-2104	53	9	utility	utility	NOUN
ajlm-2104	53	10	of	of	ADP
ajlm-2104	53	11	haematological	haematological	ADJ
ajlm-2104	53	12	cell	cell	NOUN
ajlm-2104	53	13	ratios	ratio	NOUN
ajlm-2104	53	14	to	to	PART
ajlm-2104	53	15	detect	detect	VERB
ajlm-2104	53	16	gram	gram	NOUN
ajlm-2104	53	17	-	-	PUNCT
ajlm-2104	53	18	negative	negative	ADJ
ajlm-2104	53	19	bacterial	bacterial	ADJ
ajlm-2104	53	20	sepsis	sepsis	NOUN
ajlm-2104	53	21	in	in	ADP
ajlm-2104	53	22	patients	patient	NOUN
ajlm-2104	53	23	presenting	present	VERB
ajlm-2104	53	24	to	to	ADP
ajlm-2104	53	25	a	a	DET
ajlm-2104	53	26	hospital	hospital	NOUN
ajlm-2104	53	27	in	in	ADP
ajlm-2104	53	28	cape	cape	NOUN
ajlm-2104	53	29	town	town	NOUN
ajlm-2104	53	30	,	,	PUNCT
ajlm-2104	53	31	south	south	PROPN
ajlm-2104	53	32	africa	africa	PROPN
ajlm-2104	53	33	,	,	PUNCT
ajlm-2104	53	34	and	and	CCONJ
ajlm-2104	53	35	to	to	PART
ajlm-2104	53	36	correlate	correlate	VERB
ajlm-2104	53	37	the	the	DET
ajlm-2104	53	38	values	value	NOUN
ajlm-2104	53	39	with	with	ADP
ajlm-2104	53	40	serum	serum	NOUN
ajlm-2104	53	41	procalcitonin	procalcitonin	ADJ
ajlm-2104	53	42	levels	level	NOUN
ajlm-2104	53	43	.	.	PUNCT
ajlm-2104	54	1	methods	method	NOUN
ajlm-2104	54	2	ethical	ethical	ADJ
ajlm-2104	54	3	considerations	consideration	NOUN
ajlm-2104	54	4	this	this	DET
ajlm-2104	54	5	study	study	NOUN
ajlm-2104	54	6	was	be	AUX
ajlm-2104	54	7	retrospective	retrospective	ADJ
ajlm-2104	54	8	and	and	CCONJ
ajlm-2104	54	9	thus	thus	ADV
ajlm-2104	54	10	no	no	DET
ajlm-2104	54	11	additional	additional	ADJ
ajlm-2104	54	12	testing	testing	NOUN
ajlm-2104	54	13	was	be	AUX
ajlm-2104	54	14	conducted	conduct	VERB
ajlm-2104	54	15	on	on	ADP
ajlm-2104	54	16	participants	participant	NOUN
ajlm-2104	54	17	.	.	PUNCT
ajlm-2104	55	1	participant	participant	ADJ
ajlm-2104	55	2	consent	consent	NOUN
ajlm-2104	55	3	was	be	AUX
ajlm-2104	55	4	waived	waive	VERB
ajlm-2104	55	5	and	and	CCONJ
ajlm-2104	55	6	ethical	ethical	ADJ
ajlm-2104	55	7	clearance	clearance	NOUN
ajlm-2104	55	8	was	be	AUX
ajlm-2104	55	9	granted	grant	VERB
ajlm-2104	55	10	by	by	ADP
ajlm-2104	55	11	the	the	DET
ajlm-2104	55	12	cape	cape	NOUN
ajlm-2104	55	13	peninsula	peninsula	PROPN
ajlm-2104	55	14	university	university	PROPN
ajlm-2104	55	15	of	of	ADP
ajlm-2104	55	16	technology	technology	PROPN
ajlm-2104	55	17	’s	’s	PART
ajlm-2104	55	18	ethics	ethic	NOUN
ajlm-2104	55	19	committee	committee	PROPN
ajlm-2104	55	20	(	(	PUNCT
ajlm-2104	55	21	clearance	clearance	NOUN
ajlm-2104	55	22	number	number	NOUN
ajlm-2104	55	23	:	:	PUNCT
ajlm-2104	55	24	cput	cput	PROPN
ajlm-2104	55	25	/	/	SYM
ajlm-2104	55	26	bms	bms	PROPN
ajlm-2104	55	27	-	-	PUNCT
ajlm-2104	55	28	ec	ec	PROPN
ajlm-2104	55	29	2021	2021	NUM
ajlm-2104	55	30	/	/	SYM
ajlm-2104	55	31	e32	e32	NOUN
ajlm-2104	55	32	)	)	PUNCT
ajlm-2104	55	33	.	.	PUNCT
ajlm-2104	56	1	permission	permission	NOUN
ajlm-2104	56	2	to	to	PART
ajlm-2104	56	3	use	use	VERB
ajlm-2104	56	4	the	the	DET
ajlm-2104	56	5	laboratory	laboratory	NOUN
ajlm-2104	56	6	’s	’s	PART
ajlm-2104	56	7	patient	patient	ADJ
ajlm-2104	56	8	records	record	NOUN
ajlm-2104	56	9	was	be	AUX
ajlm-2104	56	10	obtained	obtain	VERB
ajlm-2104	56	11	from	from	ADP
ajlm-2104	56	12	the	the	DET
ajlm-2104	56	13	laboratory	laboratory	NOUN
ajlm-2104	56	14	.	.	PUNCT
ajlm-2104	57	1	all	all	DET
ajlm-2104	57	2	patient	patient	ADJ
ajlm-2104	57	3	records	record	NOUN
ajlm-2104	57	4	were	be	AUX
ajlm-2104	57	5	handled	handle	VERB
ajlm-2104	57	6	according	accord	VERB
ajlm-2104	57	7	to	to	ADP
ajlm-2104	57	8	the	the	DET
ajlm-2104	57	9	declaration	declaration	NOUN
ajlm-2104	57	10	of	of	ADP
ajlm-2104	57	11	helsinki	helsinki	PROPN
ajlm-2104	57	12	and	and	CCONJ
ajlm-2104	57	13	confidentiality	confidentiality	NOUN
ajlm-2104	57	14	was	be	AUX
ajlm-2104	57	15	maintained	maintain	VERB
ajlm-2104	57	16	by	by	ADP
ajlm-2104	57	17	removing	remove	VERB
ajlm-2104	57	18	all	all	DET
ajlm-2104	57	19	patient	patient	ADJ
ajlm-2104	57	20	identifiers	identifier	NOUN
ajlm-2104	57	21	.	.	PUNCT
ajlm-2104	58	1	data	datum	NOUN
ajlm-2104	58	2	were	be	AUX
ajlm-2104	58	3	stored	store	VERB
ajlm-2104	58	4	on	on	ADP
ajlm-2104	58	5	a	a	DET
ajlm-2104	58	6	password	password	NOUN
ajlm-2104	58	7	-	-	PUNCT
ajlm-2104	58	8	protected	protect	VERB
ajlm-2104	58	9	computer	computer	NOUN
ajlm-2104	58	10	which	which	PRON
ajlm-2104	58	11	was	be	AUX
ajlm-2104	58	12	only	only	ADV
ajlm-2104	58	13	accessible	accessible	ADJ
ajlm-2104	58	14	to	to	ADP
ajlm-2104	58	15	the	the	DET
ajlm-2104	58	16	primary	primary	ADJ
ajlm-2104	58	17	investigator	investigator	NOUN
ajlm-2104	58	18	.	.	PUNCT
ajlm-2104	59	1	study	study	NOUN
ajlm-2104	59	2	design	design	VERB
ajlm-2104	59	3	this	this	DET
ajlm-2104	59	4	retrospective	retrospective	ADJ
ajlm-2104	59	5	study	study	NOUN
ajlm-2104	59	6	analysed	analyse	VERB
ajlm-2104	59	7	125	125	NUM
ajlm-2104	59	8	adult	adult	NOUN
ajlm-2104	59	9	patients	patient	NOUN
ajlm-2104	59	10	(	(	PUNCT
ajlm-2104	59	11	all	all	PRON
ajlm-2104	59	12	>	>	SYM
ajlm-2104	59	13	18	18	NUM
ajlm-2104	59	14	years	year	NOUN
ajlm-2104	59	15	of	of	ADP
ajlm-2104	59	16	age	age	NOUN
ajlm-2104	59	17	)	)	PUNCT
ajlm-2104	59	18	with	with	ADP
ajlm-2104	59	19	complete	complete	ADJ
ajlm-2104	59	20	blood	blood	NOUN
ajlm-2104	59	21	count	count	NOUN
ajlm-2104	59	22	parameters	parameter	NOUN
ajlm-2104	59	23	.	.	PUNCT
ajlm-2104	60	1	the	the	DET
ajlm-2104	60	2	tests	test	NOUN
ajlm-2104	60	3	were	be	AUX
ajlm-2104	60	4	conducted	conduct	VERB
ajlm-2104	60	5	between	between	ADP
ajlm-2104	60	6	january	january	PROPN
ajlm-2104	60	7	2021	2021	NUM
ajlm-2104	60	8	and	and	CCONJ
ajlm-2104	60	9	july	july	PROPN
ajlm-2104	60	10	2021	2021	NUM
ajlm-2104	60	11	at	at	ADP
ajlm-2104	60	12	an	an	DET
ajlm-2104	60	13	iso15189	iso15189	NOUN
ajlm-2104	60	14	-	-	PUNCT
ajlm-2104	60	15	accredited	accredit	VERB
ajlm-2104	60	16	laboratory	laboratory	NOUN
ajlm-2104	60	17	in	in	ADP
ajlm-2104	60	18	cape	cape	NOUN
ajlm-2104	60	19	town	town	NOUN
ajlm-2104	60	20	,	,	PUNCT
ajlm-2104	60	21	south	south	PROPN
ajlm-2104	60	22	africa	africa	PROPN
ajlm-2104	60	23	.	.	PUNCT
ajlm-2104	61	1	based	base	VERB
ajlm-2104	61	2	on	on	ADP
ajlm-2104	61	3	procalcitonin	procalcitonin	ADJ
ajlm-2104	61	4	levels	level	NOUN
ajlm-2104	61	5	(	(	PUNCT
ajlm-2104	61	6	>	>	X
ajlm-2104	61	7	2	2	NUM
ajlm-2104	61	8	ng	ng	PROPN
ajlm-2104	61	9	/	/	SYM
ajlm-2104	61	10	l	l	NOUN
ajlm-2104	61	11	)	)	PUNCT
ajlm-2104	61	12	and	and	CCONJ
ajlm-2104	61	13	bc	bc	PROPN
ajlm-2104	61	14	results	result	NOUN
ajlm-2104	61	15	(	(	PUNCT
ajlm-2104	61	16	positive	positive	ADJ
ajlm-2104	61	17	with	with	ADP
ajlm-2104	61	18	confirmed	confirm	VERB
ajlm-2104	61	19	gram	gram	NOUN
ajlm-2104	61	20	-	-	PUNCT
ajlm-2104	61	21	negative	negative	ADJ
ajlm-2104	61	22	bacillary	bacillary	ADJ
ajlm-2104	61	23	growth	growth	NOUN
ajlm-2104	61	24	)	)	PUNCT
ajlm-2104	61	25	,	,	PUNCT
ajlm-2104	61	26	participants	participant	NOUN
ajlm-2104	61	27	were	be	AUX
ajlm-2104	61	28	divided	divide	VERB
ajlm-2104	61	29	into	into	ADP
ajlm-2104	61	30	two	two	NUM
ajlm-2104	61	31	groups	group	NOUN
ajlm-2104	61	32	comprising	comprise	VERB
ajlm-2104	61	33	those	those	PRON
ajlm-2104	61	34	with	with	ADP
ajlm-2104	61	35	confirmed	confirm	VERB
ajlm-2104	61	36	sepsis	sepsis	NOUN
ajlm-2104	61	37	(	(	PUNCT
ajlm-2104	61	38	n	n	NOUN
ajlm-2104	61	39	=	=	SYM
ajlm-2104	61	40	62	62	NUM
ajlm-2104	61	41	)	)	PUNCT
ajlm-2104	61	42	and	and	CCONJ
ajlm-2104	61	43	a	a	DET
ajlm-2104	61	44	control	control	NOUN
ajlm-2104	61	45	group	group	NOUN
ajlm-2104	61	46	(	(	PUNCT
ajlm-2104	61	47	n	n	NOUN
ajlm-2104	61	48	=	=	SYM
ajlm-2104	61	49	63	63	NUM
ajlm-2104	61	50	)	)	PUNCT
ajlm-2104	61	51	which	which	PRON
ajlm-2104	61	52	comprised	comprise	VERB
ajlm-2104	61	53	hospitalised	hospitalised	ADJ
ajlm-2104	61	54	patients	patient	NOUN
ajlm-2104	61	55	who	who	PRON
ajlm-2104	61	56	had	have	VERB
ajlm-2104	61	57	no	no	DET
ajlm-2104	61	58	clinical	clinical	ADJ
ajlm-2104	61	59	or	or	CCONJ
ajlm-2104	61	60	laboratory	laboratory	NOUN
ajlm-2104	61	61	evidence	evidence	NOUN
ajlm-2104	61	62	of	of	ADP
ajlm-2104	61	63	sepsis	sepsis	NOUN
ajlm-2104	61	64	.	.	PUNCT
ajlm-2104	62	1	the	the	DET
ajlm-2104	62	2	haematological	haematological	ADJ
ajlm-2104	62	3	cell	cell	NOUN
ajlm-2104	62	4	ratios	ratio	NOUN
ajlm-2104	62	5	and	and	CCONJ
ajlm-2104	62	6	full	full	ADJ
ajlm-2104	62	7	blood	blood	NOUN
ajlm-2104	62	8	count	count	NOUN
ajlm-2104	62	9	parameters	parameter	NOUN
ajlm-2104	62	10	were	be	AUX
ajlm-2104	62	11	then	then	ADV
ajlm-2104	62	12	compared	compare	VERB
ajlm-2104	62	13	and	and	CCONJ
ajlm-2104	62	14	correlated	correlate	VERB
ajlm-2104	62	15	using	use	VERB
ajlm-2104	62	16	statistical	statistical	ADJ
ajlm-2104	62	17	tests	test	NOUN
ajlm-2104	62	18	.	.	PUNCT
ajlm-2104	63	1	full	full	ADJ
ajlm-2104	63	2	blood	blood	NOUN
ajlm-2104	63	3	count	count	NOUN
ajlm-2104	63	4	and	and	CCONJ
ajlm-2104	63	5	haematological	haematological	ADJ
ajlm-2104	63	6	cell	cell	NOUN
ajlm-2104	63	7	ratios	ratio	NOUN
ajlm-2104	63	8	peripheral	peripheral	ADJ
ajlm-2104	63	9	blood	blood	NOUN
ajlm-2104	63	10	was	be	AUX
ajlm-2104	63	11	collected	collect	VERB
ajlm-2104	63	12	into	into	ADP
ajlm-2104	63	13	vacutainer	vacutainer	ADJ
ajlm-2104	63	14	tubes	tube	NOUN
ajlm-2104	63	15	containing	contain	VERB
ajlm-2104	63	16	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-2104	63	17	acid	acid	NOUN
ajlm-2104	63	18	.	.	PUNCT
ajlm-2104	64	1	automated	automate	VERB
ajlm-2104	64	2	full	full	ADJ
ajlm-2104	64	3	blood	blood	NOUN
ajlm-2104	64	4	and	and	CCONJ
ajlm-2104	64	5	white	white	ADJ
ajlm-2104	64	6	cell	cell	NOUN
ajlm-2104	64	7	differential	differential	NOUN
ajlm-2104	64	8	counts	count	NOUN
ajlm-2104	64	9	were	be	AUX
ajlm-2104	64	10	performed	perform	VERB
ajlm-2104	64	11	by	by	ADP
ajlm-2104	64	12	flow	flow	NOUN
ajlm-2104	64	13	cytometric	cytometric	ADJ
ajlm-2104	64	14	analysis	analysis	NOUN
ajlm-2104	64	15	on	on	ADP
ajlm-2104	64	16	the	the	DET
ajlm-2104	64	17	sysmex	sysmex	NOUN
ajlm-2104	64	18	xn	xn	PROPN
ajlm-2104	64	19	series	series	PROPN
ajlm-2104	64	20	automated	automate	VERB
ajlm-2104	64	21	analyser	analyser	NOUN
ajlm-2104	64	22	(	(	PUNCT
ajlm-2104	64	23	sysmex	sysmex	NOUN
ajlm-2104	64	24	corporation	corporation	NOUN
ajlm-2104	64	25	,	,	PUNCT
ajlm-2104	64	26	kobe	kobe	PROPN
ajlm-2104	64	27	,	,	PUNCT
ajlm-2104	64	28	hyogo	hyogo	PROPN
ajlm-2104	64	29	,	,	PUNCT
ajlm-2104	64	30	japan	japan	PROPN
ajlm-2104	64	31	)	)	PUNCT
ajlm-2104	64	32	.	.	PUNCT
ajlm-2104	65	1	the	the	DET
ajlm-2104	65	2	nlr	nlr	PROPN
ajlm-2104	65	3	and	and	CCONJ
ajlm-2104	65	4	mlr	mlr	PROPN
ajlm-2104	65	5	were	be	AUX
ajlm-2104	65	6	calculated	calculate	VERB
ajlm-2104	65	7	by	by	ADP
ajlm-2104	65	8	dividing	divide	VERB
ajlm-2104	65	9	the	the	DET
ajlm-2104	65	10	relevant	relevant	ADJ
ajlm-2104	65	11	absolute	absolute	ADJ
ajlm-2104	65	12	cell	cell	NOUN
ajlm-2104	65	13	line	line	NOUN
ajlm-2104	65	14	count	count	NOUN
ajlm-2104	65	15	by	by	ADP
ajlm-2104	65	16	the	the	DET
ajlm-2104	65	17	absolute	absolute	ADJ
ajlm-2104	65	18	lymphocyte	lymphocyte	ADJ
ajlm-2104	65	19	counts	count	NOUN
ajlm-2104	65	20	,	,	PUNCT
ajlm-2104	65	21	whereas	whereas	SCONJ
ajlm-2104	65	22	the	the	DET
ajlm-2104	65	23	plr	plr	NOUN
ajlm-2104	65	24	was	be	AUX
ajlm-2104	65	25	calculated	calculate	VERB
ajlm-2104	65	26	by	by	ADP
ajlm-2104	65	27	dividing	divide	VERB
ajlm-2104	65	28	the	the	DET
ajlm-2104	65	29	total	total	ADJ
ajlm-2104	65	30	platelet	platelet	NOUN
ajlm-2104	65	31	count	count	NOUN
ajlm-2104	65	32	by	by	ADP
ajlm-2104	65	33	the	the	DET
ajlm-2104	65	34	absolute	absolute	ADJ
ajlm-2104	65	35	lymphocyte	lymphocyte	ADJ
ajlm-2104	65	36	count	count	NOUN
ajlm-2104	65	37	.	.	PUNCT
ajlm-2104	66	1	biochemical	biochemical	ADJ
ajlm-2104	66	2	tests	test	NOUN
ajlm-2104	66	3	peripheral	peripheral	ADJ
ajlm-2104	66	4	blood	blood	NOUN
ajlm-2104	66	5	was	be	AUX
ajlm-2104	66	6	collected	collect	VERB
ajlm-2104	66	7	into	into	ADP
ajlm-2104	66	8	a	a	DET
ajlm-2104	66	9	serum	serum	NOUN
ajlm-2104	66	10	separating	separate	VERB
ajlm-2104	66	11	tube	tube	NOUN
ajlm-2104	66	12	and	and	CCONJ
ajlm-2104	66	13	centrifuged	centrifuge	VERB
ajlm-2104	66	14	at	at	ADP
ajlm-2104	66	15	4000	4000	NUM
ajlm-2104	66	16	revolutions	revolution	NOUN
ajlm-2104	66	17	per	per	ADP
ajlm-2104	66	18	minute	minute	NOUN
ajlm-2104	66	19	for	for	ADP
ajlm-2104	66	20	5	5	NUM
ajlm-2104	66	21	to	to	PART
ajlm-2104	66	22	10	10	NUM
ajlm-2104	66	23	min	min	NOUN
ajlm-2104	66	24	to	to	PART
ajlm-2104	66	25	remove	remove	VERB
ajlm-2104	66	26	the	the	DET
ajlm-2104	66	27	serum	serum	NOUN
ajlm-2104	66	28	.	.	PUNCT
ajlm-2104	67	1	procalcitonin	procalcitonin	ADJ
ajlm-2104	67	2	values	value	NOUN
ajlm-2104	67	3	were	be	AUX
ajlm-2104	67	4	then	then	ADV
ajlm-2104	67	5	generated	generate	VERB
ajlm-2104	67	6	using	use	VERB
ajlm-2104	67	7	the	the	DET
ajlm-2104	67	8	chemiluminescent	chemiluminescent	PROPN
ajlm-2104	67	9	microparticle	microparticle	PROPN
ajlm-2104	67	10	immunoassay	immunoassay	PROPN
ajlm-2104	67	11	principle	principle	PROPN
ajlm-2104	67	12	and	and	CCONJ
ajlm-2104	67	13	processed	process	VERB
ajlm-2104	67	14	on	on	ADP
ajlm-2104	67	15	the	the	DET
ajlm-2104	67	16	abbott	abbott	PROPN
ajlm-2104	67	17	alinity	alinity	PROPN
ajlm-2104	67	18	ci	ci	PROPN
ajlm-2104	67	19	and	and	CCONJ
ajlm-2104	67	20	architect	architect	NOUN
ajlm-2104	67	21	ci	ci	NOUN
ajlm-2104	67	22	analysers	analyser	NOUN
ajlm-2104	67	23	(	(	PUNCT
ajlm-2104	67	24	abbott	abbott	PROPN
ajlm-2104	67	25	laboratories	laboratories	PROPN
ajlm-2104	67	26	,	,	PUNCT
ajlm-2104	67	27	chicago	chicago	PROPN
ajlm-2104	67	28	,	,	PUNCT
ajlm-2104	67	29	illinois	illinois	PROPN
ajlm-2104	67	30	,	,	PUNCT
ajlm-2104	67	31	united	united	PROPN
ajlm-2104	67	32	states	states	PROPN
ajlm-2104	67	33	)	)	PUNCT
ajlm-2104	67	34	.	.	PUNCT
ajlm-2104	68	1	c	c	X
ajlm-2104	68	2	-	-	PUNCT
ajlm-2104	68	3	reactive	reactive	ADJ
ajlm-2104	68	4	protein	protein	NOUN
ajlm-2104	68	5	results	result	NOUN
ajlm-2104	68	6	were	be	AUX
ajlm-2104	68	7	generated	generate	VERB
ajlm-2104	68	8	by	by	ADP
ajlm-2104	68	9	immunoturbidimetry	immunoturbidimetry	NOUN
ajlm-2104	68	10	chemistry	chemistry	NOUN
ajlm-2104	68	11	assay	assay	NOUN
ajlm-2104	68	12	(	(	PUNCT
ajlm-2104	68	13	abbott	abbott	PROPN
ajlm-2104	68	14	laboratories	laboratories	PROPN
ajlm-2104	68	15	,	,	PUNCT
ajlm-2104	68	16	chicago	chicago	PROPN
ajlm-2104	68	17	,	,	PUNCT
ajlm-2104	68	18	illinois	illinois	PROPN
ajlm-2104	68	19	,	,	PUNCT
ajlm-2104	68	20	united	united	PROPN
ajlm-2104	68	21	states	states	PROPN
ajlm-2104	68	22	)	)	PUNCT
ajlm-2104	68	23	.	.	PUNCT
ajlm-2104	69	1	a	a	DET
ajlm-2104	69	2	procalcitonin	procalcitonin	ADJ
ajlm-2104	69	3	cut	cut	NOUN
ajlm-2104	69	4	-	-	PUNCT
ajlm-2104	69	5	off	off	ADP
ajlm-2104	69	6	value	value	NOUN
ajlm-2104	69	7	of	of	ADP
ajlm-2104	69	8	>	>	SYM
ajlm-2104	69	9	2	2	NUM
ajlm-2104	69	10	ng	ng	PROPN
ajlm-2104	69	11	/	/	SYM
ajlm-2104	69	12	l	l	PROPN
ajlm-2104	69	13	was	be	AUX
ajlm-2104	69	14	used	use	VERB
ajlm-2104	69	15	to	to	PART
ajlm-2104	69	16	determine	determine	VERB
ajlm-2104	69	17	if	if	SCONJ
ajlm-2104	69	18	a	a	DET
ajlm-2104	69	19	patient	patient	NOUN
ajlm-2104	69	20	had	have	VERB
ajlm-2104	69	21	sepsis.8	sepsis.8	PROPN
ajlm-2104	69	22	blood	blood	NOUN
ajlm-2104	69	23	cultures	culture	NOUN
ajlm-2104	69	24	blood	blood	NOUN
ajlm-2104	69	25	culture	culture	NOUN
ajlm-2104	69	26	samples	sample	NOUN
ajlm-2104	69	27	were	be	AUX
ajlm-2104	69	28	collected	collect	VERB
ajlm-2104	69	29	in	in	ADP
ajlm-2104	69	30	duplicate	duplicate	NOUN
ajlm-2104	69	31	for	for	ADP
ajlm-2104	69	32	anaerobic	anaerobic	NOUN
ajlm-2104	69	33	and	and	CCONJ
ajlm-2104	69	34	aerobic	aerobic	ADJ
ajlm-2104	69	35	cultures	culture	NOUN
ajlm-2104	69	36	.	.	PUNCT
ajlm-2104	70	1	cultures	culture	NOUN
ajlm-2104	70	2	were	be	AUX
ajlm-2104	70	3	incubated	incubate	VERB
ajlm-2104	70	4	and	and	CCONJ
ajlm-2104	70	5	monitored	monitor	VERB
ajlm-2104	70	6	for	for	ADP
ajlm-2104	70	7	growth	growth	NOUN
ajlm-2104	70	8	for	for	ADP
ajlm-2104	70	9	7	7	NUM
ajlm-2104	70	10	days	day	NOUN
ajlm-2104	70	11	on	on	ADP
ajlm-2104	70	12	the	the	DET
ajlm-2104	70	13	biomérieux	biomérieux	PROPN
ajlm-2104	70	14	bactalert	bactalert	PROPN
ajlm-2104	70	15	3d	3d	PROPN
ajlm-2104	70	16	system	system	NOUN
ajlm-2104	70	17	(	(	PUNCT
ajlm-2104	70	18	biomérieux	biomérieux	PROPN
ajlm-2104	70	19	,	,	PUNCT
ajlm-2104	70	20	marcy	marcy	NOUN
ajlm-2104	70	21	-	-	PUNCT
ajlm-2104	70	22	l’etoile	l’etoile	PROPN
ajlm-2104	70	23	,	,	PUNCT
ajlm-2104	70	24	france	france	PROPN
ajlm-2104	70	25	)	)	PUNCT
ajlm-2104	70	26	.	.	PUNCT
ajlm-2104	71	1	cultures	culture	NOUN
ajlm-2104	71	2	flagged	flag	VERB
ajlm-2104	71	3	for	for	ADP
ajlm-2104	71	4	growth	growth	NOUN
ajlm-2104	71	5	by	by	ADP
ajlm-2104	71	6	the	the	DET
ajlm-2104	71	7	analyser	analyser	NOUN
ajlm-2104	71	8	were	be	AUX
ajlm-2104	71	9	examined	examine	VERB
ajlm-2104	71	10	microscopically	microscopically	ADV
ajlm-2104	71	11	and	and	CCONJ
ajlm-2104	71	12	subcultured	subculture	VERB
ajlm-2104	71	13	on	on	ADP
ajlm-2104	71	14	appropriate	appropriate	ADJ
ajlm-2104	71	15	media	medium	NOUN
ajlm-2104	71	16	based	base	VERB
ajlm-2104	71	17	on	on	ADP
ajlm-2104	71	18	organism	organism	NOUN
ajlm-2104	71	19	morphology	morphology	NOUN
ajlm-2104	71	20	and	and	CCONJ
ajlm-2104	71	21	gram	gram	NOUN
ajlm-2104	71	22	stain	stain	NOUN
ajlm-2104	71	23	results	result	NOUN
ajlm-2104	71	24	.	.	PUNCT
ajlm-2104	72	1	culture	culture	NOUN
ajlm-2104	72	2	plates	plate	NOUN
ajlm-2104	72	3	were	be	AUX
ajlm-2104	72	4	examined	examine	VERB
ajlm-2104	72	5	after	after	ADP
ajlm-2104	72	6	18	18	NUM
ajlm-2104	72	7	h	h	NOUN
ajlm-2104	72	8	to	to	ADP
ajlm-2104	72	9	24	24	NUM
ajlm-2104	72	10	h	h	NOUN
ajlm-2104	72	11	of	of	ADP
ajlm-2104	72	12	incubation	incubation	NOUN
ajlm-2104	72	13	,	,	PUNCT
ajlm-2104	72	14	and	and	CCONJ
ajlm-2104	72	15	isolates	isolate	NOUN
ajlm-2104	72	16	were	be	AUX
ajlm-2104	72	17	speciated	speciate	VERB
ajlm-2104	72	18	by	by	ADP
ajlm-2104	72	19	mass	mass	ADJ
ajlm-2104	72	20	spectrometry	spectrometry	NOUN
ajlm-2104	72	21	using	use	VERB
ajlm-2104	72	22	a	a	DET
ajlm-2104	72	23	biomérieux	biomérieux	PROPN
ajlm-2104	72	24	vitek	vitek	PROPN
ajlm-2104	72	25	-	-	PUNCT
ajlm-2104	72	26	ms	ms	PROPN
ajlm-2104	72	27	’s	’s	PART
ajlm-2104	72	28	(	(	PUNCT
ajlm-2104	72	29	biomérieux	biomérieux	PROPN
ajlm-2104	72	30	,	,	PUNCT
ajlm-2104	72	31	marcy	marcy	NOUN
ajlm-2104	72	32	-	-	PUNCT
ajlm-2104	72	33	l’etoile	l’etoile	PROPN
ajlm-2104	72	34	,	,	PUNCT
ajlm-2104	72	35	france	france	PROPN
ajlm-2104	72	36	)	)	PUNCT
ajlm-2104	72	37	principle	principle	NOUN
ajlm-2104	72	38	of	of	ADP
ajlm-2104	72	39	matrix	matrix	NOUN
ajlm-2104	72	40	-	-	PUNCT
ajlm-2104	72	41	assisted	assist	VERB
ajlm-2104	72	42	laser	laser	NOUN
ajlm-2104	72	43	desorption	desorption	NOUN
ajlm-2104	72	44	ionization	ionization	NOUN
ajlm-2104	72	45	time	time	NOUN
ajlm-2104	72	46	-	-	PUNCT
ajlm-2104	72	47	of	of	ADP
ajlm-2104	72	48	-	-	PUNCT
ajlm-2104	72	49	flight	flight	NOUN
ajlm-2104	72	50	.	.	PUNCT
ajlm-2104	73	1	in	in	ADP
ajlm-2104	73	2	cases	case	NOUN
ajlm-2104	73	3	where	where	SCONJ
ajlm-2104	73	4	inadequate	inadequate	ADJ
ajlm-2104	73	5	microbial	microbial	ADJ
ajlm-2104	73	6	material	material	NOUN
ajlm-2104	73	7	was	be	AUX
ajlm-2104	73	8	available	available	ADJ
ajlm-2104	73	9	for	for	ADP
ajlm-2104	73	10	mass	mass	ADJ
ajlm-2104	73	11	spectroscopy	spectroscopy	NOUN
ajlm-2104	73	12	,	,	PUNCT
ajlm-2104	73	13	biochemical	biochemical	ADJ
ajlm-2104	73	14	analysis	analysis	NOUN
ajlm-2104	73	15	and	and	CCONJ
ajlm-2104	73	16	speciation	speciation	NOUN
ajlm-2104	73	17	were	be	AUX
ajlm-2104	73	18	performed	perform	VERB
ajlm-2104	73	19	using	use	VERB
ajlm-2104	73	20	the	the	DET
ajlm-2104	73	21	biomérieux	biomérieux	PROPN
ajlm-2104	73	22	vitek	vitek	PROPN
ajlm-2104	73	23	2	2	PROPN
ajlm-2104	73	24	(	(	PUNCT
ajlm-2104	73	25	biomérieux	biomérieux	PROPN
ajlm-2104	73	26	,	,	PUNCT
ajlm-2104	73	27	marcy	marcy	NOUN
ajlm-2104	73	28	-	-	PUNCT
ajlm-2104	73	29	l’etoile	l’etoile	PROPN
ajlm-2104	73	30	,	,	PUNCT
ajlm-2104	73	31	france	france	PROPN
ajlm-2104	73	32	)	)	PUNCT
ajlm-2104	73	33	.	.	PUNCT
ajlm-2104	74	1	only	only	ADV
ajlm-2104	74	2	cultures	culture	NOUN
ajlm-2104	74	3	with	with	ADP
ajlm-2104	74	4	gram	gram	NOUN
ajlm-2104	74	5	-	-	PUNCT
ajlm-2104	74	6	negative	negative	ADJ
ajlm-2104	74	7	bacilli	bacilli	NOUN
ajlm-2104	74	8	growth	growth	NOUN
ajlm-2104	74	9	were	be	AUX
ajlm-2104	74	10	considered	consider	VERB
ajlm-2104	74	11	for	for	ADP
ajlm-2104	74	12	the	the	DET
ajlm-2104	74	13	sepsis	sepsis	NOUN
ajlm-2104	74	14	group	group	NOUN
ajlm-2104	74	15	,	,	PUNCT
ajlm-2104	74	16	as	as	SCONJ
ajlm-2104	74	17	gram	gram	NOUN
ajlm-2104	74	18	-	-	PUNCT
ajlm-2104	74	19	positive	positive	ADJ
ajlm-2104	74	20	cocci	cocci	NOUN
ajlm-2104	74	21	are	be	AUX
ajlm-2104	74	22	most	most	ADV
ajlm-2104	74	23	likely	likely	ADJ
ajlm-2104	74	24	to	to	PART
ajlm-2104	74	25	be	be	AUX
ajlm-2104	74	26	pre	pre	ADJ
ajlm-2104	74	27	-	-	ADJ
ajlm-2104	74	28	analytical	analytical	ADJ
ajlm-2104	74	29	contaminants	contaminant	NOUN
ajlm-2104	74	30	.	.	PUNCT
ajlm-2104	75	1	data	datum	NOUN
ajlm-2104	75	2	collection	collection	NOUN
ajlm-2104	75	3	and	and	CCONJ
ajlm-2104	75	4	statistical	statistical	ADJ
ajlm-2104	75	5	methods	method	NOUN
ajlm-2104	75	6	all	all	PRON
ajlm-2104	75	7	archived	archive	VERB
ajlm-2104	75	8	full	full	ADJ
ajlm-2104	75	9	blood	blood	NOUN
ajlm-2104	75	10	counts	count	NOUN
ajlm-2104	75	11	,	,	PUNCT
ajlm-2104	75	12	differential	differential	ADJ
ajlm-2104	75	13	counts	count	NOUN
ajlm-2104	75	14	and	and	CCONJ
ajlm-2104	75	15	blood	blood	NOUN
ajlm-2104	75	16	chemistry	chemistry	NOUN
ajlm-2104	75	17	data	datum	NOUN
ajlm-2104	75	18	were	be	AUX
ajlm-2104	75	19	collected	collect	VERB
ajlm-2104	75	20	from	from	ADP
ajlm-2104	75	21	the	the	DET
ajlm-2104	75	22	laboratory	laboratory	NOUN
ajlm-2104	75	23	’s	’s	PART
ajlm-2104	75	24	information	information	NOUN
ajlm-2104	75	25	system	system	NOUN
ajlm-2104	75	26	.	.	PUNCT
ajlm-2104	76	1	consecutive	consecutive	ADJ
ajlm-2104	76	2	patients	patient	NOUN
ajlm-2104	76	3	,	,	PUNCT
ajlm-2104	76	4	>	>	X
ajlm-2104	76	5	18	18	NUM
ajlm-2104	76	6	years	year	NOUN
ajlm-2104	76	7	of	of	ADP
ajlm-2104	76	8	age	age	NOUN
ajlm-2104	76	9	,	,	PUNCT
ajlm-2104	76	10	with	with	ADP
ajlm-2104	76	11	a	a	DET
ajlm-2104	76	12	positive	positive	ADJ
ajlm-2104	76	13	bc	bc	NOUN
ajlm-2104	76	14	and	and	CCONJ
ajlm-2104	76	15	a	a	DET
ajlm-2104	76	16	negative	negative	ADJ
ajlm-2104	76	17	gram	gram	NOUN
ajlm-2104	76	18	stain	stain	NOUN
ajlm-2104	76	19	,	,	PUNCT
ajlm-2104	76	20	were	be	AUX
ajlm-2104	76	21	included	include	VERB
ajlm-2104	76	22	in	in	ADP
ajlm-2104	76	23	the	the	DET
ajlm-2104	76	24	sepsis	sepsis	NOUN
ajlm-2104	76	25	group	group	NOUN
ajlm-2104	76	26	,	,	PUNCT
ajlm-2104	76	27	while	while	SCONJ
ajlm-2104	76	28	the	the	DET
ajlm-2104	76	29	controls	control	NOUN
ajlm-2104	76	30	comprised	comprise	VERB
ajlm-2104	76	31	hospitalised	hospitalise	VERB
ajlm-2104	76	32	patients	patient	NOUN
ajlm-2104	76	33	with	with	ADP
ajlm-2104	76	34	no	no	DET
ajlm-2104	76	35	evidence	evidence	NOUN
ajlm-2104	76	36	of	of	ADP
ajlm-2104	76	37	sepsis	sepsis	NOUN
ajlm-2104	76	38	and	and	CCONJ
ajlm-2104	76	39	negative	negative	ADJ
ajlm-2104	76	40	bc	bc	PROPN
ajlm-2104	77	1	.	.	PROPN
ajlm-2104	77	2	results	result	NOUN
ajlm-2104	77	3	were	be	AUX
ajlm-2104	77	4	collated	collate	VERB
ajlm-2104	77	5	on	on	ADP
ajlm-2104	77	6	microsoft	microsoft	PROPN
ajlm-2104	77	7	excel	excel	VERB
ajlm-2104	77	8	2019	2019	NUM
ajlm-2104	77	9	(	(	PUNCT
ajlm-2104	77	10	microsoft	microsoft	PROPN
ajlm-2104	77	11	corporation	corporation	PROPN
ajlm-2104	77	12	,	,	PUNCT
ajlm-2104	77	13	redmond	redmond	PROPN
ajlm-2104	77	14	,	,	PUNCT
ajlm-2104	77	15	washington	washington	PROPN
ajlm-2104	77	16	,	,	PUNCT
ajlm-2104	77	17	united	united	PROPN
ajlm-2104	77	18	states	states	PROPN
ajlm-2104	77	19	)	)	PUNCT
ajlm-2104	77	20	and	and	CCONJ
ajlm-2104	77	21	imported	import	VERB
ajlm-2104	77	22	into	into	ADP
ajlm-2104	77	23	jamovi	jamovi	ADJ
ajlm-2104	77	24	version	version	NOUN
ajlm-2104	77	25	2.3	2.3	NUM
ajlm-2104	77	26	(	(	PUNCT
ajlm-2104	77	27	jamovi	jamovi	PROPN
ajlm-2104	77	28	project	project	NOUN
ajlm-2104	77	29	,	,	PUNCT
ajlm-2104	77	30	sydney	sydney	PROPN
ajlm-2104	77	31	,	,	PUNCT
ajlm-2104	77	32	australia	australia	PROPN
ajlm-2104	77	33	)	)	PUNCT
ajlm-2104	77	34	for	for	ADP
ajlm-2104	77	35	statistical	statistical	ADJ
ajlm-2104	77	36	analysis	analysis	NOUN
ajlm-2104	77	37	.	.	PUNCT
ajlm-2104	78	1	subjects	subject	NOUN
ajlm-2104	78	2	were	be	AUX
ajlm-2104	78	3	assigned	assign	VERB
ajlm-2104	78	4	unique	unique	ADJ
ajlm-2104	78	5	identifiers	identifier	NOUN
ajlm-2104	78	6	,	,	PUNCT
ajlm-2104	78	7	and	and	CCONJ
ajlm-2104	78	8	only	only	ADV
ajlm-2104	78	9	haematology	haematology	NOUN
ajlm-2104	78	10	,	,	PUNCT
ajlm-2104	78	11	chemistry	chemistry	NOUN
ajlm-2104	78	12	,	,	PUNCT
ajlm-2104	78	13	culture	culture	NOUN
ajlm-2104	78	14	results	result	NOUN
ajlm-2104	78	15	,	,	PUNCT
ajlm-2104	78	16	age	age	NOUN
ajlm-2104	78	17	and	and	CCONJ
ajlm-2104	78	18	gender	gender	NOUN
ajlm-2104	78	19	data	datum	NOUN
ajlm-2104	78	20	were	be	AUX
ajlm-2104	78	21	collected	collect	VERB
ajlm-2104	78	22	to	to	PART
ajlm-2104	78	23	prevent	prevent	VERB
ajlm-2104	78	24	bias	bias	NOUN
ajlm-2104	78	25	and	and	CCONJ
ajlm-2104	78	26	protect	protect	VERB
ajlm-2104	78	27	confidentiality	confidentiality	NOUN
ajlm-2104	78	28	.	.	PUNCT
ajlm-2104	79	1	the	the	DET
ajlm-2104	79	2	normality	normality	NOUN
ajlm-2104	79	3	of	of	ADP
ajlm-2104	79	4	the	the	DET
ajlm-2104	79	5	data	datum	NOUN
ajlm-2104	79	6	set	set	VERB
ajlm-2104	79	7	was	be	AUX
ajlm-2104	79	8	established	establish	VERB
ajlm-2104	79	9	by	by	ADP
ajlm-2104	79	10	jamovi	jamovi	PROPN
ajlm-2104	79	11	’s	’s	PART
ajlm-2104	79	12	frequency	frequency	NOUN
ajlm-2104	79	13	statistics	statistic	NOUN
ajlm-2104	79	14	,	,	PUNCT
ajlm-2104	79	15	with	with	SCONJ
ajlm-2104	79	16	the	the	DET
ajlm-2104	79	17	range	range	NOUN
ajlm-2104	79	18	of	of	ADP
ajlm-2104	79	19	−1	−1	NOUN
ajlm-2104	79	20	to	to	ADP
ajlm-2104	79	21	1	1	NUM
ajlm-2104	79	22	considered	consider	VERB
ajlm-2104	79	23	to	to	PART
ajlm-2104	79	24	be	be	AUX
ajlm-2104	79	25	normally	normally	ADV
ajlm-2104	79	26	distributed	distribute	VERB
ajlm-2104	79	27	.	.	PUNCT
ajlm-2104	80	1	skewed	skewed	ADJ
ajlm-2104	80	2	data	datum	NOUN
ajlm-2104	80	3	were	be	AUX
ajlm-2104	80	4	presented	present	VERB
ajlm-2104	80	5	in	in	ADP
ajlm-2104	80	6	quartiles	quartile	NOUN
ajlm-2104	80	7	,	,	PUNCT
ajlm-2104	80	8	and	and	CCONJ
ajlm-2104	80	9	significance	significance	NOUN
ajlm-2104	80	10	was	be	AUX
ajlm-2104	80	11	assessed	assess	VERB
ajlm-2104	80	12	using	use	VERB
ajlm-2104	80	13	the	the	DET
ajlm-2104	80	14	kruskal	kruskal	PROPN
ajlm-2104	80	15	-	-	PUNCT
ajlm-2104	80	16	wallis	wallis	PROPN
ajlm-2104	80	17	’s	’s	PART
ajlm-2104	80	18	test.34	test.34	NOUN
ajlm-2104	80	19	normally	normally	ADV
ajlm-2104	80	20	distributed	distribute	VERB
ajlm-2104	80	21	data	datum	NOUN
ajlm-2104	80	22	were	be	AUX
ajlm-2104	80	23	presented	present	VERB
ajlm-2104	80	24	as	as	ADP
ajlm-2104	80	25	standard	standard	ADJ
ajlm-2104	80	26	deviations	deviation	NOUN
ajlm-2104	80	27	,	,	PUNCT
ajlm-2104	80	28	and	and	CCONJ
ajlm-2104	80	29	significance	significance	NOUN
ajlm-2104	80	30	was	be	AUX
ajlm-2104	80	31	determined	determine	VERB
ajlm-2104	80	32	using	use	VERB
ajlm-2104	80	33	the	the	DET
ajlm-2104	80	34	one	one	NUM
ajlm-2104	80	35	-	-	PUNCT
ajlm-2104	80	36	way	way	NOUN
ajlm-2104	80	37	analysis	analysis	NOUN
ajlm-2104	80	38	of	of	ADP
ajlm-2104	80	39	variance	variance	NOUN
ajlm-2104	80	40	test	test	NOUN
ajlm-2104	80	41	with	with	ADP
ajlm-2104	80	42	p	p	X
ajlm-2104	80	43	<	<	X
ajlm-2104	80	44	0.05	0.05	NUM
ajlm-2104	80	45	considered	consider	VERB
ajlm-2104	80	46	significant	significant	ADJ
ajlm-2104	80	47	.	.	PUNCT
ajlm-2104	81	1	correlations	correlation	NOUN
ajlm-2104	81	2	between	between	ADP
ajlm-2104	81	3	analytes	analyte	NOUN
ajlm-2104	81	4	were	be	AUX
ajlm-2104	81	5	assessed	assess	VERB
ajlm-2104	81	6	by	by	ADP
ajlm-2104	81	7	bivariate	bivariate	ADJ
ajlm-2104	81	8	regression	regression	NOUN
ajlm-2104	81	9	,	,	PUNCT
ajlm-2104	81	10	and	and	CCONJ
ajlm-2104	81	11	a	a	DET
ajlm-2104	81	12	p	p	NOUN
ajlm-2104	81	13	-	-	PUNCT
ajlm-2104	81	14	value	value	NOUN
ajlm-2104	81	15	of	of	ADP
ajlm-2104	81	16	<	<	X
ajlm-2104	81	17	0.05	0.05	NUM
ajlm-2104	81	18	was	be	AUX
ajlm-2104	81	19	considered	consider	VERB
ajlm-2104	81	20	significant	significant	ADJ
ajlm-2104	81	21	.	.	PUNCT
ajlm-2104	82	1	receiver	receiver	ADJ
ajlm-2104	82	2	operating	operate	VERB
ajlm-2104	82	3	characteristic	characteristic	ADJ
ajlm-2104	82	4	curves	curve	NOUN
ajlm-2104	82	5	were	be	AUX
ajlm-2104	82	6	constructed	construct	VERB
ajlm-2104	82	7	to	to	PART
ajlm-2104	82	8	evaluate	evaluate	VERB
ajlm-2104	82	9	cell	cell	NOUN
ajlm-2104	82	10	ratios	ratio	NOUN
ajlm-2104	82	11	as	as	ADP
ajlm-2104	82	12	possible	possible	ADJ
ajlm-2104	82	13	diagnostic	diagnostic	ADJ
ajlm-2104	82	14	screening	screening	NOUN
ajlm-2104	82	15	markers	marker	NOUN
ajlm-2104	82	16	for	for	ADP
ajlm-2104	82	17	sepsis	sepsis	NOUN
ajlm-2104	82	18	.	.	PUNCT
ajlm-2104	83	1	results	result	NOUN
ajlm-2104	83	2	general	general	ADJ
ajlm-2104	83	3	characteristics	characteristic	NOUN
ajlm-2104	83	4	the	the	DET
ajlm-2104	83	5	study	study	NOUN
ajlm-2104	83	6	comprised	comprise	VERB
ajlm-2104	83	7	125	125	NUM
ajlm-2104	83	8	patients	patient	NOUN
ajlm-2104	83	9	’	'	PUNCT
ajlm-2104	83	10	data	datum	NOUN
ajlm-2104	83	11	.	.	PUNCT
ajlm-2104	84	1	patients	patient	NOUN
ajlm-2104	84	2	were	be	AUX
ajlm-2104	84	3	over	over	ADP
ajlm-2104	84	4	18	18	NUM
ajlm-2104	84	5	years	year	NOUN
ajlm-2104	84	6	;	;	PUNCT
ajlm-2104	84	7	62	62	NUM
ajlm-2104	84	8	had	have	VERB
ajlm-2104	84	9	sepsis	sepsis	NOUN
ajlm-2104	84	10	,	,	PUNCT
ajlm-2104	84	11	while	while	SCONJ
ajlm-2104	84	12	63	63	NUM
ajlm-2104	84	13	had	have	VERB
ajlm-2104	84	14	no	no	DET
ajlm-2104	84	15	sepsis	sepsis	NOUN
ajlm-2104	84	16	(	(	PUNCT
ajlm-2104	84	17	control	control	NOUN
ajlm-2104	84	18	group	group	NOUN
ajlm-2104	84	19	)	)	PUNCT
ajlm-2104	84	20	.	.	PUNCT
ajlm-2104	85	1	the	the	DET
ajlm-2104	85	2	62	62	NUM
ajlm-2104	85	3	sepsis	sepsis	NOUN
ajlm-2104	85	4	patients	patient	NOUN
ajlm-2104	85	5	had	have	VERB
ajlm-2104	85	6	gram	gram	NOUN
ajlm-2104	85	7	-	-	PUNCT
ajlm-2104	85	8	negative	negative	ADJ
ajlm-2104	85	9	bacteria	bacteria	NOUN
ajlm-2104	85	10	(	(	PUNCT
ajlm-2104	85	11	pseudomonas	pseudomona	NOUN
ajlm-2104	85	12	aeruginosa	aeruginosa	NOUN
ajlm-2104	85	13	,	,	PUNCT
ajlm-2104	85	14	klebsiella	klebsiella	NOUN
ajlm-2104	85	15	pneumoniae	pneumoniae	NOUN
ajlm-2104	85	16	,	,	PUNCT
ajlm-2104	85	17	escherichia	escherichia	NOUN
ajlm-2104	85	18	coli	coli	NOUN
ajlm-2104	85	19	and	and	CCONJ
ajlm-2104	85	20	serratia	serratia	NOUN
ajlm-2104	85	21	marcescens	marcescen	NOUN
ajlm-2104	85	22	)	)	PUNCT
ajlm-2104	85	23	isolated	isolate	VERB
ajlm-2104	85	24	from	from	ADP
ajlm-2104	85	25	their	their	PRON
ajlm-2104	85	26	bc	bc	PROPN
ajlm-2104	85	27	and	and	CCONJ
ajlm-2104	85	28	had	have	VERB
ajlm-2104	85	29	a	a	DET
ajlm-2104	85	30	procalcitonin	procalcitonin	ADJ
ajlm-2104	85	31	value	value	NOUN
ajlm-2104	85	32	>	>	X
ajlm-2104	85	33	2	2	NUM
ajlm-2104	85	34	ng	ng	PROPN
ajlm-2104	85	35	/	/	SYM
ajlm-2104	85	36	l.	l.	NOUN
ajlm-2104	85	37	of	of	ADP
ajlm-2104	85	38	the	the	DET
ajlm-2104	85	39	62	62	NUM
ajlm-2104	85	40	patients	patient	NOUN
ajlm-2104	85	41	,	,	PUNCT
ajlm-2104	85	42	32	32	NUM
ajlm-2104	85	43	were	be	AUX
ajlm-2104	85	44	male	male	ADJ
ajlm-2104	85	45	,	,	PUNCT
ajlm-2104	85	46	and	and	CCONJ
ajlm-2104	85	47	the	the	DET
ajlm-2104	85	48	group	group	NOUN
ajlm-2104	85	49	’s	’s	PART
ajlm-2104	85	50	median	median	ADJ
ajlm-2104	85	51	age	age	NOUN
ajlm-2104	85	52	was	be	AUX
ajlm-2104	85	53	65	65	NUM
ajlm-2104	85	54	(	(	PUNCT
ajlm-2104	85	55	range	range	NOUN
ajlm-2104	85	56	:	:	PUNCT
ajlm-2104	85	57	30–87	30–87	NUM
ajlm-2104	85	58	)	)	PUNCT
ajlm-2104	85	59	.	.	PUNCT
ajlm-2104	86	1	the	the	DET
ajlm-2104	86	2	results	result	NOUN
ajlm-2104	86	3	were	be	AUX
ajlm-2104	86	4	compared	compare	VERB
ajlm-2104	86	5	to	to	ADP
ajlm-2104	86	6	63	63	NUM
ajlm-2104	86	7	controls	control	NOUN
ajlm-2104	86	8	over	over	ADP
ajlm-2104	86	9	18	18	NUM
ajlm-2104	86	10	years	year	NOUN
ajlm-2104	86	11	(	(	PUNCT
ajlm-2104	86	12	19–77	19–77	NUM
ajlm-2104	86	13	)	)	PUNCT
ajlm-2104	86	14	with	with	ADP
ajlm-2104	86	15	no	no	DET
ajlm-2104	86	16	evidence	evidence	NOUN
ajlm-2104	86	17	of	of	ADP
ajlm-2104	86	18	sepsis	sepsis	NOUN
ajlm-2104	86	19	(	(	PUNCT
ajlm-2104	86	20	table	table	NOUN
ajlm-2104	86	21	1	1	NUM
ajlm-2104	86	22	)	)	PUNCT
ajlm-2104	86	23	.	.	PUNCT
ajlm-2104	87	1	table	table	NOUN
ajlm-2104	87	2	1	1	NUM
ajlm-2104	87	3	:	:	PUNCT
ajlm-2104	87	4	 	 	SPACE
ajlm-2104	87	5	demographic	demographic	ADJ
ajlm-2104	87	6	data	datum	NOUN
ajlm-2104	87	7	of	of	ADP
ajlm-2104	87	8	sepsis	sepsis	NOUN
ajlm-2104	87	9	and	and	CCONJ
ajlm-2104	87	10	non	non	ADJ
ajlm-2104	87	11	-	-	ADJ
ajlm-2104	87	12	sepsis	sepsis	ADJ
ajlm-2104	87	13	patients	patient	NOUN
ajlm-2104	87	14	analysed	analyse	VERB
ajlm-2104	87	15	between	between	ADP
ajlm-2104	87	16	january	january	PROPN
ajlm-2104	87	17	2021	2021	NUM
ajlm-2104	87	18	and	and	CCONJ
ajlm-2104	87	19	july	july	PROPN
ajlm-2104	87	20	2021	2021	NUM
ajlm-2104	87	21	in	in	ADP
ajlm-2104	87	22	cape	cape	NOUN
ajlm-2104	87	23	town	town	NOUN
ajlm-2104	87	24	,	,	PUNCT
ajlm-2104	87	25	south	south	PROPN
ajlm-2104	87	26	africa	africa	PROPN
ajlm-2104	87	27	.	.	PUNCT
ajlm-2104	88	1	haematology	haematology	NOUN
ajlm-2104	88	2	patients	patient	NOUN
ajlm-2104	88	3	with	with	ADP
ajlm-2104	88	4	sepsis	sepsis	NOUN
ajlm-2104	88	5	had	have	VERB
ajlm-2104	88	6	a	a	DET
ajlm-2104	88	7	significantly	significantly	ADV
ajlm-2104	88	8	elevated	elevated	ADJ
ajlm-2104	88	9	white	white	ADJ
ajlm-2104	88	10	cell	cell	NOUN
ajlm-2104	88	11	and	and	CCONJ
ajlm-2104	88	12	neutrophil	neutrophil	ADJ
ajlm-2104	88	13	count	count	NOUN
ajlm-2104	88	14	compared	compare	VERB
ajlm-2104	88	15	to	to	ADP
ajlm-2104	88	16	the	the	DET
ajlm-2104	88	17	control	control	NOUN
ajlm-2104	88	18	group	group	NOUN
ajlm-2104	88	19	(	(	PUNCT
ajlm-2104	88	20	p	p	X
ajlm-2104	88	21	<	<	X
ajlm-2104	88	22	0.001	0.001	NUM
ajlm-2104	88	23	)	)	PUNCT
ajlm-2104	88	24	.	.	PUNCT
ajlm-2104	89	1	the	the	DET
ajlm-2104	89	2	absolute	absolute	ADJ
ajlm-2104	89	3	lymphocyte	lymphocyte	ADJ
ajlm-2104	89	4	count	count	NOUN
ajlm-2104	89	5	was	be	AUX
ajlm-2104	89	6	significantly	significantly	ADV
ajlm-2104	89	7	reduced	reduce	VERB
ajlm-2104	89	8	in	in	ADP
ajlm-2104	89	9	the	the	DET
ajlm-2104	89	10	sepsis	sepsis	NOUN
ajlm-2104	89	11	group	group	NOUN
ajlm-2104	89	12	(	(	PUNCT
ajlm-2104	89	13	p	p	X
ajlm-2104	89	14	<	<	X
ajlm-2104	89	15	0.001	0.001	NUM
ajlm-2104	89	16	)	)	PUNCT
ajlm-2104	89	17	and	and	CCONJ
ajlm-2104	89	18	,	,	PUNCT
ajlm-2104	89	19	similarly	similarly	ADV
ajlm-2104	89	20	,	,	PUNCT
ajlm-2104	89	21	the	the	DET
ajlm-2104	89	22	median	median	ADJ
ajlm-2104	89	23	platelet	platelet	NOUN
ajlm-2104	89	24	count	count	NOUN
ajlm-2104	89	25	was	be	AUX
ajlm-2104	89	26	lower	low	ADJ
ajlm-2104	89	27	(	(	PUNCT
ajlm-2104	89	28	p	p	X
ajlm-2104	89	29	<	<	X
ajlm-2104	89	30	0.001	0.001	NUM
ajlm-2104	89	31	)	)	PUNCT
ajlm-2104	89	32	.	.	PUNCT
ajlm-2104	90	1	in	in	ADP
ajlm-2104	90	2	contrast	contrast	NOUN
ajlm-2104	90	3	,	,	PUNCT
ajlm-2104	90	4	although	although	SCONJ
ajlm-2104	90	5	the	the	DET
ajlm-2104	90	6	median	median	ADJ
ajlm-2104	90	7	absolute	absolute	ADJ
ajlm-2104	90	8	monocyte	monocyte	NOUN
ajlm-2104	90	9	counts	count	VERB
ajlm-2104	90	10	varied	varied	ADJ
ajlm-2104	90	11	,	,	PUNCT
ajlm-2104	90	12	there	there	PRON
ajlm-2104	90	13	was	be	VERB
ajlm-2104	90	14	no	no	DET
ajlm-2104	90	15	statistical	statistical	ADJ
ajlm-2104	90	16	significance	significance	NOUN
ajlm-2104	90	17	in	in	ADP
ajlm-2104	90	18	monocyte	monocyte	NOUN
ajlm-2104	90	19	counts	count	NOUN
ajlm-2104	90	20	between	between	ADP
ajlm-2104	90	21	the	the	DET
ajlm-2104	90	22	sepsis	sepsis	NOUN
ajlm-2104	90	23	and	and	CCONJ
ajlm-2104	90	24	control	control	NOUN
ajlm-2104	90	25	groups	group	NOUN
ajlm-2104	90	26	(	(	PUNCT
ajlm-2104	90	27	p	p	X
ajlm-2104	90	28	=	=	NOUN
ajlm-2104	90	29	0.377	0.377	NUM
ajlm-2104	90	30	)	)	PUNCT
ajlm-2104	90	31	(	(	PUNCT
ajlm-2104	90	32	table	table	NOUN
ajlm-2104	90	33	1	1	NUM
ajlm-2104	90	34	)	)	PUNCT
ajlm-2104	90	35	.	.	PUNCT
ajlm-2104	91	1	all	all	DET
ajlm-2104	91	2	three	three	NUM
ajlm-2104	91	3	cell	cell	NOUN
ajlm-2104	91	4	ratios	ratio	NOUN
ajlm-2104	91	5	varied	varied	ADJ
ajlm-2104	91	6	significantly	significantly	ADV
ajlm-2104	91	7	between	between	ADP
ajlm-2104	91	8	the	the	DET
ajlm-2104	91	9	two	two	NUM
ajlm-2104	91	10	study	study	NOUN
ajlm-2104	91	11	groups	group	NOUN
ajlm-2104	91	12	,	,	PUNCT
ajlm-2104	91	13	most	most	ADV
ajlm-2104	91	14	notably	notably	ADV
ajlm-2104	91	15	the	the	DET
ajlm-2104	91	16	median	median	ADJ
ajlm-2104	91	17	nlr	nlr	PROPN
ajlm-2104	91	18	being	be	AUX
ajlm-2104	91	19	8.62	8.62	NUM
ajlm-2104	91	20	times	time	NOUN
ajlm-2104	91	21	higher	high	ADJ
ajlm-2104	91	22	in	in	ADP
ajlm-2104	91	23	the	the	DET
ajlm-2104	91	24	sepsis	sepsis	NOUN
ajlm-2104	91	25	group	group	NOUN
ajlm-2104	91	26	,	,	PUNCT
ajlm-2104	91	27	whereas	whereas	SCONJ
ajlm-2104	91	28	the	the	DET
ajlm-2104	91	29	mlr	mlr	NOUN
ajlm-2104	91	30	and	and	CCONJ
ajlm-2104	91	31	plr	plr	NOUN
ajlm-2104	91	32	were	be	AUX
ajlm-2104	91	33	3.06	3.06	NUM
ajlm-2104	91	34	and	and	CCONJ
ajlm-2104	91	35	0.71	0.71	NUM
ajlm-2104	91	36	times	time	NOUN
ajlm-2104	91	37	higher	high	ADJ
ajlm-2104	91	38	.	.	PUNCT
ajlm-2104	92	1	the	the	DET
ajlm-2104	92	2	differences	difference	NOUN
ajlm-2104	92	3	in	in	ADP
ajlm-2104	92	4	cell	cell	NOUN
ajlm-2104	92	5	ratios	ratio	NOUN
ajlm-2104	92	6	were	be	AUX
ajlm-2104	92	7	statistically	statistically	ADV
ajlm-2104	92	8	significant	significant	ADJ
ajlm-2104	92	9	,	,	PUNCT
ajlm-2104	92	10	with	with	ADP
ajlm-2104	92	11	p	p	X
ajlm-2104	92	12	<	<	X
ajlm-2104	92	13	0.001	0.001	NUM
ajlm-2104	92	14	(	(	PUNCT
ajlm-2104	92	15	table	table	NOUN
ajlm-2104	92	16	1	1	NUM
ajlm-2104	92	17	)	)	PUNCT
ajlm-2104	92	18	.	.	PUNCT
ajlm-2104	93	1	neutrophil	neutrophil	PROPN
ajlm-2104	93	2	-	-	PUNCT
ajlm-2104	93	3	to	to	ADP
ajlm-2104	93	4	-	-	PUNCT
ajlm-2104	93	5	lymphocyte	lymphocyte	ADJ
ajlm-2104	93	6	ratio	ratio	NOUN
ajlm-2104	93	7	although	although	SCONJ
ajlm-2104	93	8	the	the	DET
ajlm-2104	93	9	nlr	nlr	PROPN
ajlm-2104	93	10	varied	vary	VERB
ajlm-2104	93	11	in	in	ADP
ajlm-2104	93	12	those	those	PRON
ajlm-2104	93	13	with	with	ADP
ajlm-2104	93	14	sepsis	sepsis	NOUN
ajlm-2104	93	15	,	,	PUNCT
ajlm-2104	93	16	values	value	NOUN
ajlm-2104	93	17	were	be	AUX
ajlm-2104	93	18	statistically	statistically	ADV
ajlm-2104	93	19	significantly	significantly	ADV
ajlm-2104	93	20	elevated	elevate	VERB
ajlm-2104	93	21	(	(	PUNCT
ajlm-2104	93	22	p	p	X
ajlm-2104	93	23	<	<	X
ajlm-2104	93	24	0.001	0.001	NUM
ajlm-2104	93	25	)	)	PUNCT
ajlm-2104	93	26	compared	compare	VERB
ajlm-2104	93	27	to	to	ADP
ajlm-2104	93	28	the	the	DET
ajlm-2104	93	29	control	control	NOUN
ajlm-2104	93	30	group	group	NOUN
ajlm-2104	93	31	(	(	PUNCT
ajlm-2104	93	32	figure	figure	NOUN
ajlm-2104	93	33	1a	1a	NOUN
ajlm-2104	93	34	)	)	PUNCT
ajlm-2104	93	35	,	,	PUNCT
ajlm-2104	93	36	which	which	PRON
ajlm-2104	93	37	all	all	PRON
ajlm-2104	93	38	fell	fall	VERB
ajlm-2104	93	39	within	within	ADP
ajlm-2104	93	40	the	the	DET
ajlm-2104	93	41	reported	report	VERB
ajlm-2104	93	42	nlr	nlr	PROPN
ajlm-2104	93	43	reference	reference	NOUN
ajlm-2104	93	44	interval	interval	NOUN
ajlm-2104	93	45	of	of	ADP
ajlm-2104	93	46	0.78	0.78	NUM
ajlm-2104	93	47	to	to	ADP
ajlm-2104	93	48	3.53	3.53	NUM
ajlm-2104	93	49	with	with	ADP
ajlm-2104	93	50	a	a	DET
ajlm-2104	93	51	mean	mean	NOUN
ajlm-2104	93	52	of	of	ADP
ajlm-2104	93	53	1.65.21	1.65.21	PROPN
ajlm-2104	93	54	despite	despite	SCONJ
ajlm-2104	93	55	the	the	DET
ajlm-2104	93	56	high	high	ADJ
ajlm-2104	93	57	levels	level	NOUN
ajlm-2104	93	58	of	of	ADP
ajlm-2104	93	59	both	both	CCONJ
ajlm-2104	93	60	nlr	nlr	PROPN
ajlm-2104	93	61	and	and	CCONJ
ajlm-2104	93	62	procalcitonin	procalcitonin	VERB
ajlm-2104	93	63	,	,	PUNCT
ajlm-2104	93	64	no	no	DET
ajlm-2104	93	65	correlation	correlation	NOUN
ajlm-2104	93	66	was	be	AUX
ajlm-2104	93	67	detected	detect	VERB
ajlm-2104	93	68	between	between	ADP
ajlm-2104	93	69	the	the	DET
ajlm-2104	93	70	two	two	NUM
ajlm-2104	93	71	tests	test	NOUN
ajlm-2104	93	72	(	(	PUNCT
ajlm-2104	93	73	r	r	NOUN
ajlm-2104	93	74	=	=	SYM
ajlm-2104	93	75	0.218	0.218	NUM
ajlm-2104	93	76	;	;	PUNCT
ajlm-2104	93	77	p	p	NOUN
ajlm-2104	93	78	=	=	NOUN
ajlm-2104	93	79	0.088	0.088	NUM
ajlm-2104	93	80	)	)	PUNCT
ajlm-2104	93	81	(	(	PUNCT
ajlm-2104	93	82	figure	figure	NOUN
ajlm-2104	93	83	1b	1b	NUM
ajlm-2104	93	84	)	)	PUNCT
ajlm-2104	93	85	.	.	PUNCT
ajlm-2104	94	1	figure	figure	VERB
ajlm-2104	94	2	1	1	NUM
ajlm-2104	94	3	:	:	PUNCT
ajlm-2104	94	4	neutrophil	neutrophil	ADJ
ajlm-2104	94	5	-	-	PUNCT
ajlm-2104	94	6	lyphocyte	lyphocyte	NOUN
ajlm-2104	94	7	ratio	ratio	NOUN
ajlm-2104	94	8	characteristics	characteristic	NOUN
ajlm-2104	94	9	among	among	ADP
ajlm-2104	94	10	62	62	NUM
ajlm-2104	94	11	patients	patient	NOUN
ajlm-2104	94	12	with	with	ADP
ajlm-2104	94	13	sepsis	sepsis	NOUN
ajlm-2104	94	14	compared	compare	VERB
ajlm-2104	94	15	to	to	ADP
ajlm-2104	94	16	63	63	NUM
ajlm-2104	94	17	non	non	ADJ
ajlm-2104	94	18	-	-	ADJ
ajlm-2104	94	19	sepsis	sepsis	NOUN
ajlm-2104	94	20	controls	control	NOUN
ajlm-2104	94	21	presenting	present	VERB
ajlm-2104	94	22	between	between	ADP
ajlm-2104	94	23	january	january	PROPN
ajlm-2104	94	24	2021	2021	NUM
ajlm-2104	94	25	and	and	CCONJ
ajlm-2104	94	26	july	july	PROPN
ajlm-2104	94	27	2021	2021	NUM
ajlm-2104	94	28	in	in	ADP
ajlm-2104	94	29	cape	cape	NOUN
ajlm-2104	94	30	town	town	NOUN
ajlm-2104	94	31	,	,	PUNCT
ajlm-2104	94	32	south	south	PROPN
ajlm-2104	94	33	africa	africa	PROPN
ajlm-2104	94	34	.	.	PUNCT
ajlm-2104	95	1	(	(	PUNCT
ajlm-2104	95	2	a	a	X
ajlm-2104	95	3	)	)	PUNCT
ajlm-2104	95	4	the	the	DET
ajlm-2104	95	5	median	median	ADJ
ajlm-2104	95	6	and	and	CCONJ
ajlm-2104	95	7	interquartile	interquartile	ADJ
ajlm-2104	95	8	range	range	NOUN
ajlm-2104	95	9	of	of	ADP
ajlm-2104	95	10	the	the	DET
ajlm-2104	95	11	neutrophil	neutrophil	ADJ
ajlm-2104	95	12	-	-	PUNCT
ajlm-2104	95	13	lymphocyte	lymphocyte	NOUN
ajlm-2104	95	14	ratio	ratio	NOUN
ajlm-2104	95	15	.	.	PUNCT
ajlm-2104	96	1	(	(	PUNCT
ajlm-2104	96	2	b	b	X
ajlm-2104	96	3	)	)	PUNCT
ajlm-2104	96	4	the	the	DET
ajlm-2104	96	5	correlation	correlation	NOUN
ajlm-2104	96	6	between	between	ADP
ajlm-2104	96	7	the	the	DET
ajlm-2104	96	8	neutrophil	neutrophil	ADJ
ajlm-2104	96	9	-	-	PUNCT
ajlm-2104	96	10	lymphocyte	lymphocyte	NOUN
ajlm-2104	96	11	ratio	ratio	NOUN
ajlm-2104	96	12	and	and	CCONJ
ajlm-2104	96	13	procalcitonin	procalcitonin	NOUN
ajlm-2104	96	14	.	.	PUNCT
ajlm-2104	97	1	monocyte	monocyte	PROPN
ajlm-2104	97	2	-	-	PUNCT
ajlm-2104	97	3	to	to	ADP
ajlm-2104	97	4	-	-	PUNCT
ajlm-2104	97	5	lymphocyte	lymphocyte	ADJ
ajlm-2104	97	6	ratio	ratio	NOUN
ajlm-2104	97	7	similarly	similarly	ADV
ajlm-2104	97	8	,	,	PUNCT
ajlm-2104	97	9	although	although	SCONJ
ajlm-2104	97	10	the	the	DET
ajlm-2104	97	11	mlr	mlr	NOUN
ajlm-2104	97	12	showed	show	VERB
ajlm-2104	97	13	a	a	DET
ajlm-2104	97	14	large	large	ADJ
ajlm-2104	97	15	variation	variation	NOUN
ajlm-2104	97	16	,	,	PUNCT
ajlm-2104	97	17	it	it	PRON
ajlm-2104	97	18	was	be	AUX
ajlm-2104	97	19	significantly	significantly	ADV
ajlm-2104	97	20	elevated	elevate	VERB
ajlm-2104	97	21	when	when	SCONJ
ajlm-2104	97	22	compared	compare	VERB
ajlm-2104	97	23	to	to	ADP
ajlm-2104	97	24	the	the	DET
ajlm-2104	97	25	non	non	ADJ
ajlm-2104	97	26	-	-	ADJ
ajlm-2104	97	27	septic	septic	ADJ
ajlm-2104	97	28	control	control	NOUN
ajlm-2104	97	29	group	group	NOUN
ajlm-2104	97	30	(	(	PUNCT
ajlm-2104	97	31	p	p	X
ajlm-2104	97	32	<	<	X
ajlm-2104	97	33	0.001	0.001	NUM
ajlm-2104	97	34	)	)	PUNCT
ajlm-2104	97	35	(	(	PUNCT
ajlm-2104	97	36	figure	figure	NOUN
ajlm-2104	97	37	2a	2a	NUM
ajlm-2104	97	38	)	)	PUNCT
ajlm-2104	97	39	.	.	PUNCT
ajlm-2104	98	1	no	no	DET
ajlm-2104	98	2	significant	significant	ADJ
ajlm-2104	98	3	correlation	correlation	NOUN
ajlm-2104	98	4	could	could	AUX
ajlm-2104	98	5	be	be	AUX
ajlm-2104	98	6	detected	detect	VERB
ajlm-2104	98	7	between	between	ADP
ajlm-2104	98	8	the	the	DET
ajlm-2104	98	9	mlr	mlr	PROPN
ajlm-2104	98	10	and	and	CCONJ
ajlm-2104	98	11	procalcitonin	procalcitonin	ADJ
ajlm-2104	98	12	levels	level	NOUN
ajlm-2104	98	13	(	(	PUNCT
ajlm-2104	98	14	r	r	NOUN
ajlm-2104	98	15	=	=	SYM
ajlm-2104	98	16	0.202	0.202	NUM
ajlm-2104	98	17	;	;	PUNCT
ajlm-2104	98	18	p	p	X
ajlm-2104	98	19	=	=	NOUN
ajlm-2104	98	20	0.07	0.07	NUM
ajlm-2104	98	21	)	)	PUNCT
ajlm-2104	98	22	(	(	PUNCT
ajlm-2104	98	23	figure	figure	NOUN
ajlm-2104	98	24	2b	2b	NOUN
ajlm-2104	98	25	)	)	PUNCT
ajlm-2104	98	26	.	.	PUNCT
ajlm-2104	99	1	figure	figure	VERB
ajlm-2104	99	2	2	2	NUM
ajlm-2104	99	3	:	:	PUNCT
ajlm-2104	99	4	monocyte	monocyte	ADJ
ajlm-2104	99	5	-	-	PUNCT
ajlm-2104	99	6	lymphocyte	lymphocyte	ADJ
ajlm-2104	99	7	ratio	ratio	NOUN
ajlm-2104	99	8	characteristics	characteristic	NOUN
ajlm-2104	99	9	among	among	ADP
ajlm-2104	99	10	62	62	NUM
ajlm-2104	99	11	patients	patient	NOUN
ajlm-2104	99	12	with	with	ADP
ajlm-2104	99	13	sepsis	sepsis	NOUN
ajlm-2104	99	14	compared	compare	VERB
ajlm-2104	99	15	to	to	ADP
ajlm-2104	99	16	63	63	NUM
ajlm-2104	99	17	controls	control	NOUN
ajlm-2104	99	18	diagnosed	diagnose	VERB
ajlm-2104	99	19	between	between	ADP
ajlm-2104	99	20	january	january	PROPN
ajlm-2104	99	21	2021	2021	NUM
ajlm-2104	99	22	and	and	CCONJ
ajlm-2104	99	23	july	july	PROPN
ajlm-2104	99	24	2021	2021	NUM
ajlm-2104	99	25	in	in	ADP
ajlm-2104	99	26	cape	cape	NOUN
ajlm-2104	99	27	town	town	NOUN
ajlm-2104	99	28	,	,	PUNCT
ajlm-2104	99	29	south	south	PROPN
ajlm-2104	99	30	africa	africa	PROPN
ajlm-2104	99	31	.	.	PUNCT
ajlm-2104	100	1	(	(	PUNCT
ajlm-2104	100	2	a	a	X
ajlm-2104	100	3	)	)	PUNCT
ajlm-2104	100	4	the	the	DET
ajlm-2104	100	5	median	median	ADJ
ajlm-2104	100	6	and	and	CCONJ
ajlm-2104	100	7	interquartile	interquartile	ADJ
ajlm-2104	100	8	range	range	NOUN
ajlm-2104	100	9	of	of	ADP
ajlm-2104	100	10	the	the	DET
ajlm-2104	100	11	monocyte	monocyte	ADJ
ajlm-2104	100	12	-	-	PUNCT
ajlm-2104	100	13	lymphocyte	lymphocyte	ADJ
ajlm-2104	100	14	ratio	ratio	NOUN
ajlm-2104	100	15	.	.	PUNCT
ajlm-2104	101	1	(	(	PUNCT
ajlm-2104	101	2	b	b	X
ajlm-2104	101	3	)	)	PUNCT
ajlm-2104	101	4	the	the	DET
ajlm-2104	101	5	correlation	correlation	NOUN
ajlm-2104	101	6	between	between	ADP
ajlm-2104	101	7	the	the	DET
ajlm-2104	101	8	monocyte	monocyte	ADJ
ajlm-2104	101	9	-	-	PUNCT
ajlm-2104	101	10	lymphocyte	lymphocyte	NOUN
ajlm-2104	101	11	ratio	ratio	NOUN
ajlm-2104	101	12	and	and	CCONJ
ajlm-2104	101	13	procalcitonin	procalcitonin	NOUN
ajlm-2104	101	14	.	.	PUNCT
ajlm-2104	102	1	platelet	platelet	NOUN
ajlm-2104	102	2	-	-	PUNCT
ajlm-2104	102	3	to	to	ADP
ajlm-2104	102	4	-	-	PUNCT
ajlm-2104	102	5	lymphocyte	lymphocyte	NOUN
ajlm-2104	102	6	ratio	ratio	NOUN
ajlm-2104	102	7	the	the	DET
ajlm-2104	102	8	plr	plr	NOUN
ajlm-2104	102	9	in	in	ADP
ajlm-2104	102	10	those	those	PRON
ajlm-2104	102	11	with	with	ADP
ajlm-2104	102	12	diagnosed	diagnose	VERB
ajlm-2104	102	13	sepsis	sepsis	NOUN
ajlm-2104	102	14	was	be	AUX
ajlm-2104	102	15	significantly	significantly	ADV
ajlm-2104	102	16	higher	high	ADJ
ajlm-2104	102	17	than	than	ADP
ajlm-2104	102	18	in	in	ADP
ajlm-2104	102	19	the	the	DET
ajlm-2104	102	20	control	control	NOUN
ajlm-2104	102	21	group	group	NOUN
ajlm-2104	102	22	(	(	PUNCT
ajlm-2104	102	23	p	p	X
ajlm-2104	102	24	<	<	X
ajlm-2104	102	25	0.001	0.001	NUM
ajlm-2104	102	26	)	)	PUNCT
ajlm-2104	102	27	(	(	PUNCT
ajlm-2104	102	28	figure	figure	NOUN
ajlm-2104	102	29	3a	3a	NUM
ajlm-2104	102	30	)	)	PUNCT
ajlm-2104	102	31	;	;	PUNCT
ajlm-2104	102	32	however	however	ADV
ajlm-2104	102	33	,	,	PUNCT
ajlm-2104	102	34	no	no	DET
ajlm-2104	102	35	significant	significant	ADJ
ajlm-2104	102	36	correlation	correlation	NOUN
ajlm-2104	102	37	could	could	AUX
ajlm-2104	102	38	be	be	AUX
ajlm-2104	102	39	detected	detect	VERB
ajlm-2104	102	40	between	between	ADP
ajlm-2104	102	41	the	the	DET
ajlm-2104	102	42	plr	plr	NOUN
ajlm-2104	102	43	and	and	CCONJ
ajlm-2104	102	44	procalcitonin	procalcitonin	ADJ
ajlm-2104	102	45	levels	level	NOUN
ajlm-2104	102	46	(	(	PUNCT
ajlm-2104	102	47	r	r	NOUN
ajlm-2104	102	48	=	=	NOUN
ajlm-2104	102	49	0.069	0.069	NUM
ajlm-2104	102	50	;	;	PUNCT
ajlm-2104	102	51	p	p	X
ajlm-2104	102	52	=	=	NOUN
ajlm-2104	102	53	0.602	0.602	NUM
ajlm-2104	102	54	)	)	PUNCT
ajlm-2104	102	55	(	(	PUNCT
ajlm-2104	102	56	figure	figure	NOUN
ajlm-2104	102	57	3b	3b	NUM
ajlm-2104	102	58	)	)	PUNCT
ajlm-2104	102	59	.	.	PUNCT
ajlm-2104	103	1	figure	figure	VERB
ajlm-2104	103	2	3	3	NUM
ajlm-2104	103	3	:	:	PUNCT
ajlm-2104	103	4	platelet	platelet	ADJ
ajlm-2104	103	5	-	-	PUNCT
ajlm-2104	103	6	lymphocyte	lymphocyte	NOUN
ajlm-2104	103	7	ratio	ratio	NOUN
ajlm-2104	103	8	characteristics	characteristic	NOUN
ajlm-2104	103	9	among	among	ADP
ajlm-2104	103	10	62	62	NUM
ajlm-2104	103	11	patients	patient	NOUN
ajlm-2104	103	12	with	with	ADP
ajlm-2104	103	13	sepsis	sepsis	NOUN
ajlm-2104	103	14	compared	compare	VERB
ajlm-2104	103	15	to	to	ADP
ajlm-2104	103	16	63	63	NUM
ajlm-2104	103	17	controls	control	NOUN
ajlm-2104	103	18	presenting	present	VERB
ajlm-2104	103	19	between	between	ADP
ajlm-2104	103	20	january	january	PROPN
ajlm-2104	103	21	2021	2021	NUM
ajlm-2104	103	22	and	and	CCONJ
ajlm-2104	103	23	july	july	PROPN
ajlm-2104	103	24	2021	2021	NUM
ajlm-2104	103	25	.	.	PUNCT
ajlm-2104	104	1	(	(	PUNCT
ajlm-2104	104	2	a	a	X
ajlm-2104	104	3	)	)	PUNCT
ajlm-2104	104	4	the	the	DET
ajlm-2104	104	5	median	median	ADJ
ajlm-2104	104	6	and	and	CCONJ
ajlm-2104	104	7	interquartile	interquartile	ADJ
ajlm-2104	104	8	range	range	NOUN
ajlm-2104	104	9	of	of	ADP
ajlm-2104	104	10	the	the	DET
ajlm-2104	104	11	platelet	platelet	ADJ
ajlm-2104	104	12	-	-	PUNCT
ajlm-2104	104	13	lymphocyte	lymphocyte	NOUN
ajlm-2104	104	14	ratio	ratio	NOUN
ajlm-2104	104	15	.	.	PUNCT
ajlm-2104	105	1	(	(	PUNCT
ajlm-2104	105	2	b	b	X
ajlm-2104	105	3	)	)	PUNCT
ajlm-2104	105	4	the	the	DET
ajlm-2104	105	5	correlation	correlation	NOUN
ajlm-2104	105	6	between	between	ADP
ajlm-2104	105	7	the	the	DET
ajlm-2104	105	8	platelet	platelet	NOUN
ajlm-2104	105	9	lymphocyte	lymphocyte	ADJ
ajlm-2104	105	10	ratio	ratio	NOUN
ajlm-2104	105	11	and	and	CCONJ
ajlm-2104	105	12	procalcitonin	procalcitonin	NOUN
ajlm-2104	105	13	.	.	PUNCT
ajlm-2104	106	1	receiver	receiver	ADJ
ajlm-2104	106	2	operating	operate	VERB
ajlm-2104	106	3	characteristic	characteristic	ADJ
ajlm-2104	106	4	curve	curve	NOUN
ajlm-2104	106	5	analysis	analysis	NOUN
ajlm-2104	106	6	among	among	ADP
ajlm-2104	106	7	the	the	DET
ajlm-2104	106	8	three	three	NUM
ajlm-2104	106	9	cell	cell	NOUN
ajlm-2104	106	10	ratios	ratio	NOUN
ajlm-2104	106	11	assessed	assess	VERB
ajlm-2104	106	12	,	,	PUNCT
ajlm-2104	106	13	the	the	DET
ajlm-2104	106	14	nlr	nlr	PROPN
ajlm-2104	106	15	was	be	AUX
ajlm-2104	106	16	established	establish	VERB
ajlm-2104	106	17	as	as	ADP
ajlm-2104	106	18	the	the	DET
ajlm-2104	106	19	best	good	ADJ
ajlm-2104	106	20	diagnostic	diagnostic	ADJ
ajlm-2104	106	21	screening	screening	NOUN
ajlm-2104	106	22	marker	marker	NOUN
ajlm-2104	106	23	(	(	PUNCT
ajlm-2104	106	24	area	area	NOUN
ajlm-2104	106	25	under	under	ADP
ajlm-2104	106	26	curve	curve	NOUN
ajlm-2104	106	27	:	:	PUNCT
ajlm-2104	106	28	0.977	0.977	NUM
ajlm-2104	106	29	;	;	PUNCT
ajlm-2104	106	30	youden	youden	PROPN
ajlm-2104	106	31	index	index	NOUN
ajlm-2104	106	32	:	:	PUNCT
ajlm-2104	106	33	0.855	0.855	NUM
ajlm-2104	106	34	)	)	PUNCT
ajlm-2104	106	35	,	,	PUNCT
ajlm-2104	106	36	while	while	SCONJ
ajlm-2104	106	37	the	the	DET
ajlm-2104	106	38	mlr	mlr	NOUN
ajlm-2104	106	39	was	be	AUX
ajlm-2104	106	40	considered	consider	VERB
ajlm-2104	106	41	to	to	PART
ajlm-2104	106	42	be	be	AUX
ajlm-2104	106	43	good	good	ADJ
ajlm-2104	106	44	(	(	PUNCT
ajlm-2104	106	45	area	area	NOUN
ajlm-2104	106	46	under	under	ADP
ajlm-2104	106	47	curve	curve	NOUN
ajlm-2104	106	48	:	:	PUNCT
ajlm-2104	106	49	0.877	0.877	NUM
ajlm-2104	106	50	;	;	PUNCT
ajlm-2104	106	51	youden	youden	PROPN
ajlm-2104	106	52	index	index	NOUN
ajlm-2104	106	53	:	:	PUNCT
ajlm-2104	106	54	0.710	0.710	NUM
ajlm-2104	106	55	)	)	PUNCT
ajlm-2104	106	56	.	.	PUNCT
ajlm-2104	107	1	the	the	DET
ajlm-2104	107	2	plr	plr	NOUN
ajlm-2104	107	3	only	only	ADV
ajlm-2104	107	4	performed	perform	VERB
ajlm-2104	107	5	moderately	moderately	ADV
ajlm-2104	107	6	(	(	PUNCT
ajlm-2104	107	7	area	area	NOUN
ajlm-2104	107	8	under	under	ADP
ajlm-2104	107	9	curve	curve	NOUN
ajlm-2104	107	10	:	:	PUNCT
ajlm-2104	107	11	0.699	0.699	NUM
ajlm-2104	107	12	;	;	PUNCT
ajlm-2104	107	13	youden	youden	PROPN
ajlm-2104	107	14	index	index	NOUN
ajlm-2104	107	15	:	:	PUNCT
ajlm-2104	107	16	0.455	0.455	NUM
ajlm-2104	107	17	)	)	PUNCT
ajlm-2104	107	18	(	(	PUNCT
ajlm-2104	107	19	figure	figure	NOUN
ajlm-2104	107	20	4	4	NUM
ajlm-2104	107	21	)	)	PUNCT
ajlm-2104	107	22	.	.	PUNCT
ajlm-2104	108	1	figure	figure	VERB
ajlm-2104	108	2	4	4	NUM
ajlm-2104	108	3	:	:	PUNCT
ajlm-2104	108	4	receiver	receiver	ADJ
ajlm-2104	108	5	operating	operate	VERB
ajlm-2104	108	6	characteristic	characteristic	ADJ
ajlm-2104	108	7	curves	curve	NOUN
ajlm-2104	108	8	for	for	ADP
ajlm-2104	108	9	the	the	DET
ajlm-2104	108	10	neutrophil	neutrophil	ADJ
ajlm-2104	108	11	-	-	PUNCT
ajlm-2104	108	12	lymphocyte	lymphocyte	NOUN
ajlm-2104	108	13	ratio	ratio	NOUN
ajlm-2104	108	14	,	,	PUNCT
ajlm-2104	108	15	monocyte	monocyte	ADJ
ajlm-2104	108	16	-	-	PUNCT
ajlm-2104	108	17	lymphocyte	lymphocyte	NOUN
ajlm-2104	108	18	ratio	ratio	NOUN
ajlm-2104	108	19	and	and	CCONJ
ajlm-2104	108	20	the	the	DET
ajlm-2104	108	21	platelet	platelet	ADJ
ajlm-2104	108	22	-	-	PUNCT
ajlm-2104	108	23	lymphocyte	lymphocyte	ADJ
ajlm-2104	108	24	ratio	ratio	NOUN
ajlm-2104	108	25	of	of	ADP
ajlm-2104	108	26	patients	patient	NOUN
ajlm-2104	108	27	analysed	analyse	VERB
ajlm-2104	108	28	between	between	ADP
ajlm-2104	108	29	january	january	PROPN
ajlm-2104	108	30	and	and	CCONJ
ajlm-2104	108	31	july	july	PROPN
ajlm-2104	108	32	2021	2021	NUM
ajlm-2104	108	33	in	in	ADP
ajlm-2104	108	34	cape	cape	NOUN
ajlm-2104	108	35	town	town	NOUN
ajlm-2104	108	36	,	,	PUNCT
ajlm-2104	108	37	south	south	PROPN
ajlm-2104	108	38	africa	africa	PROPN
ajlm-2104	108	39	.	.	PUNCT
ajlm-2104	109	1	discussion	discussion	NOUN
ajlm-2104	109	2	in	in	ADP
ajlm-2104	109	3	this	this	DET
ajlm-2104	109	4	retrospective	retrospective	ADJ
ajlm-2104	109	5	study	study	NOUN
ajlm-2104	109	6	of	of	ADP
ajlm-2104	109	7	62	62	NUM
ajlm-2104	109	8	sepsis	sepsis	NOUN
ajlm-2104	109	9	and	and	CCONJ
ajlm-2104	109	10	63	63	NUM
ajlm-2104	109	11	control	control	NOUN
ajlm-2104	109	12	patients	patient	NOUN
ajlm-2104	109	13	,	,	PUNCT
ajlm-2104	109	14	the	the	DET
ajlm-2104	109	15	nlr	nlr	PROPN
ajlm-2104	109	16	,	,	PUNCT
ajlm-2104	109	17	mlr	mlr	PROPN
ajlm-2104	109	18	,	,	PUNCT
ajlm-2104	109	19	plr	plr	NOUN
ajlm-2104	109	20	,	,	PUNCT
ajlm-2104	109	21	white	white	ADJ
ajlm-2104	109	22	blood	blood	NOUN
ajlm-2104	109	23	cell	cell	NOUN
ajlm-2104	109	24	count	count	NOUN
ajlm-2104	109	25	and	and	CCONJ
ajlm-2104	109	26	neutrophil	neutrophil	ADJ
ajlm-2104	109	27	count	count	NOUN
ajlm-2104	109	28	were	be	AUX
ajlm-2104	109	29	significantly	significantly	ADV
ajlm-2104	109	30	elevated	elevate	VERB
ajlm-2104	109	31	in	in	ADP
ajlm-2104	109	32	those	those	PRON
ajlm-2104	109	33	with	with	ADP
ajlm-2104	109	34	sepsis	sepsis	NOUN
ajlm-2104	109	35	(	(	PUNCT
ajlm-2104	109	36	p	p	X
ajlm-2104	109	37	<	<	X
ajlm-2104	109	38	0.001	0.001	NUM
ajlm-2104	109	39	)	)	PUNCT
ajlm-2104	109	40	.	.	PUNCT
ajlm-2104	110	1	conversely	conversely	ADV
ajlm-2104	110	2	,	,	PUNCT
ajlm-2104	110	3	there	there	PRON
ajlm-2104	110	4	was	be	VERB
ajlm-2104	110	5	no	no	DET
ajlm-2104	110	6	significant	significant	ADJ
ajlm-2104	110	7	difference	difference	NOUN
ajlm-2104	110	8	in	in	ADP
ajlm-2104	110	9	the	the	DET
ajlm-2104	110	10	absolute	absolute	ADJ
ajlm-2104	110	11	monocyte	monocyte	NOUN
ajlm-2104	110	12	count	count	NOUN
ajlm-2104	110	13	between	between	ADP
ajlm-2104	110	14	the	the	DET
ajlm-2104	110	15	two	two	NUM
ajlm-2104	110	16	groups	group	NOUN
ajlm-2104	110	17	(	(	PUNCT
ajlm-2104	110	18	p	p	X
ajlm-2104	110	19	=	=	NOUN
ajlm-2104	110	20	0.377	0.377	NUM
ajlm-2104	110	21	)	)	PUNCT
ajlm-2104	110	22	.	.	PUNCT
ajlm-2104	111	1	furthermore	furthermore	ADV
ajlm-2104	111	2	,	,	PUNCT
ajlm-2104	111	3	despite	despite	SCONJ
ajlm-2104	111	4	the	the	DET
ajlm-2104	111	5	significantly	significantly	ADV
ajlm-2104	111	6	increased	increase	VERB
ajlm-2104	111	7	full	full	ADJ
ajlm-2104	111	8	blood	blood	NOUN
ajlm-2104	111	9	count	count	NOUN
ajlm-2104	111	10	parameters	parameter	NOUN
ajlm-2104	111	11	in	in	ADP
ajlm-2104	111	12	the	the	DET
ajlm-2104	111	13	sepsis	sepsis	NOUN
ajlm-2104	111	14	group	group	NOUN
ajlm-2104	111	15	,	,	PUNCT
ajlm-2104	111	16	no	no	DET
ajlm-2104	111	17	correlation	correlation	NOUN
ajlm-2104	111	18	was	be	AUX
ajlm-2104	111	19	detected	detect	VERB
ajlm-2104	111	20	between	between	ADP
ajlm-2104	111	21	the	the	DET
ajlm-2104	111	22	cell	cell	NOUN
ajlm-2104	111	23	ratios	ratio	NOUN
ajlm-2104	111	24	and	and	CCONJ
ajlm-2104	111	25	procalcitonin	procalcitonin	VERB
ajlm-2104	111	26	.	.	PUNCT
ajlm-2104	112	1	the	the	DET
ajlm-2104	112	2	receiver	receiver	NOUN
ajlm-2104	112	3	operating	operate	VERB
ajlm-2104	112	4	characteristic	characteristic	ADJ
ajlm-2104	112	5	curve	curve	NOUN
ajlm-2104	112	6	analysis	analysis	NOUN
ajlm-2104	112	7	established	establish	VERB
ajlm-2104	112	8	that	that	SCONJ
ajlm-2104	112	9	the	the	DET
ajlm-2104	112	10	nlr	nlr	PROPN
ajlm-2104	112	11	was	be	AUX
ajlm-2104	112	12	the	the	DET
ajlm-2104	112	13	best	good	ADJ
ajlm-2104	112	14	screening	screening	NOUN
ajlm-2104	112	15	marker	marker	NOUN
ajlm-2104	112	16	for	for	ADP
ajlm-2104	112	17	sepsis	sepsis	NOUN
ajlm-2104	112	18	amongst	amongst	ADP
ajlm-2104	112	19	the	the	DET
ajlm-2104	112	20	three	three	NUM
ajlm-2104	112	21	cell	cell	NOUN
ajlm-2104	112	22	ratios	ratio	NOUN
ajlm-2104	112	23	.	.	PUNCT
ajlm-2104	113	1	researchers	researcher	NOUN
ajlm-2104	113	2	have	have	AUX
ajlm-2104	113	3	demonstrated	demonstrate	VERB
ajlm-2104	113	4	that	that	SCONJ
ajlm-2104	113	5	an	an	DET
ajlm-2104	113	6	elevated	elevated	ADJ
ajlm-2104	113	7	nlr	nlr	PROPN
ajlm-2104	113	8	indicates	indicate	VERB
ajlm-2104	113	9	sepsis	sepsis	NOUN
ajlm-2104	113	10	and	and	CCONJ
ajlm-2104	113	11	predicts	predict	VERB
ajlm-2104	113	12	morbidity	morbidity	NOUN
ajlm-2104	113	13	and	and	CCONJ
ajlm-2104	113	14	mortality	mortality	NOUN
ajlm-2104	113	15	.	.	PUNCT
ajlm-2104	114	1	for	for	ADP
ajlm-2104	114	2	example	example	NOUN
ajlm-2104	114	3	,	,	PUNCT
ajlm-2104	114	4	a	a	DET
ajlm-2104	114	5	study	study	NOUN
ajlm-2104	114	6	conducted	conduct	VERB
ajlm-2104	114	7	on	on	ADP
ajlm-2104	114	8	60	60	NUM
ajlm-2104	114	9	000	000	NUM
ajlm-2104	114	10	intensive	intensive	ADJ
ajlm-2104	114	11	care	care	NOUN
ajlm-2104	114	12	patients	patient	NOUN
ajlm-2104	114	13	from	from	ADP
ajlm-2104	114	14	the	the	DET
ajlm-2104	114	15	beth	beth	PROPN
ajlm-2104	114	16	israel	israel	PROPN
ajlm-2104	114	17	deaconess	deaconess	PROPN
ajlm-2104	114	18	medical	medical	PROPN
ajlm-2104	114	19	center	center	NOUN
ajlm-2104	114	20	in	in	ADP
ajlm-2104	114	21	the	the	DET
ajlm-2104	114	22	united	united	PROPN
ajlm-2104	114	23	states	states	PROPN
ajlm-2104	114	24	between	between	ADP
ajlm-2104	114	25	june	june	PROPN
ajlm-2104	114	26	2001	2001	NUM
ajlm-2104	114	27	and	and	CCONJ
ajlm-2104	114	28	october	october	PROPN
ajlm-2104	114	29	2012	2012	NUM
ajlm-2104	114	30	concluded	conclude	VERB
ajlm-2104	114	31	that	that	SCONJ
ajlm-2104	114	32	an	an	DET
ajlm-2104	114	33	nlr	nlr	PROPN
ajlm-2104	114	34	of	of	ADP
ajlm-2104	114	35	>	>	DET
ajlm-2104	114	36	20.25	20.25	NUM
ajlm-2104	114	37	in	in	ADP
ajlm-2104	114	38	adults	adult	NOUN
ajlm-2104	114	39	was	be	AUX
ajlm-2104	114	40	associated	associate	VERB
ajlm-2104	114	41	with	with	ADP
ajlm-2104	114	42	an	an	DET
ajlm-2104	114	43	elevated	elevated	ADJ
ajlm-2104	114	44	mortality	mortality	NOUN
ajlm-2104	114	45	risk	risk	NOUN
ajlm-2104	114	46	after	after	ADP
ajlm-2104	114	47	28	28	NUM
ajlm-2104	114	48	days.22	days.22	NOUN
ajlm-2104	114	49	although	although	SCONJ
ajlm-2104	114	50	other	other	ADJ
ajlm-2104	114	51	studies	study	NOUN
ajlm-2104	114	52	support	support	VERB
ajlm-2104	114	53	this	this	DET
ajlm-2104	114	54	finding,23,24	finding,23,24	VERB
ajlm-2104	114	55	controversy	controversy	NOUN
ajlm-2104	114	56	over	over	ADP
ajlm-2104	114	57	cut	cut	VERB
ajlm-2104	114	58	-	-	PUNCT
ajlm-2104	114	59	off	off	ADP
ajlm-2104	114	60	values	value	NOUN
ajlm-2104	114	61	remains	remain	VERB
ajlm-2104	114	62	.	.	PUNCT
ajlm-2104	115	1	in	in	ADP
ajlm-2104	115	2	a	a	DET
ajlm-2104	115	3	similar	similar	ADJ
ajlm-2104	115	4	study	study	NOUN
ajlm-2104	115	5	to	to	ADP
ajlm-2104	115	6	ours	ours	PRON
ajlm-2104	115	7	,	,	PUNCT
ajlm-2104	115	8	a	a	DET
ajlm-2104	115	9	retrospective	retrospective	ADJ
ajlm-2104	115	10	laboratory	laboratory	NOUN
ajlm-2104	115	11	analysis	analysis	NOUN
ajlm-2104	115	12	of	of	ADP
ajlm-2104	115	13	1468	1468	NUM
ajlm-2104	115	14	turkish	turkish	ADJ
ajlm-2104	115	15	patients	patient	NOUN
ajlm-2104	115	16	recommended	recommend	VERB
ajlm-2104	115	17	an	an	DET
ajlm-2104	115	18	nlr	nlr	PROPN
ajlm-2104	115	19	cut	cut	NOUN
ajlm-2104	115	20	-	-	PUNCT
ajlm-2104	115	21	off	off	NOUN
ajlm-2104	115	22	of	of	ADP
ajlm-2104	115	23	>	>	DET
ajlm-2104	115	24	5	5	NUM
ajlm-2104	115	25	as	as	ADP
ajlm-2104	115	26	being	be	AUX
ajlm-2104	115	27	highly	highly	ADV
ajlm-2104	115	28	suggestive	suggestive	ADJ
ajlm-2104	115	29	of	of	ADP
ajlm-2104	115	30	sepsis.35	sepsis.35	NOUN
ajlm-2104	115	31	in	in	ADP
ajlm-2104	115	32	this	this	DET
ajlm-2104	115	33	current	current	ADJ
ajlm-2104	115	34	study	study	NOUN
ajlm-2104	115	35	,	,	PUNCT
ajlm-2104	115	36	we	we	PRON
ajlm-2104	115	37	defined	define	VERB
ajlm-2104	115	38	sepsis	sepsis	NOUN
ajlm-2104	115	39	based	base	VERB
ajlm-2104	115	40	on	on	ADP
ajlm-2104	115	41	a	a	DET
ajlm-2104	115	42	positive	positive	ADJ
ajlm-2104	115	43	bc	bc	PROPN
ajlm-2104	115	44	;	;	PUNCT
ajlm-2104	115	45	eight	eight	NUM
ajlm-2104	115	46	of	of	ADP
ajlm-2104	115	47	the	the	DET
ajlm-2104	115	48	62	62	NUM
ajlm-2104	115	49	(	(	PUNCT
ajlm-2104	115	50	13	13	NUM
ajlm-2104	115	51	%	%	NOUN
ajlm-2104	115	52	)	)	PUNCT
ajlm-2104	115	53	confirmed	confirm	VERB
ajlm-2104	115	54	sepsis	sepsis	NOUN
ajlm-2104	115	55	patients	patient	NOUN
ajlm-2104	115	56	had	have	VERB
ajlm-2104	115	57	an	an	DET
ajlm-2104	115	58	nlr	nlr	PROPN
ajlm-2104	115	59	<	<	X
ajlm-2104	115	60	5	5	NUM
ajlm-2104	115	61	suggesting	suggest	VERB
ajlm-2104	115	62	that	that	SCONJ
ajlm-2104	115	63	a	a	DET
ajlm-2104	115	64	cut	cut	VERB
ajlm-2104	115	65	-	-	PUNCT
ajlm-2104	115	66	off	off	ADP
ajlm-2104	115	67	value	value	NOUN
ajlm-2104	115	68	of	of	ADP
ajlm-2104	115	69	>	>	SYM
ajlm-2104	115	70	5	5	NUM
ajlm-2104	115	71	is	be	AUX
ajlm-2104	115	72	significant	significant	ADJ
ajlm-2104	115	73	.	.	PUNCT
ajlm-2104	116	1	however	however	ADV
ajlm-2104	116	2	,	,	PUNCT
ajlm-2104	116	3	an	an	DET
ajlm-2104	116	4	nlr	nlr	NOUN
ajlm-2104	116	5	of	of	ADP
ajlm-2104	116	6	>	>	X
ajlm-2104	116	7	5	5	NUM
ajlm-2104	116	8	can	can	AUX
ajlm-2104	116	9	not	not	PART
ajlm-2104	116	10	be	be	AUX
ajlm-2104	116	11	used	use	VERB
ajlm-2104	116	12	in	in	ADP
ajlm-2104	116	13	isolation	isolation	NOUN
ajlm-2104	116	14	to	to	PART
ajlm-2104	116	15	indicate	indicate	VERB
ajlm-2104	116	16	sepsis	sepsis	NOUN
ajlm-2104	116	17	in	in	ADP
ajlm-2104	116	18	africa	africa	PROPN
ajlm-2104	116	19	due	due	ADP
ajlm-2104	116	20	to	to	ADP
ajlm-2104	116	21	the	the	DET
ajlm-2104	116	22	high	high	ADJ
ajlm-2104	116	23	frequency	frequency	NOUN
ajlm-2104	116	24	of	of	ADP
ajlm-2104	116	25	benign	benign	ADJ
ajlm-2104	116	26	ethnic	ethnic	ADJ
ajlm-2104	116	27	neutropenia	neutropenia	NOUN
ajlm-2104	116	28	which	which	PRON
ajlm-2104	116	29	may	may	AUX
ajlm-2104	116	30	result	result	VERB
ajlm-2104	116	31	in	in	ADP
ajlm-2104	116	32	a	a	DET
ajlm-2104	116	33	lower	low	ADJ
ajlm-2104	116	34	nlr	nlr	NOUN
ajlm-2104	116	35	in	in	ADP
ajlm-2104	116	36	healthy	healthy	ADJ
ajlm-2104	116	37	individuals	individual	NOUN
ajlm-2104	116	38	.	.	PUNCT
ajlm-2104	117	1	although	although	SCONJ
ajlm-2104	117	2	the	the	DET
ajlm-2104	117	3	nlr	nlr	PROPN
ajlm-2104	117	4	,	,	PUNCT
ajlm-2104	117	5	in	in	ADP
ajlm-2104	117	6	this	this	DET
ajlm-2104	117	7	current	current	ADJ
ajlm-2104	117	8	study	study	NOUN
ajlm-2104	117	9	,	,	PUNCT
ajlm-2104	117	10	was	be	AUX
ajlm-2104	117	11	significantly	significantly	ADV
ajlm-2104	117	12	increased	increase	VERB
ajlm-2104	117	13	in	in	ADP
ajlm-2104	117	14	patients	patient	NOUN
ajlm-2104	117	15	with	with	ADP
ajlm-2104	117	16	sepsis	sepsis	NOUN
ajlm-2104	117	17	,	,	PUNCT
ajlm-2104	117	18	there	there	PRON
ajlm-2104	117	19	was	be	VERB
ajlm-2104	117	20	no	no	DET
ajlm-2104	117	21	significant	significant	ADJ
ajlm-2104	117	22	correlation	correlation	NOUN
ajlm-2104	117	23	with	with	ADP
ajlm-2104	117	24	procalcitonin	procalcitonin	ADJ
ajlm-2104	117	25	levels	level	NOUN
ajlm-2104	117	26	.	.	PUNCT
ajlm-2104	118	1	one	one	NUM
ajlm-2104	118	2	reason	reason	NOUN
ajlm-2104	118	3	for	for	ADP
ajlm-2104	118	4	this	this	DET
ajlm-2104	118	5	finding	finding	NOUN
ajlm-2104	118	6	could	could	AUX
ajlm-2104	118	7	be	be	AUX
ajlm-2104	118	8	that	that	SCONJ
ajlm-2104	118	9	the	the	DET
ajlm-2104	118	10	nlr	nlr	PROPN
ajlm-2104	118	11	and	and	CCONJ
ajlm-2104	118	12	procalcitonin	procalcitonin	ADJ
ajlm-2104	118	13	can	can	AUX
ajlm-2104	118	14	be	be	AUX
ajlm-2104	118	15	elevated	elevate	VERB
ajlm-2104	118	16	in	in	ADP
ajlm-2104	118	17	several	several	ADJ
ajlm-2104	118	18	conditions	condition	NOUN
ajlm-2104	118	19	,	,	PUNCT
ajlm-2104	118	20	with	with	ADP
ajlm-2104	118	21	neither	neither	DET
ajlm-2104	118	22	test	test	NOUN
ajlm-2104	118	23	being	be	AUX
ajlm-2104	118	24	specific	specific	ADJ
ajlm-2104	118	25	for	for	ADP
ajlm-2104	118	26	sepsis.17,36	sepsis.17,36	ADJ
ajlm-2104	118	27	neutrophil	neutrophil	ADJ
ajlm-2104	118	28	counts	count	NOUN
ajlm-2104	118	29	and	and	CCONJ
ajlm-2104	118	30	the	the	DET
ajlm-2104	118	31	nlr	nlr	PROPN
ajlm-2104	118	32	can	can	AUX
ajlm-2104	118	33	be	be	AUX
ajlm-2104	118	34	influenced	influence	VERB
ajlm-2104	118	35	by	by	ADP
ajlm-2104	118	36	numerous	numerous	ADJ
ajlm-2104	118	37	variables	variable	NOUN
ajlm-2104	118	38	,	,	PUNCT
ajlm-2104	118	39	including	include	VERB
ajlm-2104	118	40	age	age	NOUN
ajlm-2104	118	41	,	,	PUNCT
ajlm-2104	118	42	obesity	obesity	NOUN
ajlm-2104	118	43	,	,	PUNCT
ajlm-2104	118	44	hiv	hiv	PROPN
ajlm-2104	118	45	,	,	PUNCT
ajlm-2104	118	46	cardiovascular	cardiovascular	ADJ
ajlm-2104	118	47	disease	disease	NOUN
ajlm-2104	118	48	,	,	PUNCT
ajlm-2104	118	49	type	type	NOUN
ajlm-2104	118	50	2	2	NUM
ajlm-2104	118	51	diabetes	diabetes	NOUN
ajlm-2104	118	52	and	and	CCONJ
ajlm-2104	118	53	malignancy.24	malignancy.24	PRON
ajlm-2104	118	54	both	both	PRON
ajlm-2104	118	55	procalcitonin	procalcitonin	VERB
ajlm-2104	118	56	and	and	CCONJ
ajlm-2104	118	57	the	the	DET
ajlm-2104	118	58	nlr	nlr	PROPN
ajlm-2104	118	59	measure	measure	VERB
ajlm-2104	118	60	different	different	ADJ
ajlm-2104	118	61	processes	process	NOUN
ajlm-2104	118	62	,	,	PUNCT
ajlm-2104	118	63	and	and	CCONJ
ajlm-2104	118	64	therefore	therefore	ADV
ajlm-2104	118	65	neither	neither	PRON
ajlm-2104	118	66	should	should	AUX
ajlm-2104	118	67	be	be	AUX
ajlm-2104	118	68	used	use	VERB
ajlm-2104	118	69	in	in	ADP
ajlm-2104	118	70	isolation	isolation	NOUN
ajlm-2104	118	71	to	to	PART
ajlm-2104	118	72	diagnose	diagnose	VERB
ajlm-2104	118	73	or	or	CCONJ
ajlm-2104	118	74	predict	predict	VERB
ajlm-2104	118	75	the	the	DET
ajlm-2104	118	76	outcome	outcome	NOUN
ajlm-2104	118	77	in	in	ADP
ajlm-2104	118	78	patients	patient	NOUN
ajlm-2104	118	79	with	with	ADP
ajlm-2104	118	80	sepsis	sepsis	NOUN
ajlm-2104	118	81	.	.	PUNCT
ajlm-2104	119	1	although	although	SCONJ
ajlm-2104	119	2	our	our	PRON
ajlm-2104	119	3	study	study	NOUN
ajlm-2104	119	4	revealed	reveal	VERB
ajlm-2104	119	5	no	no	DET
ajlm-2104	119	6	significant	significant	ADJ
ajlm-2104	119	7	difference	difference	NOUN
ajlm-2104	119	8	in	in	ADP
ajlm-2104	119	9	the	the	DET
ajlm-2104	119	10	monocyte	monocyte	NOUN
ajlm-2104	119	11	count	count	NOUN
ajlm-2104	119	12	between	between	ADP
ajlm-2104	119	13	those	those	PRON
ajlm-2104	119	14	with	with	ADP
ajlm-2104	119	15	and	and	CCONJ
ajlm-2104	119	16	without	without	ADP
ajlm-2104	119	17	sepsis	sepsis	NOUN
ajlm-2104	119	18	,	,	PUNCT
ajlm-2104	119	19	the	the	DET
ajlm-2104	119	20	mlr	mlr	NOUN
ajlm-2104	119	21	was	be	AUX
ajlm-2104	119	22	significantly	significantly	ADV
ajlm-2104	119	23	elevated	elevate	VERB
ajlm-2104	119	24	in	in	ADP
ajlm-2104	119	25	the	the	DET
ajlm-2104	119	26	sepsis	sepsis	NOUN
ajlm-2104	119	27	group	group	NOUN
ajlm-2104	119	28	(	(	PUNCT
ajlm-2104	119	29	p	p	X
ajlm-2104	119	30	<	<	X
ajlm-2104	119	31	0.001	0.001	NUM
ajlm-2104	119	32	)	)	PUNCT
ajlm-2104	119	33	,	,	PUNCT
ajlm-2104	119	34	which	which	PRON
ajlm-2104	119	35	was	be	AUX
ajlm-2104	119	36	mainly	mainly	ADV
ajlm-2104	119	37	due	due	ADJ
ajlm-2104	119	38	to	to	ADP
ajlm-2104	119	39	a	a	DET
ajlm-2104	119	40	decreased	decrease	VERB
ajlm-2104	119	41	lymphocyte	lymphocyte	ADJ
ajlm-2104	119	42	count	count	NOUN
ajlm-2104	119	43	.	.	PUNCT
ajlm-2104	120	1	this	this	DET
ajlm-2104	120	2	finding	finding	NOUN
ajlm-2104	120	3	implies	imply	VERB
ajlm-2104	120	4	that	that	SCONJ
ajlm-2104	120	5	the	the	DET
ajlm-2104	120	6	mlr	mlr	NOUN
ajlm-2104	120	7	could	could	AUX
ajlm-2104	120	8	be	be	AUX
ajlm-2104	120	9	an	an	DET
ajlm-2104	120	10	additional	additional	ADJ
ajlm-2104	120	11	valuable	valuable	ADJ
ajlm-2104	120	12	indicator	indicator	NOUN
ajlm-2104	120	13	of	of	ADP
ajlm-2104	120	14	sepsis	sepsis	NOUN
ajlm-2104	120	15	.	.	PUNCT
ajlm-2104	121	1	reports	report	NOUN
ajlm-2104	121	2	examining	examine	VERB
ajlm-2104	121	3	the	the	DET
ajlm-2104	121	4	use	use	NOUN
ajlm-2104	121	5	of	of	ADP
ajlm-2104	121	6	the	the	DET
ajlm-2104	121	7	mlr	mlr	NOUN
ajlm-2104	121	8	are	be	AUX
ajlm-2104	121	9	scant	scant	ADJ
ajlm-2104	121	10	and	and	CCONJ
ajlm-2104	121	11	unclear	unclear	ADJ
ajlm-2104	121	12	,	,	PUNCT
ajlm-2104	121	13	with	with	ADP
ajlm-2104	121	14	one	one	NUM
ajlm-2104	121	15	study	study	NOUN
ajlm-2104	121	16	of	of	ADP
ajlm-2104	121	17	152	152	NUM
ajlm-2104	121	18	patients	patient	NOUN
ajlm-2104	121	19	diagnosed	diagnose	VERB
ajlm-2104	121	20	with	with	ADP
ajlm-2104	121	21	klebsiella	klebsiella	PROPN
ajlm-2104	121	22	pheumonia	pheumonia	PROPN
ajlm-2104	121	23	in	in	ADP
ajlm-2104	121	24	china	china	PROPN
ajlm-2104	121	25	,	,	PUNCT
ajlm-2104	121	26	between	between	ADP
ajlm-2104	121	27	january	january	PROPN
ajlm-2104	121	28	2014	2014	NUM
ajlm-2104	121	29	and	and	CCONJ
ajlm-2104	121	30	december	december	PROPN
ajlm-2104	121	31	2017	2017	NUM
ajlm-2104	121	32	,	,	PUNCT
ajlm-2104	121	33	demonstrating	demonstrate	VERB
ajlm-2104	121	34	an	an	DET
ajlm-2104	121	35	association	association	NOUN
ajlm-2104	121	36	with	with	ADP
ajlm-2104	121	37	negative	negative	ADJ
ajlm-2104	121	38	bc28	bc28	PROPN
ajlm-2104	121	39	and	and	CCONJ
ajlm-2104	121	40	another	another	DET
ajlm-2104	121	41	prospective	prospective	ADJ
ajlm-2104	121	42	analysis	analysis	NOUN
ajlm-2104	121	43	of	of	ADP
ajlm-2104	121	44	392	392	NUM
ajlm-2104	121	45	patients	patient	NOUN
ajlm-2104	121	46	diagnosed	diagnose	VERB
ajlm-2104	121	47	over	over	ADP
ajlm-2104	121	48	a	a	DET
ajlm-2104	121	49	4	4	NUM
ajlm-2104	121	50	-	-	PUNCT
ajlm-2104	121	51	year	year	NOUN
ajlm-2104	121	52	period	period	NOUN
ajlm-2104	121	53	in	in	ADP
ajlm-2104	121	54	serbia	serbia	PROPN
ajlm-2104	121	55	reporting	report	VERB
ajlm-2104	121	56	only	only	ADV
ajlm-2104	121	57	a	a	DET
ajlm-2104	121	58	moderate	moderate	ADJ
ajlm-2104	121	59	association	association	NOUN
ajlm-2104	121	60	with	with	ADP
ajlm-2104	121	61	sepsis.29	sepsis.29	NOUN
ajlm-2104	121	62	due	due	ADP
ajlm-2104	121	63	to	to	ADP
ajlm-2104	121	64	these	these	DET
ajlm-2104	121	65	conflicting	conflict	VERB
ajlm-2104	121	66	observations	observation	NOUN
ajlm-2104	121	67	,	,	PUNCT
ajlm-2104	121	68	further	further	ADJ
ajlm-2104	121	69	studies	study	NOUN
ajlm-2104	121	70	in	in	ADP
ajlm-2104	121	71	different	different	ADJ
ajlm-2104	121	72	population	population	NOUN
ajlm-2104	121	73	groups	group	NOUN
ajlm-2104	121	74	are	be	AUX
ajlm-2104	121	75	recommended	recommend	VERB
ajlm-2104	121	76	.	.	PUNCT
ajlm-2104	122	1	in	in	ADP
ajlm-2104	122	2	this	this	DET
ajlm-2104	122	3	current	current	ADJ
ajlm-2104	122	4	study	study	NOUN
ajlm-2104	122	5	,	,	PUNCT
ajlm-2104	122	6	as	as	SCONJ
ajlm-2104	122	7	expected	expect	VERB
ajlm-2104	122	8	,	,	PUNCT
ajlm-2104	122	9	platelet	platelet	NOUN
ajlm-2104	122	10	counts	count	NOUN
ajlm-2104	122	11	in	in	ADP
ajlm-2104	122	12	those	those	PRON
ajlm-2104	122	13	with	with	ADP
ajlm-2104	122	14	sepsis	sepsis	NOUN
ajlm-2104	122	15	were	be	AUX
ajlm-2104	122	16	significantly	significantly	ADV
ajlm-2104	122	17	reduced	reduce	VERB
ajlm-2104	122	18	(	(	PUNCT
ajlm-2104	122	19	p	p	X
ajlm-2104	122	20	<	<	X
ajlm-2104	122	21	0.001	0.001	NUM
ajlm-2104	122	22	)	)	PUNCT
ajlm-2104	122	23	,	,	PUNCT
ajlm-2104	122	24	while	while	SCONJ
ajlm-2104	122	25	the	the	DET
ajlm-2104	122	26	plr	plr	NOUN
ajlm-2104	122	27	,	,	PUNCT
ajlm-2104	122	28	although	although	SCONJ
ajlm-2104	122	29	showing	show	VERB
ajlm-2104	122	30	a	a	DET
ajlm-2104	122	31	wide	wide	ADJ
ajlm-2104	122	32	variation	variation	NOUN
ajlm-2104	122	33	,	,	PUNCT
ajlm-2104	122	34	was	be	AUX
ajlm-2104	122	35	significantly	significantly	ADV
ajlm-2104	122	36	different	different	ADJ
ajlm-2104	122	37	to	to	ADP
ajlm-2104	122	38	the	the	DET
ajlm-2104	122	39	control	control	NOUN
ajlm-2104	122	40	group	group	NOUN
ajlm-2104	122	41	(	(	PUNCT
ajlm-2104	122	42	p	p	X
ajlm-2104	122	43	<	<	X
ajlm-2104	122	44	0.001	0.001	NUM
ajlm-2104	122	45	)	)	PUNCT
ajlm-2104	122	46	.	.	PUNCT
ajlm-2104	123	1	however	however	ADV
ajlm-2104	123	2	,	,	PUNCT
ajlm-2104	123	3	receiver	receiver	ADJ
ajlm-2104	123	4	operating	operate	VERB
ajlm-2104	123	5	characteristic	characteristic	ADJ
ajlm-2104	123	6	curve	curve	NOUN
ajlm-2104	123	7	analysis	analysis	NOUN
ajlm-2104	123	8	demonstrated	demonstrate	VERB
ajlm-2104	123	9	that	that	SCONJ
ajlm-2104	123	10	the	the	DET
ajlm-2104	123	11	plr	plr	NOUN
ajlm-2104	123	12	only	only	ADV
ajlm-2104	123	13	had	have	VERB
ajlm-2104	123	14	moderate	moderate	ADJ
ajlm-2104	123	15	diagnostic	diagnostic	ADJ
ajlm-2104	123	16	value	value	NOUN
ajlm-2104	123	17	.	.	PUNCT
ajlm-2104	124	1	these	these	DET
ajlm-2104	124	2	results	result	NOUN
ajlm-2104	124	3	support	support	VERB
ajlm-2104	124	4	two	two	NUM
ajlm-2104	124	5	previous	previous	ADJ
ajlm-2104	124	6	research	research	NOUN
ajlm-2104	124	7	reports	report	NOUN
ajlm-2104	124	8	,	,	PUNCT
ajlm-2104	124	9	one	one	NUM
ajlm-2104	124	10	conducted	conduct	VERB
ajlm-2104	124	11	between	between	ADP
ajlm-2104	124	12	january	january	PROPN
ajlm-2104	124	13	2011	2011	NUM
ajlm-2104	124	14	and	and	CCONJ
ajlm-2104	124	15	july	july	PROPN
ajlm-2104	124	16	2013	2013	NUM
ajlm-2104	124	17	in	in	ADP
ajlm-2104	124	18	the	the	DET
ajlm-2104	124	19	netherlands	netherlands	PROPN
ajlm-2104	124	20	and	and	CCONJ
ajlm-2104	124	21	another	another	PRON
ajlm-2104	124	22	undertaken	undertake	VERB
ajlm-2104	124	23	between	between	ADP
ajlm-2104	124	24	2001	2001	NUM
ajlm-2104	124	25	and	and	CCONJ
ajlm-2104	124	26	2008	2008	NUM
ajlm-2104	124	27	in	in	ADP
ajlm-2104	124	28	china	china	PROPN
ajlm-2104	124	29	,	,	PUNCT
ajlm-2104	124	30	which	which	PRON
ajlm-2104	124	31	demonstrated	demonstrate	VERB
ajlm-2104	124	32	that	that	SCONJ
ajlm-2104	124	33	low	low	ADJ
ajlm-2104	124	34	platelet	platelet	NOUN
ajlm-2104	124	35	count	count	NOUN
ajlm-2104	124	36	and	and	CCONJ
ajlm-2104	124	37	elevated	elevated	ADJ
ajlm-2104	124	38	plr	plr	NOUN
ajlm-2104	124	39	are	be	AUX
ajlm-2104	124	40	associated	associate	VERB
ajlm-2104	124	41	with	with	ADP
ajlm-2104	124	42	sepsis	sepsis	NOUN
ajlm-2104	124	43	and	and	CCONJ
ajlm-2104	124	44	a	a	DET
ajlm-2104	124	45	worse	bad	ADJ
ajlm-2104	124	46	prognosis	prognosis	NOUN
ajlm-2104	124	47	in	in	ADP
ajlm-2104	124	48	cases	case	NOUN
ajlm-2104	124	49	of	of	ADP
ajlm-2104	124	50	severe	severe	ADJ
ajlm-2104	124	51	thrombocytopenia.32,33	thrombocytopenia.32,33	NOUN
ajlm-2104	124	52	calculating	calculate	VERB
ajlm-2104	124	53	the	the	DET
ajlm-2104	124	54	plr	plr	NOUN
ajlm-2104	124	55	could	could	AUX
ajlm-2104	124	56	provide	provide	VERB
ajlm-2104	124	57	valuable	valuable	ADJ
ajlm-2104	124	58	information	information	NOUN
ajlm-2104	124	59	if	if	SCONJ
ajlm-2104	124	60	analysed	analyse	VERB
ajlm-2104	124	61	with	with	ADP
ajlm-2104	124	62	other	other	ADJ
ajlm-2104	124	63	cell	cell	NOUN
ajlm-2104	124	64	ratios	ratio	NOUN
ajlm-2104	124	65	and	and	CCONJ
ajlm-2104	124	66	full	full	ADJ
ajlm-2104	124	67	blood	blood	NOUN
ajlm-2104	124	68	count	count	NOUN
ajlm-2104	124	69	parameters	parameter	NOUN
ajlm-2104	124	70	.	.	PUNCT
ajlm-2104	125	1	limitations	limitation	NOUN
ajlm-2104	125	2	in	in	ADP
ajlm-2104	125	3	this	this	DET
ajlm-2104	125	4	study	study	NOUN
ajlm-2104	125	5	,	,	PUNCT
ajlm-2104	125	6	we	we	PRON
ajlm-2104	125	7	hypothesised	hypothesise	VERB
ajlm-2104	125	8	that	that	SCONJ
ajlm-2104	125	9	simple	simple	ADJ
ajlm-2104	125	10	full	full	ADJ
ajlm-2104	125	11	blood	blood	NOUN
ajlm-2104	125	12	count	count	NOUN
ajlm-2104	125	13	parameters	parameter	NOUN
ajlm-2104	125	14	,	,	PUNCT
ajlm-2104	125	15	utilised	utilise	VERB
ajlm-2104	125	16	together	together	ADV
ajlm-2104	125	17	with	with	ADP
ajlm-2104	125	18	calculating	calculate	VERB
ajlm-2104	125	19	haematological	haematological	ADJ
ajlm-2104	125	20	cell	cell	NOUN
ajlm-2104	125	21	ratios	ratio	NOUN
ajlm-2104	125	22	,	,	PUNCT
ajlm-2104	125	23	could	could	AUX
ajlm-2104	125	24	provide	provide	VERB
ajlm-2104	125	25	an	an	DET
ajlm-2104	125	26	early	early	ADJ
ajlm-2104	125	27	screening	screening	NOUN
ajlm-2104	125	28	tool	tool	NOUN
ajlm-2104	125	29	for	for	ADP
ajlm-2104	125	30	sepsis	sepsis	NOUN
ajlm-2104	125	31	.	.	PUNCT
ajlm-2104	126	1	however	however	ADV
ajlm-2104	126	2	,	,	PUNCT
ajlm-2104	126	3	as	as	SCONJ
ajlm-2104	126	4	this	this	PRON
ajlm-2104	126	5	was	be	AUX
ajlm-2104	126	6	a	a	DET
ajlm-2104	126	7	laboratory	laboratory	NOUN
ajlm-2104	126	8	-	-	PUNCT
ajlm-2104	126	9	based	base	VERB
ajlm-2104	126	10	study	study	NOUN
ajlm-2104	126	11	,	,	PUNCT
ajlm-2104	126	12	a	a	DET
ajlm-2104	126	13	significant	significant	ADJ
ajlm-2104	126	14	limitation	limitation	NOUN
ajlm-2104	126	15	of	of	ADP
ajlm-2104	126	16	this	this	DET
ajlm-2104	126	17	work	work	NOUN
ajlm-2104	126	18	was	be	AUX
ajlm-2104	126	19	the	the	DET
ajlm-2104	126	20	lack	lack	NOUN
ajlm-2104	126	21	of	of	ADP
ajlm-2104	126	22	clinical	clinical	ADJ
ajlm-2104	126	23	information	information	NOUN
ajlm-2104	126	24	,	,	PUNCT
ajlm-2104	126	25	and	and	CCONJ
ajlm-2104	126	26	therefore	therefore	ADV
ajlm-2104	126	27	we	we	PRON
ajlm-2104	126	28	could	could	AUX
ajlm-2104	126	29	not	not	PART
ajlm-2104	126	30	link	link	VERB
ajlm-2104	126	31	these	these	DET
ajlm-2104	126	32	parameters	parameter	NOUN
ajlm-2104	126	33	with	with	ADP
ajlm-2104	126	34	disease	disease	NOUN
ajlm-2104	126	35	severity	severity	NOUN
ajlm-2104	126	36	,	,	PUNCT
ajlm-2104	126	37	the	the	DET
ajlm-2104	126	38	sequential	sequential	ADJ
ajlm-2104	126	39	organ	organ	NOUN
ajlm-2104	126	40	failure	failure	NOUN
ajlm-2104	126	41	assessment	assessment	NOUN
ajlm-2104	126	42	score	score	NOUN
ajlm-2104	126	43	or	or	CCONJ
ajlm-2104	126	44	outcome	outcome	NOUN
ajlm-2104	126	45	.	.	PUNCT
ajlm-2104	127	1	furthermore	furthermore	ADV
ajlm-2104	127	2	,	,	PUNCT
ajlm-2104	127	3	emerging	emerge	VERB
ajlm-2104	127	4	parameters	parameter	NOUN
ajlm-2104	127	5	such	such	ADJ
ajlm-2104	127	6	as	as	ADP
ajlm-2104	127	7	the	the	DET
ajlm-2104	127	8	monocyte	monocyte	NOUN
ajlm-2104	127	9	distribution	distribution	NOUN
ajlm-2104	127	10	width	width	NOUN
ajlm-2104	127	11	were	be	AUX
ajlm-2104	127	12	not	not	PART
ajlm-2104	127	13	investigated	investigate	VERB
ajlm-2104	127	14	.	.	PUNCT
ajlm-2104	128	1	conclusion	conclusion	NOUN
ajlm-2104	128	2	an	an	DET
ajlm-2104	128	3	automated	automate	VERB
ajlm-2104	128	4	full	full	ADJ
ajlm-2104	128	5	blood	blood	NOUN
ajlm-2104	128	6	count	count	NOUN
ajlm-2104	128	7	and	and	CCONJ
ajlm-2104	128	8	differential	differential	NOUN
ajlm-2104	128	9	are	be	AUX
ajlm-2104	128	10	widely	widely	ADV
ajlm-2104	128	11	available	available	ADJ
ajlm-2104	128	12	.	.	PUNCT
ajlm-2104	129	1	it	it	PRON
ajlm-2104	129	2	is	be	AUX
ajlm-2104	129	3	a	a	DET
ajlm-2104	129	4	simple	simple	ADJ
ajlm-2104	129	5	test	test	NOUN
ajlm-2104	129	6	that	that	PRON
ajlm-2104	129	7	is	be	AUX
ajlm-2104	129	8	easy	easy	ADJ
ajlm-2104	129	9	to	to	PART
ajlm-2104	129	10	perform	perform	VERB
ajlm-2104	129	11	,	,	PUNCT
ajlm-2104	129	12	inexpensive	inexpensive	ADJ
ajlm-2104	129	13	and	and	CCONJ
ajlm-2104	129	14	is	be	AUX
ajlm-2104	129	15	the	the	DET
ajlm-2104	129	16	first	first	ADJ
ajlm-2104	129	17	investigation	investigation	NOUN
ajlm-2104	129	18	requested	request	VERB
ajlm-2104	129	19	by	by	ADP
ajlm-2104	129	20	clinicians	clinician	NOUN
ajlm-2104	129	21	in	in	ADP
ajlm-2104	129	22	the	the	DET
ajlm-2104	129	23	emergency	emergency	NOUN
ajlm-2104	129	24	ward	ward	NOUN
ajlm-2104	129	25	.	.	PUNCT
ajlm-2104	130	1	although	although	SCONJ
ajlm-2104	130	2	procalcitonin	procalcitonin	ADJ
ajlm-2104	130	3	and	and	CCONJ
ajlm-2104	130	4	bc	bc	PROPN
ajlm-2104	130	5	remain	remain	VERB
ajlm-2104	130	6	the	the	DET
ajlm-2104	130	7	gold	gold	ADJ
ajlm-2104	130	8	standard	standard	NOUN
ajlm-2104	130	9	for	for	ADP
ajlm-2104	130	10	sepsis	sepsis	NOUN
ajlm-2104	130	11	diagnosis	diagnosis	NOUN
ajlm-2104	130	12	,	,	PUNCT
ajlm-2104	130	13	they	they	PRON
ajlm-2104	130	14	are	be	AUX
ajlm-2104	130	15	often	often	ADV
ajlm-2104	130	16	only	only	ADV
ajlm-2104	130	17	available	available	ADJ
ajlm-2104	130	18	in	in	ADP
ajlm-2104	130	19	central	central	ADJ
ajlm-2104	130	20	laboratories	laboratory	NOUN
ajlm-2104	130	21	.	.	PUNCT
ajlm-2104	131	1	our	our	PRON
ajlm-2104	131	2	results	result	NOUN
ajlm-2104	131	3	suggest	suggest	VERB
ajlm-2104	131	4	that	that	SCONJ
ajlm-2104	131	5	although	although	SCONJ
ajlm-2104	131	6	each	each	DET
ajlm-2104	131	7	full	full	ADJ
ajlm-2104	131	8	blood	blood	NOUN
ajlm-2104	131	9	count	count	NOUN
ajlm-2104	131	10	parameter	parameter	NOUN
ajlm-2104	131	11	should	should	AUX
ajlm-2104	131	12	not	not	PART
ajlm-2104	131	13	be	be	AUX
ajlm-2104	131	14	used	use	VERB
ajlm-2104	131	15	alone	alone	ADV
ajlm-2104	131	16	,	,	PUNCT
ajlm-2104	131	17	used	use	VERB
ajlm-2104	131	18	together	together	ADV
ajlm-2104	131	19	they	they	PRON
ajlm-2104	131	20	could	could	AUX
ajlm-2104	131	21	provide	provide	VERB
ajlm-2104	131	22	a	a	DET
ajlm-2104	131	23	simple	simple	ADJ
ajlm-2104	131	24	screening	screening	NOUN
ajlm-2104	131	25	tool	tool	NOUN
ajlm-2104	131	26	for	for	ADP
ajlm-2104	131	27	the	the	DET
ajlm-2104	131	28	detection	detection	NOUN
ajlm-2104	131	29	of	of	ADP
ajlm-2104	131	30	early	early	ADJ
ajlm-2104	131	31	sepsis	sepsis	NOUN
ajlm-2104	131	32	in	in	ADP
ajlm-2104	131	33	limited	limited	ADJ
ajlm-2104	131	34	-	-	PUNCT
ajlm-2104	131	35	resource	resource	NOUN
ajlm-2104	131	36	settings	setting	NOUN
ajlm-2104	131	37	.	.	PUNCT
ajlm-2104	132	1	acknowledgements	acknowledgement	NOUN
ajlm-2104	132	2	we	we	PRON
ajlm-2104	132	3	would	would	AUX
ajlm-2104	132	4	like	like	VERB
ajlm-2104	132	5	to	to	PART
ajlm-2104	132	6	acknowledge	acknowledge	VERB
ajlm-2104	132	7	dr	dr	PROPN
ajlm-2104	132	8	niehaus	niehaus	PROPN
ajlm-2104	132	9	for	for	ADP
ajlm-2104	132	10	assistance	assistance	NOUN
ajlm-2104	132	11	in	in	ADP
ajlm-2104	132	12	the	the	DET
ajlm-2104	132	13	collection	collection	NOUN
ajlm-2104	132	14	of	of	ADP
ajlm-2104	132	15	data	datum	NOUN
ajlm-2104	132	16	.	.	PUNCT
ajlm-2104	133	1	competing	compete	VERB
ajlm-2104	133	2	interests	interest	NOUN
ajlm-2104	133	3	the	the	DET
ajlm-2104	133	4	authors	author	NOUN
ajlm-2104	133	5	declare	declare	VERB
ajlm-2104	133	6	that	that	SCONJ
ajlm-2104	133	7	they	they	PRON
ajlm-2104	133	8	have	have	VERB
ajlm-2104	133	9	no	no	DET
ajlm-2104	133	10	financial	financial	ADJ
ajlm-2104	133	11	or	or	CCONJ
ajlm-2104	133	12	personal	personal	ADJ
ajlm-2104	133	13	relationships	relationship	NOUN
ajlm-2104	133	14	that	that	PRON
ajlm-2104	133	15	may	may	AUX
ajlm-2104	133	16	have	have	AUX
ajlm-2104	133	17	inappropriately	inappropriately	ADV
ajlm-2104	133	18	influenced	influence	VERB
ajlm-2104	133	19	them	they	PRON
ajlm-2104	133	20	in	in	ADP
ajlm-2104	133	21	writing	write	VERB
ajlm-2104	133	22	this	this	DET
ajlm-2104	133	23	article	article	NOUN
ajlm-2104	133	24	.	.	PUNCT
ajlm-2104	134	1	authors	author	NOUN
ajlm-2104	134	2	’	’	PART
ajlm-2104	134	3	contributions	contribution	NOUN
ajlm-2104	134	4	j.v.r	j.v.r	NOUN
ajlm-2104	134	5	.	.	PROPN
ajlm-2104	134	6	conceptualised	conceptualise	VERB
ajlm-2104	134	7	the	the	DET
ajlm-2104	134	8	study	study	NOUN
ajlm-2104	134	9	,	,	PUNCT
ajlm-2104	134	10	wrote	write	VERB
ajlm-2104	134	11	the	the	DET
ajlm-2104	134	12	first	first	ADJ
ajlm-2104	134	13	draft	draft	NOUN
ajlm-2104	134	14	of	of	ADP
ajlm-2104	134	15	the	the	DET
ajlm-2104	134	16	manuscript	manuscript	NOUN
ajlm-2104	134	17	,	,	PUNCT
ajlm-2104	134	18	collected	collect	VERB
ajlm-2104	134	19	and	and	CCONJ
ajlm-2104	134	20	analysed	analyse	VERB
ajlm-2104	134	21	the	the	DET
ajlm-2104	134	22	data	datum	NOUN
ajlm-2104	134	23	and	and	CCONJ
ajlm-2104	134	24	approved	approve	VERB
ajlm-2104	134	25	the	the	DET
ajlm-2104	134	26	final	final	ADJ
ajlm-2104	134	27	manuscript	manuscript	NOUN
ajlm-2104	134	28	for	for	ADP
ajlm-2104	134	29	publication	publication	NOUN
ajlm-2104	134	30	.	.	PUNCT
ajlm-2104	135	1	s.d	s.d	PROPN
ajlm-2104	135	2	.	.	PROPN
ajlm-2104	135	3	performed	perform	VERB
ajlm-2104	135	4	statistical	statistical	ADJ
ajlm-2104	135	5	analysis	analysis	NOUN
ajlm-2104	135	6	,	,	PUNCT
ajlm-2104	135	7	provided	provide	VERB
ajlm-2104	135	8	intellectual	intellectual	ADJ
ajlm-2104	135	9	input	input	NOUN
ajlm-2104	135	10	and	and	CCONJ
ajlm-2104	135	11	approved	approve	VERB
ajlm-2104	135	12	the	the	DET
ajlm-2104	135	13	final	final	ADJ
ajlm-2104	135	14	manuscript	manuscript	NOUN
ajlm-2104	135	15	for	for	ADP
ajlm-2104	135	16	publication	publication	NOUN
ajlm-2104	135	17	.	.	PUNCT
ajlm-2104	136	1	c.s	c.s	PROPN
ajlm-2104	136	2	.	.	PROPN
ajlm-2104	136	3	supervised	supervise	VERB
ajlm-2104	136	4	the	the	DET
ajlm-2104	136	5	collection	collection	NOUN
ajlm-2104	136	6	of	of	ADP
ajlm-2104	136	7	data	datum	NOUN
ajlm-2104	136	8	,	,	PUNCT
ajlm-2104	136	9	provided	provide	VERB
ajlm-2104	136	10	intellectual	intellectual	ADJ
ajlm-2104	136	11	input	input	NOUN
ajlm-2104	136	12	and	and	CCONJ
ajlm-2104	136	13	approved	approve	VERB
ajlm-2104	136	14	the	the	DET
ajlm-2104	136	15	final	final	ADJ
ajlm-2104	136	16	manuscript	manuscript	NOUN
ajlm-2104	136	17	for	for	ADP
ajlm-2104	136	18	publication	publication	NOUN
ajlm-2104	136	19	.	.	PUNCT
ajlm-2104	137	1	g.m.d	g.m.d	PROPN
ajlm-2104	137	2	.	.	PROPN
ajlm-2104	137	3	supervised	supervise	VERB
ajlm-2104	137	4	the	the	DET
ajlm-2104	137	5	project	project	NOUN
ajlm-2104	137	6	,	,	PUNCT
ajlm-2104	137	7	performed	perform	VERB
ajlm-2104	137	8	analysis	analysis	NOUN
ajlm-2104	137	9	of	of	ADP
ajlm-2104	137	10	the	the	DET
ajlm-2104	137	11	data	datum	NOUN
ajlm-2104	137	12	,	,	PUNCT
ajlm-2104	137	13	provided	provide	VERB
ajlm-2104	137	14	intellectual	intellectual	ADJ
ajlm-2104	137	15	input	input	NOUN
ajlm-2104	137	16	and	and	CCONJ
ajlm-2104	137	17	authorised	authorise	VERB
ajlm-2104	137	18	the	the	DET
ajlm-2104	137	19	final	final	ADJ
ajlm-2104	137	20	draft	draft	NOUN
ajlm-2104	137	21	for	for	ADP
ajlm-2104	137	22	publication	publication	NOUN
ajlm-2104	137	23	.	.	PUNCT
ajlm-2104	138	1	sources	source	NOUN
ajlm-2104	138	2	of	of	ADP
ajlm-2104	138	3	support	support	NOUN
ajlm-2104	138	4	this	this	DET
ajlm-2104	138	5	research	research	NOUN
ajlm-2104	138	6	received	receive	VERB
ajlm-2104	138	7	no	no	DET
ajlm-2104	138	8	specific	specific	ADJ
ajlm-2104	138	9	grant	grant	NOUN
ajlm-2104	138	10	from	from	ADP
ajlm-2104	138	11	any	any	DET
ajlm-2104	138	12	funding	funding	NOUN
ajlm-2104	138	13	agency	agency	NOUN
ajlm-2104	138	14	in	in	ADP
ajlm-2104	138	15	the	the	DET
ajlm-2104	138	16	public	public	ADJ
ajlm-2104	138	17	,	,	PUNCT
ajlm-2104	138	18	commercial	commercial	ADJ
ajlm-2104	138	19	or	or	CCONJ
ajlm-2104	138	20	not	not	PART
ajlm-2104	138	21	-	-	PUNCT
ajlm-2104	138	22	for	for	ADP
ajlm-2104	138	23	-	-	PUNCT
ajlm-2104	138	24	profit	profit	NOUN
ajlm-2104	138	25	sectors	sector	NOUN
ajlm-2104	138	26	.	.	PUNCT
ajlm-2104	139	1	data	datum	NOUN
ajlm-2104	139	2	availability	availability	NOUN
ajlm-2104	139	3	all	all	DET
ajlm-2104	139	4	data	datum	NOUN
ajlm-2104	139	5	generated	generate	VERB
ajlm-2104	139	6	from	from	ADP
ajlm-2104	139	7	this	this	DET
ajlm-2104	139	8	study	study	NOUN
ajlm-2104	139	9	are	be	AUX
ajlm-2104	139	10	available	available	ADJ
ajlm-2104	139	11	on	on	ADP
ajlm-2104	139	12	request	request	NOUN
ajlm-2104	139	13	from	from	ADP
ajlm-2104	139	14	the	the	DET
ajlm-2104	139	15	corresponding	corresponding	ADJ
ajlm-2104	139	16	author	author	NOUN
ajlm-2104	139	17	,	,	PUNCT
ajlm-2104	139	18	g.m.d	g.m.d	PROPN
ajlm-2104	139	19	.	.	PUNCT
ajlm-2104	139	20	disclaimer	disclaimer	VERB
ajlm-2104	139	21	the	the	DET
ajlm-2104	139	22	views	view	NOUN
ajlm-2104	139	23	and	and	CCONJ
ajlm-2104	139	24	opinions	opinion	NOUN
ajlm-2104	139	25	expressed	express	VERB
ajlm-2104	139	26	in	in	ADP
ajlm-2104	139	27	this	this	DET
ajlm-2104	139	28	manuscript	manuscript	NOUN
ajlm-2104	139	29	are	be	AUX
ajlm-2104	139	30	those	those	PRON
ajlm-2104	139	31	of	of	ADP
ajlm-2104	139	32	the	the	DET
ajlm-2104	139	33	authors	author	NOUN
ajlm-2104	139	34	and	and	CCONJ
ajlm-2104	139	35	do	do	AUX
ajlm-2104	139	36	not	not	PART
ajlm-2104	139	37	reflect	reflect	VERB
ajlm-2104	139	38	any	any	DET
ajlm-2104	139	39	official	official	ADJ
ajlm-2104	139	40	policy	policy	NOUN
ajlm-2104	139	41	or	or	CCONJ
ajlm-2104	139	42	postion	postion	NOUN
ajlm-2104	139	43	of	of	ADP
ajlm-2104	139	44	any	any	DET
ajlm-2104	139	45	affliated	affliated	ADJ
ajlm-2104	139	46	agency	agency	NOUN
ajlm-2104	139	47	or	or	CCONJ
ajlm-2104	139	48	authors	author	NOUN
ajlm-2104	139	49	.	.	PUNCT
ajlm-2104	140	1	references	reference	NOUN
ajlm-2104	140	2	gül	gül	PROPN
ajlm-2104	140	3	f	f	PROPN
ajlm-2104	140	4	,	,	PUNCT
ajlm-2104	140	5	arslantaş	arslantaş	PROPN
ajlm-2104	140	6	mk	mk	PROPN
ajlm-2104	140	7	,	,	PUNCT
ajlm-2104	140	8	cinel	cinel	PROPN
ajlm-2104	140	9	i̇	i̇	PROPN
ajlm-2104	140	10	,	,	PUNCT
ajlm-2104	140	11	kumar	kumar	PROPN
ajlm-2104	140	12	a.	a.	NOUN
ajlm-2104	140	13	changing	change	VERB
ajlm-2104	140	14	definitions	definition	NOUN
ajlm-2104	140	15	of	of	ADP
ajlm-2104	140	16	sepsis	sepsis	NOUN
ajlm-2104	140	17	.	.	PUNCT
ajlm-2104	141	1	turk	turk	PROPN
ajlm-2104	141	2	j	j	PROPN
ajlm-2104	141	3	anaesthesiol	anaesthesiol	PROPN
ajlm-2104	141	4	reanim	reanim	PROPN
ajlm-2104	141	5	.	.	PUNCT
ajlm-2104	142	1	2017;45(3):129–138	2017;45(3):129–138	NUM
ajlm-2104	142	2	.	.	PUNCT
ajlm-2104	143	1	https://doi.org/10.5152/tjar.2017.93753	https://doi.org/10.5152/tjar.2017.93753	PROPN
ajlm-2104	143	2	zick	zick	PROPN
ajlm-2104	143	3	m.	m.	NOUN
ajlm-2104	143	4	the	the	DET
ajlm-2104	143	5	first	first	PROPN
ajlm-2104	143	6	esa	esa	PROPN
ajlm-2104	143	7	european	european	ADJ
ajlm-2104	143	8	sepsis	sepsis	NOUN
ajlm-2104	143	9	report	report	NOUN
ajlm-2104	143	10	[	[	X
ajlm-2104	143	11	homepage	homepage	NOUN
ajlm-2104	143	12	on	on	ADP
ajlm-2104	143	13	the	the	DET
ajlm-2104	143	14	internet	internet	NOUN
ajlm-2104	143	15	]	]	PUNCT
ajlm-2104	143	16	.	.	PUNCT
ajlm-2104	144	1	2021	2021	NUM
ajlm-2104	144	2	.	.	PUNCT
ajlm-2104	145	1	available	available	ADJ
ajlm-2104	145	2	from	from	ADP
ajlm-2104	145	3	:	:	PUNCT
ajlm-2104	145	4	https://www.global-sepsis-alliance.org/news/2021/9/9/the-first-esa-european-sepsis-report	https://www.global-sepsis-alliance.org/news/2021/9/9/the-first-esa-european-sepsis-report	NOUN
ajlm-2104	145	5	rowe	rowe	PROPN
ajlm-2104	145	6	t	t	PROPN
ajlm-2104	145	7	,	,	PUNCT
ajlm-2104	145	8	araujo	araujo	PROPN
ajlm-2104	145	9	klb	klb	PROPN
ajlm-2104	145	10	,	,	PUNCT
ajlm-2104	145	11	van	van	PROPN
ajlm-2104	145	12	ness	ness	NOUN
ajlm-2104	145	13	ph	ph	PROPN
ajlm-2104	145	14	,	,	PUNCT
ajlm-2104	145	15	pisani	pisani	PROPN
ajlm-2104	145	16	ma	ma	PROPN
ajlm-2104	145	17	,	,	PUNCT
ajlm-2104	145	18	juthani	juthani	PROPN
ajlm-2104	145	19	-	-	PUNCT
ajlm-2104	145	20	mehta	mehta	PROPN
ajlm-2104	145	21	m.	m.	NOUN
ajlm-2104	145	22	outcomes	outcome	NOUN
ajlm-2104	145	23	of	of	ADP
ajlm-2104	145	24	older	old	ADJ
ajlm-2104	145	25	adults	adult	NOUN
ajlm-2104	145	26	with	with	ADP
ajlm-2104	145	27	sepsis	sepsis	NOUN
ajlm-2104	145	28	at	at	ADP
ajlm-2104	145	29	admission	admission	NOUN
ajlm-2104	145	30	to	to	ADP
ajlm-2104	145	31	an	an	DET
ajlm-2104	145	32	intensive	intensive	ADJ
ajlm-2104	145	33	care	care	NOUN
ajlm-2104	145	34	unit	unit	NOUN
ajlm-2104	145	35	.	.	PUNCT
ajlm-2104	146	1	open	open	ADJ
ajlm-2104	146	2	forum	forum	PROPN
ajlm-2104	146	3	infect	infect	VERB
ajlm-2104	146	4	dis	dis	PROPN
ajlm-2104	146	5	.	.	PUNCT
ajlm-2104	147	1	2016;3(1):ofw010	2016;3(1):ofw010	NUM
ajlm-2104	147	2	.	.	PUNCT
ajlm-2104	147	3	https://doi.org/10.1093/ofid/ofw010	https://doi.org/10.1093/ofid/ofw010	PROPN
ajlm-2104	147	4	vincent	vincent	PROPN
ajlm-2104	147	5	jl	jl	PROPN
ajlm-2104	147	6	,	,	PUNCT
ajlm-2104	147	7	moreno	moreno	PROPN
ajlm-2104	147	8	r	r	PROPN
ajlm-2104	147	9	,	,	PUNCT
ajlm-2104	147	10	takala	takala	PROPN
ajlm-2104	147	11	j	j	PROPN
ajlm-2104	147	12	,	,	PUNCT
ajlm-2104	147	13	et	et	PROPN
ajlm-2104	147	14	al	al	PROPN
ajlm-2104	147	15	.	.	PUNCT
ajlm-2104	148	1	the	the	DET
ajlm-2104	148	2	sofa	sofa	NOUN
ajlm-2104	148	3	(	(	PUNCT
ajlm-2104	148	4	sepsis	sepsis	NOUN
ajlm-2104	148	5	-	-	PUNCT
ajlm-2104	148	6	related	relate	VERB
ajlm-2104	148	7	organ	organ	NOUN
ajlm-2104	148	8	failure	failure	NOUN
ajlm-2104	148	9	assessment	assessment	NOUN
ajlm-2104	148	10	)	)	PUNCT
ajlm-2104	148	11	score	score	NOUN
ajlm-2104	148	12	to	to	PART
ajlm-2104	148	13	describe	describe	VERB
ajlm-2104	148	14	organ	organ	NOUN
ajlm-2104	148	15	dysfunction	dysfunction	NOUN
ajlm-2104	148	16	/	/	SYM
ajlm-2104	148	17	failure	failure	NOUN
ajlm-2104	148	18	.	.	PUNCT
ajlm-2104	149	1	on	on	ADP
ajlm-2104	149	2	behalf	behalf	NOUN
ajlm-2104	149	3	of	of	ADP
ajlm-2104	149	4	the	the	DET
ajlm-2104	149	5	working	working	NOUN
ajlm-2104	149	6	group	group	NOUN
ajlm-2104	149	7	on	on	ADP
ajlm-2104	149	8	sepsis	sepsis	NOUN
ajlm-2104	149	9	-	-	PUNCT
ajlm-2104	149	10	related	relate	VERB
ajlm-2104	149	11	problems	problem	NOUN
ajlm-2104	149	12	of	of	ADP
ajlm-2104	149	13	the	the	DET
ajlm-2104	149	14	european	european	ADJ
ajlm-2104	149	15	society	society	NOUN
ajlm-2104	149	16	of	of	ADP
ajlm-2104	149	17	intensive	intensive	ADJ
ajlm-2104	149	18	care	care	NOUN
ajlm-2104	149	19	medicine	medicine	NOUN
ajlm-2104	149	20	.	.	PUNCT
ajlm-2104	150	1	intensive	intensive	ADJ
ajlm-2104	150	2	care	care	NOUN
ajlm-2104	150	3	med	me	VERB
ajlm-2104	150	4	.	.	PUNCT
ajlm-2104	151	1	1996;22(7):707–710	1996;22(7):707–710	NUM
ajlm-2104	151	2	.	.	PUNCT
ajlm-2104	152	1	https://doi.org/10.1007/bf01709751	https://doi.org/10.1007/bf01709751	PROPN
ajlm-2104	152	2	lambden	lambden	PROPN
ajlm-2104	152	3	s	s	PROPN
ajlm-2104	152	4	,	,	PUNCT
ajlm-2104	152	5	laterre	laterre	ADJ
ajlm-2104	152	6	pf	pf	NOUN
ajlm-2104	152	7	,	,	PUNCT
ajlm-2104	152	8	levy	levy	NOUN
ajlm-2104	152	9	mm	mm	PROPN
ajlm-2104	152	10	,	,	PUNCT
ajlm-2104	152	11	francois	francois	PROPN
ajlm-2104	152	12	b.	b.	PROPN
ajlm-2104	153	1	the	the	DET
ajlm-2104	153	2	sofa	sofa	NOUN
ajlm-2104	153	3	score	score	NOUN
ajlm-2104	153	4	-	-	PUNCT
ajlm-2104	153	5	development	development	NOUN
ajlm-2104	153	6	,	,	PUNCT
ajlm-2104	153	7	utility	utility	NOUN
ajlm-2104	153	8	and	and	CCONJ
ajlm-2104	153	9	challenges	challenge	NOUN
ajlm-2104	153	10	of	of	ADP
ajlm-2104	153	11	accurate	accurate	ADJ
ajlm-2104	153	12	assessment	assessment	NOUN
ajlm-2104	153	13	in	in	ADP
ajlm-2104	153	14	clinical	clinical	ADJ
ajlm-2104	153	15	trials	trial	NOUN
ajlm-2104	153	16	.	.	PUNCT
ajlm-2104	154	1	crit	crit	PROPN
ajlm-2104	154	2	care	care	NOUN
ajlm-2104	154	3	.	.	PUNCT
ajlm-2104	155	1	2019;23(1):374	2019;23(1):374	NUM
ajlm-2104	155	2	.	.	PUNCT
ajlm-2104	156	1	https://doi.org/10.1186/s13054-019-2663-7	https://doi.org/10.1186/s13054-019-2663-7	PROPN
ajlm-2104	156	2	sinha	sinha	PROPN
ajlm-2104	156	3	m	m	PROPN
ajlm-2104	156	4	,	,	PUNCT
ajlm-2104	156	5	jupe	jupe	PROPN
ajlm-2104	156	6	j	j	PROPN
ajlm-2104	156	7	,	,	PUNCT
ajlm-2104	156	8	mack	mack	PROPN
ajlm-2104	156	9	h	h	PROPN
ajlm-2104	156	10	,	,	PUNCT
ajlm-2104	156	11	coleman	coleman	PROPN
ajlm-2104	156	12	tp	tp	PROPN
ajlm-2104	156	13	,	,	PUNCT
ajlm-2104	156	14	lawrence	lawrence	PROPN
ajlm-2104	156	15	sm	sm	PROPN
ajlm-2104	156	16	,	,	PUNCT
ajlm-2104	156	17	fraley	fraley	PROPN
ajlm-2104	156	18	si	si	PROPN
ajlm-2104	156	19	.	.	PUNCT
ajlm-2104	156	20	emerging	emerge	VERB
ajlm-2104	156	21	technologies	technology	NOUN
ajlm-2104	156	22	for	for	ADP
ajlm-2104	156	23	molecular	molecular	ADJ
ajlm-2104	156	24	diagnosis	diagnosis	NOUN
ajlm-2104	156	25	of	of	ADP
ajlm-2104	156	26	sepsis	sepsis	NOUN
ajlm-2104	156	27	.	.	PUNCT
ajlm-2104	157	1	clin	clin	PROPN
ajlm-2104	157	2	microbiol	microbiol	PROPN
ajlm-2104	157	3	rev	rev	VERB
ajlm-2104	157	4	.	.	PROPN
ajlm-2104	157	5	2018;31(2):e00089	2018;31(2):e00089	NUM
ajlm-2104	157	6	-	-	SYM
ajlm-2104	157	7	17	17	NUM
ajlm-2104	157	8	.	.	PUNCT
ajlm-2104	158	1	https://doi.org/10.1128/cmr.00089-17	https://doi.org/10.1128/cmr.00089-17	PROPN
ajlm-2104	158	2	chaudhury	chaudhury	PROPN
ajlm-2104	158	3	a	a	PRON
ajlm-2104	158	4	,	,	PUNCT
ajlm-2104	158	5	sachin	sachin	ADJ
ajlm-2104	158	6	sumant	sumant	PROPN
ajlm-2104	158	7	g	g	PROPN
ajlm-2104	158	8	,	,	PUNCT
ajlm-2104	158	9	jayaprada	jayaprada	PROPN
ajlm-2104	158	10	r	r	PROPN
ajlm-2104	158	11	,	,	PUNCT
ajlm-2104	158	12	kalawat	kalawat	NOUN
ajlm-2104	158	13	u	u	PROPN
ajlm-2104	158	14	,	,	PUNCT
ajlm-2104	158	15	ramana	ramana	PROPN
ajlm-2104	158	16	b.	b.	PROPN
ajlm-2104	158	17	procalcitonin	procalcitonin	VERB
ajlm-2104	158	18	in	in	ADP
ajlm-2104	158	19	sepsis	sepsis	NOUN
ajlm-2104	158	20	and	and	CCONJ
ajlm-2104	158	21	bacterial	bacterial	ADJ
ajlm-2104	158	22	infections	infection	NOUN
ajlm-2104	158	23	.	.	PUNCT
ajlm-2104	159	1	j	j	PROPN
ajlm-2104	159	2	clin	clin	PROPN
ajlm-2104	159	3	sci	sci	PROPN
ajlm-2104	159	4	res	re	NOUN
ajlm-2104	159	5	.	.	PUNCT
ajlm-2104	160	1	2013;2(4):216–224	2013;2(4):216–224	NUM
ajlm-2104	160	2	.	.	NOUN
ajlm-2104	160	3	https://doi.org/10.15380/2277-5706.jcsr.13.015	https://doi.org/10.15380/2277-5706.jcsr.13.015	PROPN
ajlm-2104	160	4	thermo	thermo	PROPN
ajlm-2104	160	5	fisher	fisher	PROPN
ajlm-2104	160	6	scientific	scientific	PROPN
ajlm-2104	160	7	,	,	PUNCT
ajlm-2104	160	8	pct	pct	NOUN
ajlm-2104	160	9	test	test	NOUN
ajlm-2104	160	10	results	result	NOUN
ajlm-2104	160	11	|	|	ADV
ajlm-2104	160	12	interpreting	interpret	VERB
ajlm-2104	160	13	procalcitonin	procalcitonin	ADJ
ajlm-2104	160	14	level	level	NOUN
ajlm-2104	161	1	[	[	X
ajlm-2104	161	2	homepage	homepage	NOUN
ajlm-2104	161	3	on	on	ADP
ajlm-2104	161	4	the	the	DET
ajlm-2104	161	5	internet	internet	NOUN
ajlm-2104	161	6	]	]	PUNCT
ajlm-2104	161	7	.	.	PUNCT
ajlm-2104	162	1	thermo	thermo	PROPN
ajlm-2104	162	2	fisher	fisher	PROPN
ajlm-2104	162	3	scientific	scientific	PROPN
ajlm-2104	162	4	;	;	PUNCT
ajlm-2104	162	5	2022	2022	NUM
ajlm-2104	162	6	[	[	X
ajlm-2104	162	7	cited	cite	VERB
ajlm-2104	162	8	2022	2022	NUM
ajlm-2104	162	9	aug	aug	PROPN
ajlm-2104	162	10	18	18	NUM
ajlm-2104	162	11	]	]	PUNCT
ajlm-2104	162	12	.	.	PUNCT
ajlm-2104	163	1	available	available	ADJ
ajlm-2104	163	2	from	from	ADP
ajlm-2104	163	3	:	:	PUNCT
ajlm-2104	163	4	https://www.thermofisher.com/procalcitonin/wo/en/understanding-procalcitonin/interpreting-pct-results.html	https://www.thermofisher.com/procalcitonin/wo/en/understanding-procalcitonin/interpreting-pct-results.html	PROPN
ajlm-2104	163	5	?	?	PUNCT
ajlm-2104	164	1	gregoriano	gregoriano	PROPN
ajlm-2104	164	2	c	c	NOUN
ajlm-2104	164	3	,	,	PUNCT
ajlm-2104	164	4	heilmann	heilmann	PROPN
ajlm-2104	164	5	e	e	NOUN
ajlm-2104	164	6	,	,	PUNCT
ajlm-2104	164	7	molitor	molitor	PROPN
ajlm-2104	164	8	a	a	PROPN
ajlm-2104	164	9	,	,	PUNCT
ajlm-2104	164	10	schuetz	schuetz	ADJ
ajlm-2104	164	11	p.	p.	NOUN
ajlm-2104	164	12	role	role	NOUN
ajlm-2104	164	13	of	of	ADP
ajlm-2104	164	14	procalcitonin	procalcitonin	ADJ
ajlm-2104	164	15	use	use	NOUN
ajlm-2104	164	16	in	in	ADP
ajlm-2104	164	17	the	the	DET
ajlm-2104	164	18	management	management	NOUN
ajlm-2104	164	19	of	of	ADP
ajlm-2104	164	20	sepsis	sepsis	NOUN
ajlm-2104	164	21	.	.	PUNCT
ajlm-2104	165	1	j	j	PROPN
ajlm-2104	165	2	thorac	thorac	PROPN
ajlm-2104	165	3	dis	dis	PROPN
ajlm-2104	165	4	.	.	PUNCT
ajlm-2104	166	1	2020;12(suppl	2020;12(suppl	NOUN
ajlm-2104	166	2	1):s5	1):s5	NUM
ajlm-2104	166	3	–	–	PUNCT
ajlm-2104	166	4	s15	s15	NOUN
ajlm-2104	166	5	.	.	PUNCT
ajlm-2104	167	1	https://doi.org/10.21037/jtd.2019.11.63	https://doi.org/10.21037/jtd.2019.11.63	ADP
ajlm-2104	167	2	anush	anush	PROPN
ajlm-2104	167	3	mm	mm	PROPN
ajlm-2104	167	4	,	,	PUNCT
ajlm-2104	167	5	ashok	ashok	PROPN
ajlm-2104	167	6	vk	vk	PROPN
ajlm-2104	167	7	,	,	PUNCT
ajlm-2104	167	8	sarma	sarma	PROPN
ajlm-2104	167	9	ri	ri	PROPN
ajlm-2104	167	10	,	,	PUNCT
ajlm-2104	167	11	pillai	pillai	PROPN
ajlm-2104	167	12	sk	sk	PROPN
ajlm-2104	167	13	.	.	PROPN
ajlm-2104	167	14	role	role	NOUN
ajlm-2104	167	15	of	of	ADP
ajlm-2104	167	16	c	c	NOUN
ajlm-2104	167	17	-	-	PUNCT
ajlm-2104	167	18	reactive	reactive	ADJ
ajlm-2104	167	19	protein	protein	NOUN
ajlm-2104	167	20	as	as	ADP
ajlm-2104	167	21	an	an	DET
ajlm-2104	167	22	indicator	indicator	NOUN
ajlm-2104	167	23	for	for	ADP
ajlm-2104	167	24	determining	determine	VERB
ajlm-2104	167	25	the	the	DET
ajlm-2104	167	26	outcome	outcome	NOUN
ajlm-2104	167	27	of	of	ADP
ajlm-2104	167	28	sepsis	sepsis	NOUN
ajlm-2104	167	29	.	.	PUNCT
ajlm-2104	168	1	indian	indian	PROPN
ajlm-2104	168	2	j	j	PROPN
ajlm-2104	168	3	crit	crit	PROPN
ajlm-2104	168	4	care	care	PROPN
ajlm-2104	168	5	med	me	VERB
ajlm-2104	168	6	.	.	PUNCT
ajlm-2104	169	1	2019;23(1):11–14	2019;23(1):11–14	X
ajlm-2104	169	2	.	.	PUNCT
ajlm-2104	169	3	https://doi.org/10.5005/jp-journals-10071-23105	https://doi.org/10.5005/jp-journals-10071-23105	ADJ
ajlm-2104	169	4	permatasari	permatasari	ADJ
ajlm-2104	169	5	aaiy	aaiy	NOUN
ajlm-2104	169	6	,	,	PUNCT
ajlm-2104	169	7	sanjaya	sanjaya	PROPN
ajlm-2104	169	8	igph	igph	NOUN
ajlm-2104	169	9	,	,	PUNCT
ajlm-2104	169	10	widiana	widiana	PROPN
ajlm-2104	169	11	igr	igr	PROPN
ajlm-2104	169	12	,	,	PUNCT
ajlm-2104	169	13	et	et	PROPN
ajlm-2104	169	14	al	al	PROPN
ajlm-2104	169	15	.	.	PUNCT
ajlm-2104	170	1	role	role	NOUN
ajlm-2104	170	2	of	of	ADP
ajlm-2104	170	3	procalcitonin	procalcitonin	ADJ
ajlm-2104	170	4	and	and	CCONJ
ajlm-2104	170	5	c	c	NOUN
ajlm-2104	170	6	-	-	PUNCT
ajlm-2104	170	7	reactive	reactive	ADJ
ajlm-2104	170	8	protein	protein	NOUN
ajlm-2104	170	9	as	as	ADP
ajlm-2104	170	10	markers	marker	NOUN
ajlm-2104	170	11	of	of	ADP
ajlm-2104	170	12	sepsis	sepsis	NOUN
ajlm-2104	170	13	in	in	ADP
ajlm-2104	170	14	major	major	ADJ
ajlm-2104	170	15	burn	burn	NOUN
ajlm-2104	170	16	patients	patient	NOUN
ajlm-2104	170	17	:	:	PUNCT
ajlm-2104	170	18	a	a	DET
ajlm-2104	170	19	systematic	systematic	ADJ
ajlm-2104	170	20	review	review	NOUN
ajlm-2104	170	21	and	and	CCONJ
ajlm-2104	170	22	meta	meta	ADJ
ajlm-2104	170	23	-	-	PUNCT
ajlm-2104	170	24	analysis	analysis	NOUN
ajlm-2104	170	25	.	.	PUNCT
ajlm-2104	171	1	j	j	PROPN
ajlm-2104	171	2	med	med	PROPN
ajlm-2104	171	3	sci	sci	PROPN
ajlm-2104	171	4	.	.	PUNCT
ajlm-2104	172	1	2021;9(f):197–203	2021;9(f):197–203	X
ajlm-2104	172	2	.	.	PUNCT
ajlm-2104	173	1	https://doi.org/10.3889/oamjms.2021.6137	https://doi.org/10.3889/oamjms.2021.6137	PROPN
ajlm-2104	173	2	biomérieux	biomérieux	PROPN
ajlm-2104	173	3	.	.	PUNCT
ajlm-2104	173	4	bact	bact	PROPN
ajlm-2104	173	5	/	/	SYM
ajlm-2104	173	6	alert	alert	ADJ
ajlm-2104	173	7	®	®	NOUN
ajlm-2104	173	8	culture	culture	NOUN
ajlm-2104	173	9	media	medium	NOUN
ajlm-2104	173	10	[	[	X
ajlm-2104	173	11	homepage	homepage	NOUN
ajlm-2104	173	12	on	on	ADP
ajlm-2104	173	13	the	the	DET
ajlm-2104	173	14	internet	internet	NOUN
ajlm-2104	173	15	]	]	PUNCT
ajlm-2104	173	16	.	.	PUNCT
ajlm-2104	174	1	biomérieux	biomérieux	PROPN
ajlm-2104	174	2	south	south	PROPN
ajlm-2104	174	3	africa	africa	PROPN
ajlm-2104	174	4	;	;	PUNCT
ajlm-2104	174	5	2022	2022	NUM
ajlm-2104	174	6	.	.	PUNCT
ajlm-2104	175	1	available	available	ADJ
ajlm-2104	175	2	from	from	ADP
ajlm-2104	175	3	:	:	PUNCT
ajlm-2104	175	4	https://www.biomerieux.co.za/product/bactalertr-culture-media	https://www.biomerieux.co.za/product/bactalertr-culture-media	PROPN
ajlm-2104	175	5	chela	chela	PROPN
ajlm-2104	175	6	hk	hk	PROPN
ajlm-2104	175	7	,	,	PUNCT
ajlm-2104	175	8	vasudevan	vasudevan	PROPN
ajlm-2104	175	9	a	a	PROPN
ajlm-2104	175	10	,	,	PUNCT
ajlm-2104	175	11	rojas	rojas	PROPN
ajlm-2104	175	12	-	-	PUNCT
ajlm-2104	175	13	moreno	moreno	PROPN
ajlm-2104	175	14	c	c	PROPN
ajlm-2104	175	15	,	,	PUNCT
ajlm-2104	175	16	naqvi	naqvi	PROPN
ajlm-2104	175	17	sh	sh	PROPN
ajlm-2104	175	18	.	.	PROPN
ajlm-2104	175	19	approach	approach	NOUN
ajlm-2104	175	20	to	to	ADP
ajlm-2104	175	21	positive	positive	ADJ
ajlm-2104	175	22	blood	blood	NOUN
ajlm-2104	175	23	cultures	culture	NOUN
ajlm-2104	175	24	in	in	ADP
ajlm-2104	175	25	the	the	DET
ajlm-2104	175	26	hospitalised	hospitalise	VERB
ajlm-2104	175	27	patient	patient	NOUN
ajlm-2104	175	28	:	:	PUNCT
ajlm-2104	175	29	a	a	DET
ajlm-2104	175	30	review	review	NOUN
ajlm-2104	175	31	.	.	PUNCT
ajlm-2104	176	1	mo	mo	PROPN
ajlm-2104	176	2	med	med	PROPN
ajlm-2104	176	3	.	.	PUNCT
ajlm-2104	177	1	2019;116(4):313–317	2019;116(4):313–317	X
ajlm-2104	177	2	.	.	PUNCT
ajlm-2104	178	1	farkas	farkas	PROPN
ajlm-2104	178	2	j.	j.	PROPN
ajlm-2104	178	3	the	the	DET
ajlm-2104	178	4	complete	complete	ADJ
ajlm-2104	178	5	blood	blood	NOUN
ajlm-2104	178	6	count	count	NOUN
ajlm-2104	178	7	to	to	PART
ajlm-2104	178	8	diagnose	diagnose	VERB
ajlm-2104	178	9	septic	septic	ADJ
ajlm-2104	178	10	shock	shock	NOUN
ajlm-2104	178	11	.	.	PUNCT
ajlm-2104	179	1	j	j	PROPN
ajlm-2104	179	2	thorac	thorac	PROPN
ajlm-2104	179	3	dis	dis	PROPN
ajlm-2104	179	4	.	.	PUNCT
ajlm-2104	180	1	2020;12(s1):s16	2020;12(s1):s16	NUM
ajlm-2104	180	2	–	–	PUNCT
ajlm-2104	180	3	s21	s21	NOUN
ajlm-2104	180	4	.	.	PUNCT
ajlm-2104	181	1	https://doi.org/10.21037/jtd.2019.12.63	https://doi.org/10.21037/jtd.2019.12.63	X
ajlm-2104	181	2	hou	hou	PROPN
ajlm-2104	181	3	sk	sk	PROPN
ajlm-2104	181	4	,	,	PUNCT
ajlm-2104	181	5	lin	lin	PROPN
ajlm-2104	181	6	ha	ha	PROPN
ajlm-2104	181	7	,	,	PUNCT
ajlm-2104	181	8	chen	chen	PROPN
ajlm-2104	181	9	sc	sc	PROPN
ajlm-2104	181	10	,	,	PUNCT
ajlm-2104	181	11	lin	lin	PROPN
ajlm-2104	181	12	cf	cf	PROPN
ajlm-2104	181	13	,	,	PUNCT
ajlm-2104	181	14	lin	lin	PROPN
ajlm-2104	181	15	sf	sf	PROPN
ajlm-2104	181	16	.	.	PROPN
ajlm-2104	181	17	monocyte	monocyte	PROPN
ajlm-2104	181	18	distribution	distribution	NOUN
ajlm-2104	181	19	width	width	NOUN
ajlm-2104	181	20	,	,	PUNCT
ajlm-2104	181	21	neutrophil	neutrophil	NOUN
ajlm-2104	181	22	-	-	PUNCT
ajlm-2104	181	23	to	to	ADP
ajlm-2104	181	24	-	-	PUNCT
ajlm-2104	181	25	lymphocyte	lymphocyte	NOUN
ajlm-2104	181	26	ratio	ratio	NOUN
ajlm-2104	181	27	,	,	PUNCT
ajlm-2104	181	28	and	and	CCONJ
ajlm-2104	181	29	platelet	platelet	NOUN
ajlm-2104	181	30	-	-	PUNCT
ajlm-2104	181	31	to	to	ADP
ajlm-2104	181	32	-	-	PUNCT
ajlm-2104	181	33	lymphocyte	lymphocyte	ADJ
ajlm-2104	181	34	ratio	ratio	NOUN
ajlm-2104	181	35	improves	improve	VERB
ajlm-2104	181	36	early	early	ADJ
ajlm-2104	181	37	prediction	prediction	NOUN
ajlm-2104	181	38	for	for	ADP
ajlm-2104	181	39	sepsis	sepsis	NOUN
ajlm-2104	181	40	at	at	ADP
ajlm-2104	181	41	the	the	DET
ajlm-2104	181	42	emergency	emergency	NOUN
ajlm-2104	181	43	.	.	PUNCT
ajlm-2104	182	1	j	j	PROPN
ajlm-2104	182	2	pers	per	NOUN
ajlm-2104	182	3	med	me	VERB
ajlm-2104	182	4	.	.	PUNCT
ajlm-2104	183	1	2021;11(8):732	2021;11(8):732	NUM
ajlm-2104	183	2	.	.	PUNCT
ajlm-2104	184	1	https://doi.org/10.3390/jpm11080732	https://doi.org/10.3390/jpm11080732	NOUN
ajlm-2104	184	2	bone	bone	PROPN
ajlm-2104	184	3	rc	rc	PROPN
ajlm-2104	184	4	,	,	PUNCT
ajlm-2104	184	5	balk	balk	VERB
ajlm-2104	184	6	ra	ra	PROPN
ajlm-2104	184	7	,	,	PUNCT
ajlm-2104	184	8	cerra	cerra	PROPN
ajlm-2104	184	9	fb	fb	PROPN
ajlm-2104	184	10	,	,	PUNCT
ajlm-2104	184	11	et	et	PROPN
ajlm-2104	184	12	al	al	PROPN
ajlm-2104	184	13	.	.	PUNCT
ajlm-2104	185	1	definitions	definition	NOUN
ajlm-2104	185	2	for	for	ADP
ajlm-2104	185	3	sepsis	sepsis	NOUN
ajlm-2104	185	4	and	and	CCONJ
ajlm-2104	185	5	organ	organ	NOUN
ajlm-2104	185	6	failure	failure	NOUN
ajlm-2104	185	7	and	and	CCONJ
ajlm-2104	185	8	guidelines	guideline	NOUN
ajlm-2104	185	9	for	for	ADP
ajlm-2104	185	10	the	the	DET
ajlm-2104	185	11	use	use	NOUN
ajlm-2104	185	12	of	of	ADP
ajlm-2104	185	13	innovative	innovative	ADJ
ajlm-2104	185	14	therapies	therapy	NOUN
ajlm-2104	185	15	in	in	ADP
ajlm-2104	185	16	sepsis	sepsis	NOUN
ajlm-2104	185	17	.	.	PUNCT
ajlm-2104	186	1	the	the	DET
ajlm-2104	186	2	accp	accp	PROPN
ajlm-2104	186	3	/	/	SYM
ajlm-2104	186	4	sccm	sccm	PROPN
ajlm-2104	186	5	consensus	consensus	PROPN
ajlm-2104	186	6	conference	conference	NOUN
ajlm-2104	186	7	committee	committee	NOUN
ajlm-2104	186	8	.	.	PUNCT
ajlm-2104	187	1	american	american	PROPN
ajlm-2104	187	2	college	college	PROPN
ajlm-2104	187	3	of	of	ADP
ajlm-2104	187	4	chest	chest	NOUN
ajlm-2104	187	5	physicians	physician	NOUN
ajlm-2104	187	6	/	/	SYM
ajlm-2104	187	7	society	society	NOUN
ajlm-2104	187	8	of	of	ADP
ajlm-2104	187	9	critical	critical	ADJ
ajlm-2104	187	10	care	care	NOUN
ajlm-2104	187	11	medicine	medicine	NOUN
ajlm-2104	187	12	.	.	PUNCT
ajlm-2104	188	1	chest	chest	NOUN
ajlm-2104	188	2	.	.	PUNCT
ajlm-2104	189	1	1992;101(6):1644–1655	1992;101(6):1644–1655	X
ajlm-2104	189	2	.	.	PUNCT
ajlm-2104	190	1	https://doi.org/10.1378/chest.101.6.1644	https://doi.org/10.1378/chest.101.6.1644	PROPN
ajlm-2104	190	2	agnello	agnello	PROPN
ajlm-2104	190	3	l	l	PROPN
ajlm-2104	190	4	,	,	PUNCT
ajlm-2104	190	5	giglio	giglio	PROPN
ajlm-2104	190	6	rv	rv	PROPN
ajlm-2104	190	7	,	,	PUNCT
ajlm-2104	190	8	bivona	bivona	PROPN
ajlm-2104	190	9	g	g	PROPN
ajlm-2104	190	10	,	,	PUNCT
ajlm-2104	190	11	et	et	PROPN
ajlm-2104	190	12	al	al	PROPN
ajlm-2104	190	13	.	.	PUNCT
ajlm-2104	191	1	the	the	DET
ajlm-2104	191	2	value	value	NOUN
ajlm-2104	191	3	of	of	ADP
ajlm-2104	191	4	a	a	DET
ajlm-2104	191	5	complete	complete	ADJ
ajlm-2104	191	6	blood	blood	NOUN
ajlm-2104	191	7	count	count	NOUN
ajlm-2104	191	8	(	(	PUNCT
ajlm-2104	191	9	cbc	cbc	PROPN
ajlm-2104	191	10	)	)	PUNCT
ajlm-2104	191	11	for	for	ADP
ajlm-2104	191	12	sepsis	sepsis	NOUN
ajlm-2104	191	13	diagnosis	diagnosis	NOUN
ajlm-2104	191	14	and	and	CCONJ
ajlm-2104	191	15	prognosis	prognosis	NOUN
ajlm-2104	191	16	.	.	PUNCT
ajlm-2104	192	1	diagnostics	diagnostic	NOUN
ajlm-2104	192	2	.	.	PUNCT
ajlm-2104	193	1	2021;11(10):1881	2021;11(10):1881	X
ajlm-2104	193	2	.	.	X
ajlm-2104	193	3	https://doi.org/10.3390/diagnostics11101881	https://doi.org/10.3390/diagnostics11101881	PROPN
ajlm-2104	193	4	shen	shen	PROPN
ajlm-2104	193	5	xf	xf	PROPN
ajlm-2104	193	6	,	,	PUNCT
ajlm-2104	193	7	cao	cao	PROPN
ajlm-2104	193	8	k	k	PROPN
ajlm-2104	193	9	,	,	PUNCT
ajlm-2104	193	10	jiang	jiang	PROPN
ajlm-2104	193	11	jp	jp	PROPN
ajlm-2104	193	12	,	,	PUNCT
ajlm-2104	193	13	guan	guan	PROPN
ajlm-2104	193	14	wx	wx	PROPN
ajlm-2104	193	15	,	,	PUNCT
ajlm-2104	193	16	du	du	PROPN
ajlm-2104	193	17	jf	jf	PROPN
ajlm-2104	193	18	.	.	PROPN
ajlm-2104	194	1	neutrophil	neutrophil	PROPN
ajlm-2104	194	2	dysregulation	dysregulation	NOUN
ajlm-2104	194	3	during	during	ADP
ajlm-2104	194	4	sepsis	sepsis	NOUN
ajlm-2104	194	5	:	:	PUNCT
ajlm-2104	194	6	an	an	DET
ajlm-2104	194	7	overview	overview	NOUN
ajlm-2104	194	8	and	and	CCONJ
ajlm-2104	194	9	update	update	NOUN
ajlm-2104	194	10	.	.	PUNCT
ajlm-2104	195	1	j	j	PROPN
ajlm-2104	195	2	cell	cell	PROPN
ajlm-2104	195	3	mol	mol	ADP
ajlm-2104	195	4	med	med	PROPN
ajlm-2104	195	5	.	.	PUNCT
ajlm-2104	196	1	2017;21(9):1687–1697	2017;21(9):1687–1697	NUM
ajlm-2104	196	2	.	.	PUNCT
ajlm-2104	197	1	https://doi.org/10.1111/jcmm.13112	https://doi.org/10.1111/jcmm.13112	ADJ
ajlm-2104	197	2	fondoh	fondoh	PROPN
ajlm-2104	197	3	vn	vn	PROPN
ajlm-2104	197	4	,	,	PUNCT
ajlm-2104	197	5	fondoh	fondoh	PROPN
ajlm-2104	197	6	rm	rm	PROPN
ajlm-2104	197	7	,	,	PUNCT
ajlm-2104	197	8	awasom	awasom	VERB
ajlm-2104	197	9	cn	cn	PROPN
ajlm-2104	197	10	,	,	PUNCT
ajlm-2104	197	11	et	et	PROPN
ajlm-2104	197	12	al	al	PROPN
ajlm-2104	197	13	.	.	PUNCT
ajlm-2104	198	1	haematological	haematological	ADJ
ajlm-2104	198	2	reference	reference	NOUN
ajlm-2104	198	3	intervals	interval	NOUN
ajlm-2104	198	4	for	for	ADP
ajlm-2104	198	5	healthy	healthy	ADJ
ajlm-2104	198	6	adults	adult	NOUN
ajlm-2104	198	7	in	in	ADP
ajlm-2104	198	8	bamenda	bamenda	NOUN
ajlm-2104	198	9	,	,	PUNCT
ajlm-2104	198	10	cameroon	cameroon	PROPN
ajlm-2104	198	11	.	.	PUNCT
ajlm-2104	199	1	afr	afr	PROPN
ajlm-2104	199	2	j	j	PROPN
ajlm-2104	199	3	lab	lab	PROPN
ajlm-2104	199	4	med	med	PROPN
ajlm-2104	199	5	.	.	PUNCT
ajlm-2104	200	1	2020;9(1):1193	2020;9(1):1193	X
ajlm-2104	200	2	.	.	PUNCT
ajlm-2104	201	1	https://doi.org/10.4102/ajlm.v9i1.1193	https://doi.org/10.4102/ajlm.v9i1.1193	PROPN
ajlm-2104	201	2	smit	smit	PROPN
ajlm-2104	201	3	fc	fc	PROPN
ajlm-2104	201	4	,	,	PUNCT
ajlm-2104	201	5	davison	davison	PROPN
ajlm-2104	201	6	gm	gm	PROPN
ajlm-2104	201	7	,	,	PUNCT
ajlm-2104	201	8	hoffmann	hoffmann	PROPN
ajlm-2104	201	9	m	m	PROPN
ajlm-2104	201	10	,	,	PUNCT
ajlm-2104	201	11	erasmus	erasmus	PROPN
ajlm-2104	201	12	rt	rt	PROPN
ajlm-2104	201	13	,	,	PUNCT
ajlm-2104	201	14	davids	davids	PROPN
ajlm-2104	201	15	s	s	PROPN
ajlm-2104	201	16	,	,	PUNCT
ajlm-2104	201	17	matsha	matsha	PROPN
ajlm-2104	201	18	te	te	PROPN
ajlm-2104	201	19	.	.	PUNCT
ajlm-2104	201	20	full	full	ADJ
ajlm-2104	201	21	blood	blood	NOUN
ajlm-2104	201	22	count	count	NOUN
ajlm-2104	201	23	and	and	CCONJ
ajlm-2104	201	24	white	white	ADJ
ajlm-2104	201	25	cell	cell	NOUN
ajlm-2104	201	26	differential	differential	NOUN
ajlm-2104	201	27	count	count	NOUN
ajlm-2104	201	28	reference	reference	NOUN
ajlm-2104	201	29	ranges	range	NOUN
ajlm-2104	201	30	obtained	obtain	VERB
ajlm-2104	201	31	from	from	ADP
ajlm-2104	201	32	a	a	DET
ajlm-2104	201	33	healthy	healthy	ADJ
ajlm-2104	201	34	urban	urban	ADJ
ajlm-2104	201	35	south	south	ADJ
ajlm-2104	201	36	african	african	ADJ
ajlm-2104	201	37	population	population	NOUN
ajlm-2104	201	38	residing	reside	VERB
ajlm-2104	201	39	in	in	ADP
ajlm-2104	201	40	the	the	DET
ajlm-2104	201	41	western	western	ADJ
ajlm-2104	201	42	cape	cape	NOUN
ajlm-2104	201	43	of	of	ADP
ajlm-2104	201	44	south	south	PROPN
ajlm-2104	201	45	africa	africa	PROPN
ajlm-2104	201	46	.	.	PUNCT
ajlm-2104	202	1	int	int	PROPN
ajlm-2104	202	2	j	j	PROPN
ajlm-2104	202	3	lab	lab	NOUN
ajlm-2104	202	4	hematol	hematol	NOUN
ajlm-2104	202	5	.	.	PUNCT
ajlm-2104	203	1	2019;41(5):635–641	2019;41(5):635–641	X
ajlm-2104	203	2	.	.	PUNCT
ajlm-2104	204	1	https://doi.org/10.1111/ijlh.13076	https://doi.org/10.1111/ijlh.13076	PROPN
ajlm-2104	204	2	forget	forget	VERB
ajlm-2104	204	3	p	p	NOUN
ajlm-2104	204	4	,	,	PUNCT
ajlm-2104	204	5	khalifa	khalifa	PROPN
ajlm-2104	204	6	c	c	NOUN
ajlm-2104	204	7	,	,	PUNCT
ajlm-2104	204	8	defour	defour	ADJ
ajlm-2104	204	9	jp	jp	NOUN
ajlm-2104	204	10	,	,	PUNCT
ajlm-2104	204	11	latinne	latinne	PROPN
ajlm-2104	204	12	d	d	PROPN
ajlm-2104	204	13	,	,	PUNCT
ajlm-2104	204	14	van	van	PROPN
ajlm-2104	204	15	pel	pel	PROPN
ajlm-2104	204	16	mc	mc	PROPN
ajlm-2104	204	17	,	,	PUNCT
ajlm-2104	204	18	de	de	PROPN
ajlm-2104	204	19	kock	kock	PROPN
ajlm-2104	204	20	m.	m.	NOUN
ajlm-2104	204	21	what	what	PRON
ajlm-2104	204	22	is	be	AUX
ajlm-2104	204	23	the	the	DET
ajlm-2104	204	24	normal	normal	ADJ
ajlm-2104	204	25	value	value	NOUN
ajlm-2104	204	26	of	of	ADP
ajlm-2104	204	27	the	the	DET
ajlm-2104	204	28	neutrophil	neutrophil	NOUN
ajlm-2104	204	29	-	-	PUNCT
ajlm-2104	204	30	to	to	ADP
ajlm-2104	204	31	-	-	PUNCT
ajlm-2104	204	32	lymphocyte	lymphocyte	ADJ
ajlm-2104	204	33	ratio	ratio	NOUN
ajlm-2104	204	34	?	?	PUNCT
ajlm-2104	205	1	bmc	bmc	ADJ
ajlm-2104	205	2	res	re	NOUN
ajlm-2104	205	3	notes	note	NOUN
ajlm-2104	205	4	.	.	PUNCT
ajlm-2104	206	1	2017;10(1):12	2017;10(1):12	X
ajlm-2104	206	2	.	.	X
ajlm-2104	206	3	https://doi.org/10.1186/s13104-016-2335-5	https://doi.org/10.1186/s13104-016-2335-5	NUM
ajlm-2104	206	4	ye	ye	PROPN
ajlm-2104	206	5	w	w	PROPN
ajlm-2104	206	6	,	,	PUNCT
ajlm-2104	206	7	chen	chen	PROPN
ajlm-2104	206	8	x	x	PROPN
ajlm-2104	206	9	,	,	PUNCT
ajlm-2104	206	10	huang	huang	PROPN
ajlm-2104	206	11	y	y	PROPN
ajlm-2104	206	12	,	,	PUNCT
ajlm-2104	206	13	et	et	PROPN
ajlm-2104	206	14	al	al	PROPN
ajlm-2104	206	15	.	.	PUNCT
ajlm-2104	207	1	the	the	DET
ajlm-2104	207	2	association	association	NOUN
ajlm-2104	207	3	between	between	ADP
ajlm-2104	207	4	neutrophil	neutrophil	NOUN
ajlm-2104	207	5	-	-	PUNCT
ajlm-2104	207	6	to	to	ADP
ajlm-2104	207	7	-	-	PUNCT
ajlm-2104	207	8	lymphocyte	lymphocyte	ADJ
ajlm-2104	207	9	count	count	NOUN
ajlm-2104	207	10	ratio	ratio	NOUN
ajlm-2104	207	11	and	and	CCONJ
ajlm-2104	207	12	mortality	mortality	NOUN
ajlm-2104	207	13	in	in	ADP
ajlm-2104	207	14	septic	septic	ADJ
ajlm-2104	207	15	patients	patient	NOUN
ajlm-2104	207	16	:	:	PUNCT
ajlm-2104	207	17	a	a	DET
ajlm-2104	207	18	retrospective	retrospective	ADJ
ajlm-2104	207	19	analysis	analysis	NOUN
ajlm-2104	207	20	of	of	ADP
ajlm-2104	207	21	the	the	DET
ajlm-2104	207	22	mimic	mimic	ADJ
ajlm-2104	207	23	-	-	PUNCT
ajlm-2104	207	24	iii	iii	NOUN
ajlm-2104	207	25	database	database	NOUN
ajlm-2104	207	26	.	.	PUNCT
ajlm-2104	208	1	j	j	PROPN
ajlm-2104	208	2	thorac	thorac	PROPN
ajlm-2104	208	3	dis	dis	PROPN
ajlm-2104	208	4	.	.	PUNCT
ajlm-2104	209	1	2020;12(5):1843–1855	2020;12(5):1843–1855	PROPN
ajlm-2104	209	2	.	.	PUNCT
ajlm-2104	210	1	https://doi.org/10.21037/jtd-20-1169	https://doi.org/10.21037/jtd-20-1169	PROPN
ajlm-2104	210	2	rehman	rehman	PROPN
ajlm-2104	210	3	fu	fu	PROPN
ajlm-2104	210	4	,	,	PUNCT
ajlm-2104	210	5	khan	khan	PROPN
ajlm-2104	210	6	a	a	PROPN
ajlm-2104	210	7	,	,	PUNCT
ajlm-2104	210	8	aziz	aziz	PROPN
ajlm-2104	210	9	a	a	X
ajlm-2104	210	10	,	,	PUNCT
ajlm-2104	210	11	iqbal	iqbal	PROPN
ajlm-2104	210	12	m	m	PROPN
ajlm-2104	210	13	,	,	PUNCT
ajlm-2104	210	14	mahmood	mahmood	PROPN
ajlm-2104	210	15	sbz	sbz	PROPN
ajlm-2104	210	16	,	,	PUNCT
ajlm-2104	210	17	ali	ali	PROPN
ajlm-2104	210	18	n.	n.	PROPN
ajlm-2104	210	19	neutrophils	neutrophil	NOUN
ajlm-2104	210	20	to	to	ADP
ajlm-2104	210	21	lymphocyte	lymphocyte	ADJ
ajlm-2104	210	22	ratio	ratio	NOUN
ajlm-2104	210	23	:	:	PUNCT
ajlm-2104	210	24	earliest	early	ADJ
ajlm-2104	210	25	and	and	CCONJ
ajlm-2104	210	26	efficacious	efficacious	ADJ
ajlm-2104	210	27	markers	marker	NOUN
ajlm-2104	210	28	of	of	ADP
ajlm-2104	210	29	sepsis	sepsis	NOUN
ajlm-2104	210	30	.	.	PUNCT
ajlm-2104	211	1	cureus	cureus	NOUN
ajlm-2104	211	2	.	.	PUNCT
ajlm-2104	212	1	2020;12(10):e10851	2020;12(10):e10851	NOUN
ajlm-2104	212	2	.	.	PUNCT
ajlm-2104	212	3	https://doi.org/10.7759/cureus.10851	https://doi.org/10.7759/cureus.10851	NOUN
ajlm-2104	212	4	buonacera	buonacera	NOUN
ajlm-2104	212	5	a	a	NOUN
ajlm-2104	212	6	,	,	PUNCT
ajlm-2104	212	7	stancanelli	stancanelli	PROPN
ajlm-2104	212	8	b	b	PROPN
ajlm-2104	212	9	,	,	PUNCT
ajlm-2104	212	10	colaci	colaci	PROPN
ajlm-2104	212	11	m	m	PRON
ajlm-2104	212	12	,	,	PUNCT
ajlm-2104	212	13	malatino	malatino	PROPN
ajlm-2104	212	14	l.	l.	PROPN
ajlm-2104	212	15	neutrophil	neutrophil	PROPN
ajlm-2104	212	16	to	to	ADP
ajlm-2104	212	17	lymphocyte	lymphocyte	ADJ
ajlm-2104	212	18	ratio	ratio	NOUN
ajlm-2104	212	19	:	:	PUNCT
ajlm-2104	212	20	an	an	DET
ajlm-2104	212	21	emerging	emerge	VERB
ajlm-2104	212	22	marker	marker	NOUN
ajlm-2104	212	23	of	of	ADP
ajlm-2104	212	24	the	the	DET
ajlm-2104	212	25	relationships	relationship	NOUN
ajlm-2104	212	26	between	between	ADP
ajlm-2104	212	27	the	the	DET
ajlm-2104	212	28	immune	immune	ADJ
ajlm-2104	212	29	system	system	NOUN
ajlm-2104	212	30	and	and	CCONJ
ajlm-2104	212	31	diseases	disease	NOUN
ajlm-2104	212	32	.	.	PUNCT
ajlm-2104	213	1	int	int	PROPN
ajlm-2104	213	2	j	j	PROPN
ajlm-2104	213	3	mol	mol	ADP
ajlm-2104	213	4	sci	sci	PROPN
ajlm-2104	213	5	.	.	PUNCT
ajlm-2104	214	1	2022;23(7):3636	2022;23(7):3636	PROPN
ajlm-2104	214	2	.	.	PUNCT
ajlm-2104	215	1	https://doi.org/10.3390/ijms23073636	https://doi.org/10.3390/ijms23073636	PROPN
ajlm-2104	215	2	liu	liu	PROPN
ajlm-2104	215	3	x	x	PROPN
ajlm-2104	215	4	,	,	PUNCT
ajlm-2104	215	5	shen	shen	PROPN
ajlm-2104	215	6	y	y	PROPN
ajlm-2104	215	7	,	,	PUNCT
ajlm-2104	215	8	wang	wang	PROPN
ajlm-2104	215	9	h	h	PROPN
ajlm-2104	215	10	,	,	PUNCT
ajlm-2104	215	11	ge	ge	PROPN
ajlm-2104	215	12	q	q	PROPN
ajlm-2104	215	13	,	,	PUNCT
ajlm-2104	215	14	fei	fei	PROPN
ajlm-2104	215	15	a	a	X
ajlm-2104	215	16	,	,	PUNCT
ajlm-2104	215	17	pan	pan	PROPN
ajlm-2104	215	18	s.	s.	PROPN
ajlm-2104	215	19	prognostic	prognostic	PROPN
ajlm-2104	215	20	significance	significance	NOUN
ajlm-2104	215	21	of	of	ADP
ajlm-2104	215	22	neutrophil	neutrophil	ADJ
ajlm-2104	215	23	-	-	PUNCT
ajlm-2104	215	24	to	to	ADP
ajlm-2104	215	25	-	-	PUNCT
ajlm-2104	215	26	lymphocyte	lymphocyte	ADJ
ajlm-2104	215	27	ratio	ratio	NOUN
ajlm-2104	215	28	in	in	ADP
ajlm-2104	215	29	patients	patient	NOUN
ajlm-2104	215	30	with	with	ADP
ajlm-2104	215	31	sepsis	sepsis	NOUN
ajlm-2104	215	32	:	:	PUNCT
ajlm-2104	215	33	a	a	DET
ajlm-2104	215	34	prospective	prospective	ADJ
ajlm-2104	215	35	observational	observational	ADJ
ajlm-2104	215	36	study	study	NOUN
ajlm-2104	215	37	.	.	PUNCT
ajlm-2104	216	1	mediat	mediat	PROPN
ajlm-2104	216	2	inflamm	inflamm	PROPN
ajlm-2104	216	3	.	.	PUNCT
ajlm-2104	217	1	2016;2016:8191254	2016;2016:8191254	NUM
ajlm-2104	217	2	.	.	PUNCT
ajlm-2104	218	1	https://doi.org/10.1155/2016/8191254	https://doi.org/10.1155/2016/8191254	PROPN
ajlm-2104	218	2	shalova	shalova	VERB
ajlm-2104	218	3	in	in	ADP
ajlm-2104	218	4	,	,	PUNCT
ajlm-2104	218	5	lim	lim	PROPN
ajlm-2104	218	6	jy	jy	PROPN
ajlm-2104	218	7	,	,	PUNCT
ajlm-2104	218	8	chittezhath	chittezhath	NOUN
ajlm-2104	218	9	m	m	PROPN
ajlm-2104	218	10	,	,	PUNCT
ajlm-2104	218	11	et	et	PROPN
ajlm-2104	218	12	al	al	PROPN
ajlm-2104	218	13	.	.	PUNCT
ajlm-2104	219	1	human	human	PROPN
ajlm-2104	219	2	monocytes	monocyte	NOUN
ajlm-2104	219	3	undergo	undergo	VERB
ajlm-2104	219	4	functional	functional	ADJ
ajlm-2104	219	5	re	re	NOUN
ajlm-2104	219	6	-	-	NOUN
ajlm-2104	219	7	programming	programming	ADJ
ajlm-2104	219	8	during	during	ADP
ajlm-2104	219	9	sepsis	sepsis	NOUN
ajlm-2104	219	10	mediated	mediate	VERB
ajlm-2104	219	11	by	by	ADP
ajlm-2104	219	12	hypoxia	hypoxia	NOUN
ajlm-2104	219	13	-	-	PUNCT
ajlm-2104	219	14	inducible	inducible	ADJ
ajlm-2104	219	15	factor-1α	factor-1α	PROPN
ajlm-2104	219	16	.	.	PUNCT
ajlm-2104	220	1	immunity	immunity	NOUN
ajlm-2104	220	2	.	.	PUNCT
ajlm-2104	221	1	2015;42(3):484–498	2015;42(3):484–498	PROPN
ajlm-2104	221	2	.	.	PUNCT
ajlm-2104	222	1	https://doi.org/10.1016/j.immuni.2015.02.001	https://doi.org/10.1016/j.immuni.2015.02.001	PROPN
ajlm-2104	222	2	cao	cao	PROPN
ajlm-2104	223	1	c	c	PROPN
ajlm-2104	223	2	,	,	PUNCT
ajlm-2104	223	3	yu	yu	PROPN
ajlm-2104	223	4	m	m	PROPN
ajlm-2104	223	5	,	,	PUNCT
ajlm-2104	223	6	chai	chai	NOUN
ajlm-2104	223	7	y.	y.	PROPN
ajlm-2104	223	8	pathological	pathological	ADJ
ajlm-2104	223	9	alteration	alteration	NOUN
ajlm-2104	223	10	and	and	CCONJ
ajlm-2104	223	11	therapeutic	therapeutic	ADJ
ajlm-2104	223	12	implications	implication	NOUN
ajlm-2104	223	13	of	of	ADP
ajlm-2104	223	14	sepsis	sepsis	NOUN
ajlm-2104	223	15	-	-	PUNCT
ajlm-2104	223	16	induced	induce	VERB
ajlm-2104	223	17	immune	immune	ADJ
ajlm-2104	223	18	cell	cell	NOUN
ajlm-2104	223	19	apoptosis	apoptosis	NOUN
ajlm-2104	223	20	.	.	PUNCT
ajlm-2104	224	1	cell	cell	NOUN
ajlm-2104	224	2	death	death	NOUN
ajlm-2104	224	3	dis	dis	PROPN
ajlm-2104	224	4	.	.	PUNCT
ajlm-2104	225	1	2019;10:782	2019;10:782	X
ajlm-2104	225	2	.	.	PUNCT
ajlm-2104	226	1	https://doi.org/10.1038/s41419-019-2015-1	https://doi.org/10.1038/s41419-019-2015-1	PROPN
ajlm-2104	226	2	wang	wang	PROPN
ajlm-2104	226	3	jl	jl	PROPN
ajlm-2104	226	4	,	,	PUNCT
ajlm-2104	226	5	lu	lu	PROPN
ajlm-2104	226	6	xy	xy	PROPN
ajlm-2104	226	7	,	,	PUNCT
ajlm-2104	226	8	xu	xu	PROPN
ajlm-2104	226	9	xh	xh	PROPN
ajlm-2104	226	10	,	,	PUNCT
ajlm-2104	226	11	et	et	PROPN
ajlm-2104	226	12	al	al	PROPN
ajlm-2104	226	13	.	.	PROPN
ajlm-2104	226	14	predictive	predictive	ADJ
ajlm-2104	226	15	role	role	NOUN
ajlm-2104	226	16	of	of	ADP
ajlm-2104	226	17	monocyte	monocyte	NOUN
ajlm-2104	226	18	-	-	PUNCT
ajlm-2104	226	19	to	to	ADP
ajlm-2104	226	20	-	-	PUNCT
ajlm-2104	226	21	lymphocyte	lymphocyte	ADJ
ajlm-2104	226	22	ratio	ratio	NOUN
ajlm-2104	226	23	in	in	ADP
ajlm-2104	226	24	patients	patient	NOUN
ajlm-2104	226	25	with	with	ADP
ajlm-2104	226	26	klebsiella	klebsiella	NOUN
ajlm-2104	226	27	pneumonia	pneumonia	NOUN
ajlm-2104	226	28	infection	infection	NOUN
ajlm-2104	226	29	.	.	PUNCT
ajlm-2104	227	1	medicine	medicine	NOUN
ajlm-2104	227	2	.	.	PUNCT
ajlm-2104	228	1	2019;98(38):e17215	2019;98(38):e17215	X
ajlm-2104	228	2	.	.	PUNCT
ajlm-2104	229	1	https://doi.org/10.1097/md.0000000000017215	https://doi.org/10.1097/md.0000000000017215	PROPN
ajlm-2104	229	2	djordjevic	djordjevic	PROPN
ajlm-2104	229	3	d	d	PROPN
ajlm-2104	229	4	,	,	PUNCT
ajlm-2104	229	5	rondovic	rondovic	VERB
ajlm-2104	229	6	g	g	PROPN
ajlm-2104	229	7	,	,	PUNCT
ajlm-2104	229	8	surbatovic	surbatovic	PROPN
ajlm-2104	229	9	m	m	PROPN
ajlm-2104	229	10	,	,	PUNCT
ajlm-2104	229	11	et	et	PROPN
ajlm-2104	229	12	al	al	PROPN
ajlm-2104	229	13	.	.	PROPN
ajlm-2104	230	1	neutrophil	neutrophil	PROPN
ajlm-2104	230	2	-	-	PUNCT
ajlm-2104	230	3	to	to	ADP
ajlm-2104	230	4	-	-	PUNCT
ajlm-2104	230	5	lymphocyte	lymphocyte	NOUN
ajlm-2104	230	6	ratio	ratio	NOUN
ajlm-2104	230	7	,	,	PUNCT
ajlm-2104	230	8	monocyte	monocyte	NOUN
ajlm-2104	230	9	-	-	PUNCT
ajlm-2104	230	10	to	to	ADP
ajlm-2104	230	11	-	-	PUNCT
ajlm-2104	230	12	lymphocyte	lymphocyte	NOUN
ajlm-2104	230	13	ratio	ratio	NOUN
ajlm-2104	230	14	,	,	PUNCT
ajlm-2104	230	15	platelet	platelet	NOUN
ajlm-2104	230	16	-	-	PUNCT
ajlm-2104	230	17	to	to	ADP
ajlm-2104	230	18	-	-	PUNCT
ajlm-2104	230	19	lymphocyte	lymphocyte	NOUN
ajlm-2104	230	20	ratio	ratio	NOUN
ajlm-2104	230	21	,	,	PUNCT
ajlm-2104	230	22	and	and	CCONJ
ajlm-2104	230	23	mean	mean	VERB
ajlm-2104	230	24	platelet	platelet	NOUN
ajlm-2104	230	25	volume	volume	NOUN
ajlm-2104	230	26	-	-	PUNCT
ajlm-2104	230	27	to	to	ADP
ajlm-2104	230	28	-	-	PUNCT
ajlm-2104	230	29	platelet	platelet	NOUN
ajlm-2104	230	30	count	count	NOUN
ajlm-2104	230	31	ratio	ratio	NOUN
ajlm-2104	230	32	as	as	ADP
ajlm-2104	230	33	biomarkers	biomarker	NOUN
ajlm-2104	230	34	in	in	ADP
ajlm-2104	230	35	critically	critically	ADV
ajlm-2104	230	36	ill	ill	ADJ
ajlm-2104	230	37	and	and	CCONJ
ajlm-2104	230	38	injured	injured	ADJ
ajlm-2104	230	39	patients	patient	NOUN
ajlm-2104	230	40	:	:	PUNCT
ajlm-2104	230	41	which	which	DET
ajlm-2104	230	42	ratio	ratio	NOUN
ajlm-2104	230	43	to	to	PART
ajlm-2104	230	44	choose	choose	VERB
ajlm-2104	230	45	to	to	PART
ajlm-2104	230	46	predict	predict	VERB
ajlm-2104	230	47	outcome	outcome	NOUN
ajlm-2104	230	48	and	and	CCONJ
ajlm-2104	230	49	nature	nature	NOUN
ajlm-2104	230	50	of	of	ADP
ajlm-2104	230	51	bacteremia	bacteremia	NOUN
ajlm-2104	230	52	?	?	PUNCT
ajlm-2104	231	1	mediat	mediat	PROPN
ajlm-2104	231	2	inflamm	inflamm	PROPN
ajlm-2104	231	3	.	.	PUNCT
ajlm-2104	232	1	2018;2018:3758068	2018;2018:3758068	NUM
ajlm-2104	232	2	.	.	PUNCT
ajlm-2104	233	1	https://doi.org/10.1155/2018/3758068	https://doi.org/10.1155/2018/3758068	VERB
ajlm-2104	233	2	naess	naess	ADV
ajlm-2104	233	3	a	a	PRON
ajlm-2104	233	4	,	,	PUNCT
ajlm-2104	233	5	nilssen	nilssen	NOUN
ajlm-2104	233	6	ss	ss	PROPN
ajlm-2104	233	7	,	,	PUNCT
ajlm-2104	233	8	mo	mo	PROPN
ajlm-2104	233	9	r	r	PROPN
ajlm-2104	233	10	,	,	PUNCT
ajlm-2104	233	11	eide	eide	PROPN
ajlm-2104	233	12	ge	ge	PROPN
ajlm-2104	233	13	,	,	PUNCT
ajlm-2104	233	14	sjursen	sjursen	NOUN
ajlm-2104	233	15	h.	h.	PROPN
ajlm-2104	233	16	role	role	NOUN
ajlm-2104	233	17	of	of	ADP
ajlm-2104	233	18	neutrophil	neutrophil	NOUN
ajlm-2104	233	19	to	to	ADP
ajlm-2104	233	20	lymphocyte	lymphocyte	NOUN
ajlm-2104	233	21	and	and	CCONJ
ajlm-2104	233	22	monocyte	monocyte	NOUN
ajlm-2104	233	23	to	to	ADP
ajlm-2104	233	24	lymphocyte	lymphocyte	ADJ
ajlm-2104	233	25	ratios	ratio	NOUN
ajlm-2104	233	26	in	in	ADP
ajlm-2104	233	27	the	the	DET
ajlm-2104	233	28	diagnosis	diagnosis	NOUN
ajlm-2104	233	29	of	of	ADP
ajlm-2104	233	30	bacterial	bacterial	ADJ
ajlm-2104	233	31	infection	infection	NOUN
ajlm-2104	233	32	in	in	ADP
ajlm-2104	233	33	patients	patient	NOUN
ajlm-2104	233	34	with	with	ADP
ajlm-2104	233	35	fever	fever	NOUN
ajlm-2104	233	36	.	.	PUNCT
ajlm-2104	234	1	infection	infection	NOUN
ajlm-2104	234	2	.	.	PUNCT
ajlm-2104	235	1	2017;45(3):299–307	2017;45(3):299–307	X
ajlm-2104	235	2	.	.	PUNCT
ajlm-2104	236	1	https://doi.org/10.1007/s15010-016-0972-1	https://doi.org/10.1007/s15010-016-0972-1	PROPN
ajlm-2104	236	2	kim	kim	PROPN
ajlm-2104	236	3	s	s	PROPN
ajlm-2104	236	4	-	-	PROPN
ajlm-2104	236	5	j	j	PROPN
ajlm-2104	236	6	,	,	PUNCT
ajlm-2104	236	7	davis	davis	PROPN
ajlm-2104	236	8	r	r	PROPN
ajlm-2104	236	9	,	,	PUNCT
ajlm-2104	236	10	jenne	jenne	NOUN
ajlm-2104	236	11	cn	cn	PROPN
ajlm-2104	236	12	.	.	PUNCT
ajlm-2104	236	13	platelets	platelet	NOUN
ajlm-2104	236	14	as	as	ADP
ajlm-2104	236	15	modulators	modulator	NOUN
ajlm-2104	236	16	of	of	ADP
ajlm-2104	236	17	inflammation	inflammation	NOUN
ajlm-2104	236	18	.	.	PUNCT
ajlm-2104	237	1	semin	semin	PROPN
ajlm-2104	237	2	thromb	thromb	PROPN
ajlm-2104	237	3	hemost	hemost	PROPN
ajlm-2104	237	4	.	.	PUNCT
ajlm-2104	238	1	2017;44(2):91–101	2017;44(2):91–101	PRON
ajlm-2104	238	2	.	.	PUNCT
ajlm-2104	239	1	https://doi.org/10.1055/s-0037-1607432	https://doi.org/10.1055/s-0037-1607432	PROPN
ajlm-2104	239	2	claushuis	claushuis	PROPN
ajlm-2104	239	3	ta	ta	PROPN
ajlm-2104	239	4	,	,	PUNCT
ajlm-2104	239	5	van	van	PROPN
ajlm-2104	239	6	vught	vught	PROPN
ajlm-2104	239	7	la	la	PROPN
ajlm-2104	239	8	,	,	PUNCT
ajlm-2104	239	9	scicluna	scicluna	PROPN
ajlm-2104	239	10	bp	bp	PROPN
ajlm-2104	239	11	,	,	PUNCT
ajlm-2104	239	12	et	et	PROPN
ajlm-2104	239	13	al	al	PROPN
ajlm-2104	239	14	.	.	PUNCT
ajlm-2104	240	1	thrombocytopenia	thrombocytopenia	PROPN
ajlm-2104	240	2	is	be	AUX
ajlm-2104	240	3	associated	associate	VERB
ajlm-2104	240	4	with	with	ADP
ajlm-2104	240	5	a	a	DET
ajlm-2104	240	6	dysregulated	dysregulate	VERB
ajlm-2104	240	7	host	host	NOUN
ajlm-2104	240	8	response	response	NOUN
ajlm-2104	240	9	in	in	ADP
ajlm-2104	240	10	critically	critically	ADV
ajlm-2104	240	11	ill	ill	ADJ
ajlm-2104	240	12	sepsis	sepsis	NOUN
ajlm-2104	240	13	patients	patient	NOUN
ajlm-2104	240	14	.	.	PUNCT
ajlm-2104	241	1	blood	blood	NOUN
ajlm-2104	241	2	.	.	PUNCT
ajlm-2104	242	1	2016;127(24):3062–3072	2016;127(24):3062–3072	NUM
ajlm-2104	242	2	.	.	PUNCT
ajlm-2104	242	3	https://doi.org/10.1182/blood-2015-11-680744	https://doi.org/10.1182/blood-2015-11-680744	NUM
ajlm-2104	242	4	shen	shen	PROPN
ajlm-2104	243	1	y	y	PROPN
ajlm-2104	243	2	,	,	PUNCT
ajlm-2104	243	3	huang	huang	PROPN
ajlm-2104	243	4	x	x	PROPN
ajlm-2104	243	5	,	,	PUNCT
ajlm-2104	243	6	zhang	zhang	PROPN
ajlm-2104	243	7	w.	w.	PROPN
ajlm-2104	243	8	platelet	platelet	PROPN
ajlm-2104	243	9	-	-	PUNCT
ajlm-2104	243	10	to	to	ADP
ajlm-2104	243	11	-	-	PUNCT
ajlm-2104	243	12	lymphocyte	lymphocyte	NOUN
ajlm-2104	243	13	ratio	ratio	NOUN
ajlm-2104	243	14	as	as	ADP
ajlm-2104	243	15	a	a	DET
ajlm-2104	243	16	prognostic	prognostic	ADJ
ajlm-2104	243	17	predictor	predictor	NOUN
ajlm-2104	243	18	of	of	ADP
ajlm-2104	243	19	mortality	mortality	NOUN
ajlm-2104	243	20	for	for	ADP
ajlm-2104	243	21	sepsis	sepsis	NOUN
ajlm-2104	243	22	:	:	PUNCT
ajlm-2104	243	23	interaction	interaction	NOUN
ajlm-2104	243	24	effect	effect	NOUN
ajlm-2104	243	25	with	with	ADP
ajlm-2104	243	26	disease	disease	NOUN
ajlm-2104	243	27	severity	severity	NOUN
ajlm-2104	243	28	–	–	PUNCT
ajlm-2104	243	29	a	a	DET
ajlm-2104	243	30	retrospective	retrospective	ADJ
ajlm-2104	243	31	study	study	NOUN
ajlm-2104	243	32	.	.	PUNCT
ajlm-2104	244	1	bmj	bmj	PROPN
ajlm-2104	244	2	open	open	ADJ
ajlm-2104	244	3	.	.	PUNCT
ajlm-2104	245	1	2019;9	2019;9	NUM
ajlm-2104	245	2	:	:	PUNCT
ajlm-2104	245	3	e022896	e022896	NOUN
ajlm-2104	245	4	.	.	PUNCT
ajlm-2104	246	1	https://doi.org/10.1136/bmjopen-2018-022896	https://doi.org/10.1136/bmjopen-2018-022896	PROPN
ajlm-2104	246	2	mahoney	mahoney	PROPN
ajlm-2104	246	3	m	m	PROPN
ajlm-2104	246	4	,	,	PUNCT
ajlm-2104	246	5	magel	magel	PROPN
ajlm-2104	246	6	r.	r.	PROPN
ajlm-2104	246	7	estimation	estimation	NOUN
ajlm-2104	246	8	of	of	ADP
ajlm-2104	246	9	the	the	DET
ajlm-2104	246	10	power	power	NOUN
ajlm-2104	246	11	of	of	ADP
ajlm-2104	246	12	the	the	DET
ajlm-2104	246	13	kruskal	kruskal	PROPN
ajlm-2104	246	14	-	-	PUNCT
ajlm-2104	246	15	wallis	wallis	PROPN
ajlm-2104	246	16	test	test	NOUN
ajlm-2104	246	17	.	.	PUNCT
ajlm-2104	247	1	biom	biom	PROPN
ajlm-2104	247	2	j.	j.	PROPN
ajlm-2104	247	3	1996;38(5):613–630	1996;38(5):613–630	PROPN
ajlm-2104	247	4	.	.	PUNCT
ajlm-2104	248	1	https://doi.org/10.1002/bimj.4710380510	https://doi.org/10.1002/bimj.4710380510	ADJ
ajlm-2104	248	2	gürol	gürol	VERB
ajlm-2104	248	3	g	g	NOUN
ajlm-2104	248	4	,	,	PUNCT
ajlm-2104	248	5	çiftci	çiftci	NOUN
ajlm-2104	248	6	i̇h	i̇h	PROPN
ajlm-2104	248	7	,	,	PUNCT
ajlm-2104	248	8	terizi	terizi	NOUN
ajlm-2104	248	9	ha	ha	INTJ
ajlm-2104	248	10	,	,	PUNCT
ajlm-2104	248	11	atasoy	atasoy	PROPN
ajlm-2104	248	12	ar	ar	PROPN
ajlm-2104	248	13	,	,	PUNCT
ajlm-2104	248	14	ozbek	ozbek	NOUN
ajlm-2104	248	15	a	a	PROPN
ajlm-2104	248	16	,	,	PUNCT
ajlm-2104	248	17	köroğlu	köroğlu	PROPN
ajlm-2104	248	18	m.	m.	PROPN
ajlm-2104	248	19	are	be	AUX
ajlm-2104	248	20	there	there	ADV
ajlm-2104	248	21	standardised	standardised	ADJ
ajlm-2104	248	22	cut	cut	NOUN
ajlm-2104	248	23	-	-	PUNCT
ajlm-2104	248	24	off	off	ADP
ajlm-2104	248	25	values	value	NOUN
ajlm-2104	248	26	for	for	ADP
ajlm-2104	248	27	neutrophil	neutrophil	ADJ
ajlm-2104	248	28	-	-	PUNCT
ajlm-2104	248	29	lymphocyte	lymphocyte	ADJ
ajlm-2104	248	30	ratios	ratio	NOUN
ajlm-2104	248	31	in	in	ADP
ajlm-2104	248	32	bacteremia	bacteremia	NOUN
ajlm-2104	248	33	or	or	CCONJ
ajlm-2104	248	34	sepsis	sepsis	NOUN
ajlm-2104	248	35	?	?	PUNCT
ajlm-2104	249	1	j	j	PROPN
ajlm-2104	249	2	microbiol	microbiol	PROPN
ajlm-2104	249	3	biotechnol	biotechnol	NOUN
ajlm-2104	249	4	.	.	PUNCT
ajlm-2104	250	1	2015;25(4):521–525	2015;25(4):521–525	X
ajlm-2104	250	2	.	.	PUNCT
ajlm-2104	251	1	https://doi.org/10.4014/jmb.1408.08060	https://doi.org/10.4014/jmb.1408.08060	NOUN
ajlm-2104	251	2	samsudin	samsudin	VERB
ajlm-2104	251	3	i	i	PRON
ajlm-2104	251	4	,	,	PUNCT
ajlm-2104	251	5	vasikaran	vasikaran	NOUN
ajlm-2104	251	6	sd	sd	NOUN
ajlm-2104	251	7	.	.	PUNCT
ajlm-2104	252	1	clinical	clinical	ADJ
ajlm-2104	252	2	utility	utility	NOUN
ajlm-2104	252	3	and	and	CCONJ
ajlm-2104	252	4	measurement	measurement	NOUN
ajlm-2104	252	5	of	of	ADP
ajlm-2104	252	6	procalcitonin	procalcitonin	PROPN
ajlm-2104	252	7	.	.	PUNCT
ajlm-2104	253	1	clin	clin	PROPN
ajlm-2104	253	2	biochem	biochem	PROPN
ajlm-2104	253	3	rev	rev	VERB
ajlm-2104	253	4	.	.	PROPN
ajlm-2104	253	5	2017;38(2):59–68	2017;38(2):59–68	X
ajlm-2104	253	6	.	.	PUNCT